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Chapter I: Synthetic, Sequence Specific DNA Cleaving Peptides 
Synthetic peptides based on the sequence specific DNA binding domain of 
Hin recombinase have been prepared which are equiped with ethylenediaminete-
traacetic acid (EDTA) at the amino terminus. Covalent attachment of EDTA con-
verts the sequence specific DNA binding pep tides into peptides which are capable 
of DNA strand scission in the presence of iron II, a reducing agent and molecular 
oxygen. The EDTA-equiped peptides cleave DNA at Hin binding sites and provide 
information on the nucleotide postion and groove identity of the modified amino 
acid residue when bound to DNA. The EDTA-peptides were also competent at 
DNA double strand cleavage, which is a useful characteristic for identifying bind-
ing sites on large DNA fragments ( >5000 base pairs) . A general procedure for the 
incorporation of an EDTA equiped lysine residue at any position in a synthetic 
peptide is also described. 
Results with 22 synthetic peptides indicate that Hin specifically recognizes a 
minor groove 5'-AAA sequence in its binding site with the peptide sequence Arg-
Pro-Arg. Furthermore, the minor groove recognition event contributes substan-
tially to the overall binding affinity. The possibility that minor groove recognition 
of tracks of A's by the peptide sequence Arg-Pro- Arg (and similar sequences), 
may be a common recognition motif in sequence specific DNA binding proteins is 
discussed. 
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Chapter II: Distamycin-Actinomycin Hybrid Affinity Cleaving Molecules 
One approach to the design of sequence specific DNA binding molecules that 
read large sequences of double helical DNA is to couple DNA binding units of 
similar or diverse base pair specificities . Covalent attachment of his- and tris-N-
methylpyrrolecarboxamides (based on the sequence specific DNA binding antibi-
otics Netropsin and Distamycin) and an aromatic phenoxazone intercalator (based 
on the sequence specific DNA intercalator Actinomycin) creates hybrid DNA bind-
ing minor groove and intercalation compounds. Using the affinity cleaving method 
we find that a first generation hybrid, bis-(EDTA-distamycin-glycyl)phenoxazone, 
binds the sequence 51- TTATGGTTAA-3' which is consistent with simultaneous mi-
nor groove binding of the two tripyrrolecarboxamide units and intercalation of the 
phenoxazone moeity. Along with the targeted trimeric binding, the first genera-
tion hybrid also gave substantial monomeric/ dimeric binding, and exihibited only 
modest sequence specificity on large DNA fragments. 
In an attempt to reduce monomeric and dimeric binding, a second generation 
hybrid was prepared. Replacement of one pyrrolecarboxamide with a 1 aminobu-
tyric acid moeity, bis(EDTA-netropsin-glycyl)phenoxazone, generated a hybrid 
molecule which showed a reduced tendency for monomeric and dimeric DNA 
binding modes. The second generation hybrid binds to sequences of the form 
5'-(A/ T) 4GT(A/ T) 4-3' and 5'-(A/ T)4CT(A/ T)4-3' and showed substantially im-
proved sequence specificity on large DNA fragments relative to the first generation 
hybrid. 
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Chapter III: Bleomycin-Distamycin Hybrid Affinity Cleaving Molecules 
Hybrids of the sequence specific DNA binding bithiazole domain of Bleomycin 
and tris-N-methylpyrrolecarboxamide of Distamycin are described. The hybrids 
address the issue of whether or not the bithiazole unit of the GC specific Bleomycin 
is a minor groove binding function. By the affinity cleaving method we find that 
hybrids in which the bithiazole is attached to either the amino or carboxy terminus 
of the tris-N-methylpyrrolecarboxamide, do not significantly alter the sequence 
specificity of the pyrrolecarboxamide domain. The results indicate that either the 
bithiazole unit is not a minor groove binding function in the same sense as the 
tripyrrolecarboxamide, or, alternatively, the bithiazole does not include all of the 
required sequence specific DNA recognition elements of Bleomycin. 
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Chapter IV: Studies in Metalloporphyrin Mediated Affinity Cleaving 
Metalloporphyrins are known to cause DNA strand scission using a variety of 
central metals, and various reducing and oxidizing cofactors. To investigate if a 
metalloporphyrin can replace an EDTA•Fe chelate in an affinity cleaving molecule, 
a metalloporphyrin-Distamycin (PD) was prepared. PD•Fe showed very ineffi-
cient DNA cleavage compared to EDTA•Fe equiped affinity cleaving compounds. 
Additionally, PD•Fe showed no detectable sequence specific DNA cleaving ability. 
PD• Fe was also less efficient at DNA strand scission than ferriprotoporphyrin it-
self, which indicates that the DNA binding domain (tripyrrolecarboxamide) and 
cleaving domain (metalloporphyrin) are interfering with each other's function in 
the affinity cleaving compounds. 
-Vll-
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CHAPTER 1: 
Synthetic, Sequence Specific DNA Cleaving Peptides 
The interaction between DNA and DNA binding proteins is critical in the 
transfer of genetic information between the DNA "data base" and the "real word" 
of cellular function. Protein-DNA interactions are critical in DNA manipulations 
including packaging in nucleosomes, genomic rearrangements, transcription and 
replication. The sequence specificity of DNA binding proteins, i.e. the ability to 
differentiate between different DNA sequences, ranges from little or none in the 
histone like proteins responsible for chromatin formation, to the exquisite sequence 
specificity of the type I restriction endonucleases. The work described herein in-
vestigates the nature of DNA-protein interactions in general and sequence specific 
interaction in particular. Questions which are addressed include, the ability to 
sequence specifically deliver a chemicaly active group via a sequence specific DNA 
binding protein, the minimum peptide domain which is competent at sequence 
specific DNA recognition and the nature of particular DNA-protein interactions. 
My primary focus will be the conversion of a sequence specific DNA bind-
ing peptide (based on a naturally occuring protein) into a sequence specific DNA 
cleaving peptide. This conversion was accomplished through incorporation of the 
metal chelator ethylenediaminetetraacetic acid (EDTA) in the peptide. I will also 
examine the effect of peptide size on sequence specific DNA recognition and the 
-2-
feasibility of positioning the EDTA moiety at various locations in the peptide. Re-
cently a synthetic 52 amino acid peptide (139-+190; HIN52) based on the carboxy 
terminus of Hin recombinase (190 amino acids) has been shown to both bind to 
Hin recombination sites and to inhibit Hin activity. 1 I was interested in conversion 
of the HIN52, and related peptides, into sequence specific DNA cleaving peptides. 
The general features of double stranded DNA and protein structures allow 
one to predict the types of interactions which may occur between the two.2 (1) 
Ionic interactions between positively charged amino acid side chains and the DNA 
phosphate backbone would be strong, though generally nonspecific interactions, 
as would salt bridges with metal ions between negatively charged amino acid side 
chains and the phosphate backbone.3 (2) Hydrogen bonding between peptide back-
bone and/or side chains and the DNA phosphate backbone or the exposed edges of 
the bases in the minor and major grooves of the DNA, (3) hydrophobic interactions 
between protein side chains and the bases or sugars, and ( 4) intercalation (stack-
ing) of aromatic side chains between the nucleotide bases would all be potentially 
specific interactions. It appears that the greatest potential for sequence specific 
recognition occurs in the major and minor grooves of the DNA where the exposed 
edges of the bases present unique hydrogen bond donor/acceptor and hydrophobic 
contact patterns. Lists of potential hydrogen bond interactions between amino 
acid side chains and the exposed edges of the DNA bases have been compiled.4 - 6 
Predictions can also be made as to the types of protein secondary structure 
which may be important in DNA binding. It has been observed that a protein 
{3 sheet should fit in/above the minor groove of B-form DNA.7 The relative dimen-
sions and twist, and the anti-parallel nature of both a two-stranded antiparallel 
{3 sheet and the phosphate backbone are similar. Side chains along each strand of 
-3-
the {3 sheet would alternately be directed into and out of the DNA minor groove . 
Model building studies indicate that only proline and tryptophan could not be 
accommodated in the space between the minor groove and the {3 sheet .7 
It has also been noted that a protein a helix has the proper width to fit in 
the B-form DNA major groove.8 Since an a helix has a pronounced dipole moment 
which points toward the carboxy terminus, i.e. a net positive charge at the amino 
terminus,9 and the side chains also point towards the amino terminus, it would 
seem that an a helix would prefer to point its amino terminus into the DNA 
groove more so than the carboxy terminus. 
Another type of potential interaction is recognition of a particular DNA con-
formation by a protein. Structural recognition could range from detection of gross 
differences such as A versus B-form DNA to detection of more subtle differences 
such as sequence dependent variations in the groove widths, depth and helical rise 
of the DNA. Recently it has been proposed that sequence dependent DNA stiffness 
may also affect protein binding. 10 If tight protein binding induces a DNA confor-
mational change then the plasticity of the DNA, both in regions directly contacted, 
and in flanking sequences, could be an important factor. 
Several non-sequence specific DNA binding protein structures have been de-
termined by x-ray crystallography. These include the 2.3A resolution single 
stranded DNA binding protein product of Gene 5 from bacteriophage fd (87 amino 
acids), 11•12 the eukaryote nucleosome particle co crystal with DNA which contains 
two copies each of four proteins (H2A, H2B, H3 and H4) at 7 A resolution, 13 - 15 
the putative procaryote histone-like protein HU (90 amino acids) from Bacillus 
Stearothermophilus, 16 bovine pancreatic deoxyribonuclease I (DNase I, 257 amino 
-4-
acids) 17 and the Klenow fragment of DNA ploymerase I from E. Coli (~600 amino 
acids, 3.2A resolution).18,19 
Sequence Specific DNA Binding Protein Structures 
In recent years a number of x-ray crystal structures of sequence specific DNA 
binding proteins (or fragments thereof) have become available. The first three 
structures determined were DNA regulatory proteins: .\ Cro (66 amino acids) ,20- 22 
residues 1 through 92 (1-+92) of.\ repressor (236 amino acids, also called .\ ci) 23,24 
from.\ phage and the 210 amino acid catabolite gene activator protein (CAP).25- 27 
It was soon recognized that all three crystal structures had several features in 
common (see figure 1). (1) All were dimeric and C2 symmetric structures. (2) Each 
monomer contained an a helix-turn-a helix structure which was superimposable 
in the three structures. (3) The second helix of the helix-turn-helix domain had 
one face exposed to solvent and the other buried within the protein. ( 4) Both 
exposed helices within the dimeric unit were on the same face of the protein. 
(5) The seperation between the symmetrically related helices in the dimers was 
~34A which closely matches the major groove repeat distance of B-form DNA. (6) 
In both .\ Cro and .\ repressor the exposed helix is tilted approximately 30° with 
respect to the long dimension of the dimer, which closely resembles the slope of 
the B-form DNA backbone. The CAP helices, however, are tilted in the opposite 
direction. 
These similarities, along with chemical protection data from DNA complexes 
and other solution studies, led to the hypothesis that the symmetrically related 
exposed helices of the dimers (second helix of the helix-turn-helix) bind in adja-




Cro CAP ci 
Figure 1: Schematic drawings of B-form DNA and the structures of A Cro, CAP 
and A repressor ( cl). The helix-turn-helix domains are a 2-a3 for A Cro and A re-
pressor, and aE-aF for CAP.28 The view of the proteins is of the face which 
interacts with the DNA. In the stylized DNA drawing, phosphates which when 
ethylated hinder Cro binding are marked, as well as G's which are protected from 
dimethyl sulfate by Cro (major groove). 
recognition elements.28- 30 The first helix of the helix-turn-helix motif partially 
covers the binding helix and would stradle the DNA major groove. 
The conservation of the helix-turn-helix motif between these three regula-
tory proteins prompted searches through other proteins for similar amino acid 
sequences. It was found that homologous sequences were very common in DNA 
regulatory proteins but rare in other proteins.30 Table 1 shows an alignment of the 
putative helix-turn-helix domains of 16 sequence specific DNA binding proteins. 
The residues can be divided into three major classes: (1) residues involved (re-
quired) for the turn between helices and which may or may not contact the DNA, 
(2) residues which are internal to the protein, i.e. part of the hydrophobic core and 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2: a Carbon trace of the helix-turn-helix domain of A Cro (monomer 
B) .20•21 This domain is nearly superimposable on the equivalent regions of CAP 
and A repressor. (Top) Two dimensional projection of the helix-turn-helix with 
the residues numbered N to C as in Table 1. The three residues in the turn are 
shaded and the approximate extent of the two a helices marked with dashed lines. 
(Bottom) Stereo view of the helix-turn-helix. In both drawings the view is the 
same as that which the DNA major groove sees; the binding helix is the nearer of 
the two and parallel to the plane of the page, the first helix is behind the binding 
helix. 
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The first class, residues in the turn, was originally thought to require a glycine 
at position 11 (see Table 1 and figure 2), the first position of the three residue turn, 
due to the unusual backbone conformation (¢>=60°, ,P=44°) common for glycine 
but unusual for other residues.30 However it has been shown that a double mu-
tant of ). repressor containing Asp38-.Asn (position 8, Table 1 and figure 2) and 
Gly41-.Glu (position 11) is functional.31 This example points out the difficulty of 
predicting structure from protein sequence similarities since multiple amino acid 
changes may be strongly interdependent. 
The second class of residues, those contributing to the hydrophobic contacts 
between the helices, are positions 6, 7 and 10 in the first helix and 17 and 20 in 
the second. Small hydrophobic residues in positions 7 and 17 in van der Waals 
contact, as well as the nature of the turn, maintain the correct interhelical angle. 
In position 20 is usually a bulky aromatic residue which also contributes to the 
hydrophobic core. Interestingly tryptophan repressor (TRP repressor) contains 
an atypical glycine at position 20 whereas most other binding proteins have large 
hydrophobic residues with a particular preference for tryptophan. TRP repres-
sor controls tryptophan biosynthesis by binding to the L-tryptophan biosynthetic 
operon in the presence of L-tryptophan.32 Recently the x-ray crystal structure of 
the TRP repressor with bound Trp has been solved and it is clear that Trp binds 
in the cavity in the hydrophobic core caused by substitution of Gly for Trp at 
position 20.33 
The third group of residues are those implicated as DNA contacts and are 
generally in positions 3, 4 and 8 in helix one, 13 (third residue of the turn), and 14, 
15, 16, 18, 19 and 22 in the second helix. These are frequently hydrophilic residues 
and 19 is usually positively charged. For). Cro various studies have implicated Gin 
-9-
16 (position 3), Thr 17 (4), Lys 21 (7), Tyr 26 (13) , Gin 27 (14) Ser 28 (15) , Asn 
31 (18), Lys 32 (19), His 35 (22) and Arg 38 (25) as DNA contacts. For>. repressor 
residues Gin 33 (13) , Gin 44 (14), Ser 45 (15), Ala 49 (19), Asn 52 (22) and Asn 
55 (25) and for CAP residues, Arg 180 (14), Glu 181 (15), Arg 185 (19) and Lys 
188 (22) have also been proposed as DNA contacts. 
DNA-Protein Cocrystal Structures 
More recently two DNA- protein cocrystal x-ray structures have been solved. 
The structure of the 1 -->69 fragment of coliphage 434 repressor (a close relative 
t o >. repressor) bound to a 14 base pair (bp) DNA oligomer supports the helix-
turn-helix binding model described above.34 In the cocrystal the 14bp oligomers 
are stacked end to end to form a psuedocontinous double helix and are B-DNA 
like.35 Two proteins bind as a dimer to each 14bp DNA unit. Helices a:2 and a:3 
are the helix-turn-helix domain and a:3 from each monomer lies in adjacent major 
grooves (see figure 3). The 14bp DNA fragment is overwound and slightly bent 
at its center causing the DNA to curl slightly around the peptide dimer and to 
narrow the minor groove. The DNA is slightly overwound at the ends. 
The protein is folded in such a way in the complex that the amino terminus of 
helices 2, 3 and 4 all point towards the DNA. Important sequence specific major 
groove contacts are made by three glutamine side chains from a:3 : Gln 28, Gln 29 
and Gln 33 (positions 14, 15 and 19 in Table 1 and figure 2). 
The other DNA- protein cocrystal determined recently is the complex between 
the 276 amino acid Eco RI endonuclease apoprotein (the protein is missing a 
magnesium ion cofactor required for DNA strand scission) and a 13bp cognate 
oligonucleotide.36,37 The DNA recognition site for Eco RI (5'-GAATTC) is contained 
-10-
Figure 3: Representation of the strucure of the 434 repressor-DNA cocrystal.34 
The 14 bp oligomer sequence is; 51-ACAATATATATTGT. a helices are shown as cylin-
ders and all other protein structures as heavy lines. The lower protein monomer 
has some of the DNA contacting amino acids marked. The upper monomer shows 
the helix numbering. The DNA recognition helix is a 3. 
-11-
within the self-complimentary oligonucleotide 5'-TCGCGAATTCGCG which has a one 
base pair 51 overhang. As with the 434 repressor-DNA complex the DNA in the 
Eco RI complex forms a psuedocontinous double helix. The Eco RI interactions 
with DNA seen in the crystal structure are radically different from the helix-turn-
helix motif seen in the 434 repressor complex which is believed to be common in 
the regulatory proteins. Figure 4 shows a schematic drawing of one subunit of Eco 
RI bound to the oligonucleotide. 
The most striking features of the Eco RI complex are the absence of a helix-
turn-helix domain, the severe distortions of the DNA backbone and the very tight 
packing of protein into a small DNA region. The Eco RI monomer consits of a five-
stranded f3 sheet with six a helices distributed about it. The amino terminus of two 
of the helices ("inner" and "outer" in figure 4) from each subunit are directed into 
the DNA major groove and appear to be the main sequence specific recognition 
elements. In the dimer, then the amino terminus of a four-helix parrallel bundle 
is wedged into the major groove and interacts primarily with the six base pair 
recognition sequence. 
The massive intrusion by the protein into the major groove causes the DNA 
backbone to be severely distorted. The backbone distortions are primarily evident 
as three major backbone kinks. The first kink, type I neokink (the "neo" is to 
differentiate these protein induced DNA kinks from DNA sequence induced kinks), 
is at the center of the recognition site and represents an unwinding of approxi-
mately 25°. The other two kinks (type II neokinks) are symmetrically positioned 
at positions -3 and +3 relative to the center of the recognition hexanucleotide. The 
type II neokinks span the scissile phosphate and are characterized by an increased 
phosphate to phosphate separation along the strand and a bend of 20-40°. The 
-12-
Figure 4: Schematic drawing of one subunit from the dimeric Eco RI-
oligonucleotide complex.36 The other subunit in the complex would be rotated 
180 degrees about a horizontal line through the center of the first subunit in the 
plane of the page. The DNA oligomer sequence is 51-TCTCGAATTCGCG-31• 
-13-
type II neokink, smce it spans the scissile phosphate, appears to be intimately 
involved in the DNA cleavage reaction. 
The radical differences between the interaction of the regulatory proteins and 
Eco RI with DNA may be partly due to the different requirements of the two 
systems. The regulatory proteins are dimeric and bind to 15-20 base pair, sym-
metric binding sites by inserting an a helix from each subunit into two adjacent 
major grooves. The intervening minor groove is covered by the protein-protein 
dimerization domains of the two protein monomers. Eco RI is also dimeric but its 
recognition sequence is only six base pairs. Helices from both protein monomers 
interact with the same groove and recognize the same six base pairs. The much 
higher degree of protein interaction per base pair observed with Eco RI may be 
required for two reason. First the distortions of the DNA caused by Eco RI binding 
may be a requirement for strand scission. Both 434 repressor and Eco RI distort 
the DNA, but the degree of distortion caused by Eco RI is much greater. In order 
to induce this degree of distortion a more substantial and tighter packed protein 
structure may be required. The second possible reason is the required fidelity of 
the recognition event. For the regulatory proteins an occasional "miss-reading" 
of an incorrect binding site would not be overly detrimental to the host organism. 
For Eco RI on the other hand, a miss-read sequence could lead to DNA strand 
scission, an event that is considered ''fatal" to the DNA. For this reason the fidelity 
of an endonuclease recognition of DNA must be much higher than for the regula-
tory proteins, requiring a much higher degree of protein-DNA interaction packed 
tightly into a small DNA region. 
-14-
DNA Binding Protein Fragments 
Many sequence specific DNA binding proteins have been found to consists of 
two separable domains. One domain, frequently the smaller, contains all or most 
of the sequence specific DNA contacts. The other domain contains the remaining 
functions of the protein such as oligomerization or DNA modification. For example, 
limited proteolysis of 434 repressor (236 amino acids) gives a 69 amino acid amino 
terminal fragment which binds to repressor sites on DNA.38 Chymotrypsin cleavage 
of the site-specific recombinase "'(Oresolvase (183 amino acids) gives a 43 residue 
carboxy terminus fragment which binds to "'fO recombination sites. 39 Similarly both 
1-+5140 and 1-+5641 of Lac repressor (360 amino acids) bind to the 14bp LAC 
operator. More recently a synthetic 52 amino acid peptide (139-+190; HIN52) 
based on the carboxy terminus of Hin recombinase (190 amino acids) has been 
shown to both bind to Hin recombination sites and to inhibit Hin activity. 1 Since 
we are interested in conversion of the HIN 52 into a sequence specific DNA cleaving 
molecule we shall first examine Hin recombinase. 
Hin Recombinase 
Hin is a 190 amino acid site specific recombinase isolated from Salmonella 
Typhimurium.42 Its function is to switch expression of flagellin type by inverting 
a 995bp region of DNA which controls flagellin expression.43•44 Figure 5 shows 
a proposed mechanism for Hin mediated switching. 45•46 Efficient recombination 
requires two protein cofactors, FIS which binds to a cis acting recombinational 
enhancer DNA sequence, and the histone like protein HU. The recombination event 
occurs between two crossover sites designated hixL and hixR, in inverted repeat 
configuration, when they are on a supercoiled substrate.44 Each hix site is 26bp 
-15-
long, has near twofold symmetry, and shares a 14bp sequence with the other (see 
figure 6). Hin belongs to a family of recombinases that compliment one another 
and that includes Gin from phage Mu, Cin from phage Pl and Pin from the e14 
element of Escherichia coli. The crossover sites for Hin, Gin, Pin and Cin are 
shown in figure 6 and the amino acid sequences of their carboxy-terminal domains 












. . . ACCGTTTCCTGTAAACCGAGGTTTTGGATAATGGTC 
. .. ACCGTTTCCTGTAAACCGAGGTTTTGGATAAACAGC 
GAGCCTTCTCCCAAACCAACGTTTATGAAAATGAAG 
GCTCCTTCTCCCAAACC~AGGTTTTCGAGAGCCGTT 
. .. CCGAGTTCTCTTAAACCAAGGTATTGGATAACAGCA 
.. . CCGAGTTCTCTTAAACCAAGGTTTAGGATTGAAATG 
-----TTcTC--AAACC ~AGGTTT--GAtAA-----
consensus half-site TT~TC--AAACC~ 
a c a Aaa cA aAttTAt a ACA t -y6 resolvase - at g T G T c t g t T t t T t T g a a a c g g c at -
Figure 6: Comparison of the cross-over sites of the Hin family of recombinases. 
The bases in the inverted repeats are underlined; note that both the gix and 
c~ inverted repeat sequences extend further to the left. Also shown is the 26bp 
consensus site and the 13bp consensus half-site. The vertical line marks the psuedo-
C2 axis. The consensus for 16 resolvase binding to the res subsites has also been 
included. 
Hin binds cooperatively to a hix site as a dimer and the binding event has 
been investigated using chemical protection and interference assays. Figure 8 
shows dimethyl sulfate protection and interference results for Hin binding to hixL. 
-16-
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The dissociation constant for Hin binding to hixL has been estimated by quan-
titative DNase I footprinting to be 40nM at 100mM sodium chloride (~Gassoc::::::-
10kcal/ mol) . Hin protects base pairs -17 through + 16 of hixL from Dnase I, 
dimethyl sulfate and methidiumpropyl- EDTA•Fe. 
Dimethyl Sulfate Protection: 
IRL IRR 
hixL 
* * * ! * * 
51-TTCTTGAAAACCA!AGGTTTTTGAT AA-31 
31-AAGAACTTTTGG TjTCCAAAAAC T A TT-51 
A * j *** A 
Dimethyl Sulfate Interference: 
*** I ! * 
51- TTCTTGAAAA CCAAGG TTTTTGA T AA-31 
hixL 3'-AAGAACTTTTGGTjTCCAAAAACTATT-s' 
i * * * 
Figure 8: Dime thy 1 sulfate protection (top) and interference (bottom) results 
for Hin binding to hixL. Asterisks mark nucleotides protected from alkylation 
by Hin binding (top) or nucleotides which when methylated prevent Hin binding 
(bottom) . Carets (A) mark nucleotides which show enhanced reactivity towards 
dimethyl sulfate in the presence of Hin. The vertical line at the center of the 
sequence marks the psuedo-C2 axis that seperates inverted repeat left (IRL) from 
inverted repeat right (IRR) . Underlined nucleotides are conserved across the two 
half sites. The arrows mark the putative Hin cleavage sites. Dimethyl sulfate 
alkylates N3 of adenine (minor groove) and N7 of guanine (major groove). 
To determine if Hin consists of two separable domains, one of which is re-
sponsible for sequence specific DNA recognition, two peptides from the carboxy 
terminus of Hin were chosen for total synthesis. The first was chosen by compar-
ison of Hin to the related 18 resolvase of transposon 18. Since Hin and resolvase 
share 35% homology of amino acid sequence throughout their length,47 the 52 
-19-
amino acids from the carboxy terminus of Hin (residues 139-+190, HIN52) are 
homologous to the 43 amino acid chymotrypsin cleavage product of resolvase (see 
figure 7) . The second portion choosen for synthesis was the 31 amino acid sequence 
from the carboxy terminus which includes the putative helix-turn- helix domain of 
Hin (residues 160-+190; HIN31) identified by protein sequence homology with the 
regulatory proteins such as those shown in Table 1. 
HIN52 and HIN31 were prepared by standard solid phase peptide syn-
thesis procedures and the crude peptides' interactions with Hin recombination 
sites were investigated by footprinting experiments (RNase I, dimethyl sulfate 
and methidiumpropyl-EDTA•Fe) and by their ability to inhibit Hin mediated 
recombination. 1 HIN52 inhibits Hin mediated recombination and protects the 
same portions of hix binding sites as Hin with the exception of the bases from -2 
to +1 at the center of the site. The chemical protection studies indicate both minor 
and major groove protection for both Hin and HIN52 (cf. figure 8). The disso-
ciation constant for crude HIN52 at hixL IRR and 100mM sodium chloride was 
estimated at 2J.LM ( AGassoc~-7 .9kcal/mol) by quantitative footprinting analysis.1 
More recently HIN52 has been purified to homogeneity by reverse phase HPLC 
and its binding to hixL has been investigated. DNA gel mobility retardation assays 
indicate a dissociation constant of 140nM (20mM NaCl, AGassoc~-9.5kcal/mol) at 
hixL.48 The results with HIN52 suggest that Hin, like many other DNA binding 
proteins, consists of seperable domains and that the carboxy-terminal domain is 
responsible for sequence specific DNA binding. 
HIN31 on the other hand gave no indication of sequence specific DNA binding 
and did not inhibit Hin mediated recombination. If Hin uses a helix-turn-helix 
-20-
domain then the lack of specific binding by HIN31 implies that though the helix-
turn-helix may be required it is not sufficient for sequence specific binding. 
Metal Chelators Coupled to Proteins 
A number of workers have been interested in the preparation of metal chelates 
covalently linked to proteins, including monoclonal antibodies, for use as radio-
pharmaceuticals in vivo or as fluorescent tags for in vitro studies. In general this 
has been done by equipping a metal chelator with an electrophic function such as 
diazo,49,50 isothiocyano,51 o:-bromoacetyl51,52 or activated carboxyl52- 56 followed 
by random coupling to available nucleophilic sites (eg., lysyl E-amino) of proteins 
isolated from natural sources. 
More recently a modified 1,10-phenanthroline has been attached to the avail-
able lysyl E-amines of TRP repressor. 57 As described previously, TRP repressor, in 
the presence of 1-tryptophan, specifically binds to various DNA operon sites in or-
der to control tryptophan biosynthesis. In the presence of 1-tryptophan, cupric ion 
and 2-mercaptopropionic acid (as a reducing agent), the modified TRP repressor 
cleaves DNA at TRP operon sites. Analysis of the extent of 1,10-phenanthroline 
incorporation indicated that all four lysine residues of the TRP repressor had been 
modified. Despite the availability of a 2.6A x-ray structure of the wild protein,33 
the 1,10-phenanthroline-modified lysyl residue(s) responsible for the nucleolytic 
activity could not be unambiguously identified. 57 
These "shotgun" approaches to chelator attachment to a protein can lead to 
considerable uncertainty as to the number of chelators and their positions in the 
modified protein. 51 Therefore, little can be said about what portions of the protein 
are in the vicinity of the chelator. Since we too are interested in the incorporation 
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of a metal chelator (EDTA) into a protein but would like to position it at a specific 
(known) location, we have developed a different approach. 
Design of a Sequence Specific DNA Cleaving Peptide 
As with the 1,10-phenanthroline•Cu described above, attachment of EDTA•Fe 
to a DNA binding molecule creates a DNA-cleaving molecule which functions 
at physiologically relevant pH, temperature and salt conditions.58•59 If the DNA 
binding molecule is sequence specific then the EDTA•Fe is delivered to specific 
sites on the DNA.60- 63 EDTA•Fe equiped DNA binding molecules cleave DNA 
by oxidation of the ribose backbone via a diffusable oxidant, presumably hydroxyl 
radical. The cleavage reaction is dependent on a reducing agent and molecular 
oxygen, and the method has been called affinity cleaving. Affinity cleaving has 
been a successful approach to the study of sequence specific DNA recognition and 
has been applied to naturally occurring DNA binding antibiotics,60•61 designed 
DNA binding molecules,64- 67 DNA double strand formation,68 and DNA triple 
strand formation.69 
My initial goal was to extend affinity cleaving to peptides and proteins by 
introduction of EDTA•Fe at a defined location. Incorporation of EDTA into a 
helix-turn-helix domain of a sequence specific DNA binding peptide should pro-
duce an affinity cleaving molecule which not only reports DNA binding sites of the 
peptide but also identifies the groove identity (major vs. minor for right handed 
B-form DNA) and nucleotide position of the amino acid covalently linked to the 
EDTA (see figure 9). 
Since EDTA•Fe equiped DNA binding molecules cleave DNA via a diffusable 
species, cleavage is observed on both DNA strands and covers 3 to 6 base pairs. 
-22-
5' 3' 
Figure 9: Stylized drawing of an EDTA•Fe equiped helix-turn-helix peptide 
bound in the major groove of B-form DNA. 
Due to the double helical nature of right handed DNA, the groove in which the 
EDTA•Fe is bound can be identified by analysis of the cleavage patterns on both 
strands. An asymmetric cleavage pattern with maximal cleavage shifted to the 
5' or 31 side on opposite strands corresponds to the EDTA•Fe located in/ above the 
major and minor grooves, as shown in figure 10.70 
Design and Synthesis of Tribenzyl-EDTA-GABA 
In order to covalently link EDTA to HIN52 at a defined location in the peptide, 
a protected EDTA derivative was prepared which is compatible with Merrifield 
solid phase peptide synthesis . Based on the carboxyl side chain protections of 
glutamic and aspartic acids used in solid phase peptide synthesis, I chose to protect 
three of the four carboxyl arms of EDTA as benzyl esters. The fourth carboxylate 
of the EDTA was coupled to a 1-amino isobutyric acid (GABA) linker to minimize 
interference between the EDTA chelate and the secondary or tertiary structure of 
-23-
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t f i t 
Figure 10: Cleavage patterns produced by a diffusable oxidant generated by 
EDTA•Fe localized in the minor and major grooves or right handed DNA. The 
edges of the bases are shown as open bars for the minor and crosshatched bars 
for the major grooves. The height of the arrows indicate the extent of cleavage 
expected at the indicated nucleotide. 
HIN52. The resulting tribenzyl-EDTA-GABA (BEG) was suitable for coupling 
to the amino terminus of the protected, resin-bound, synthetic peptide. Though 
BEG is formally an amino acid dipeptide, it is only suitable for capping an amino 
terminus since it does not have a primary or secondary amino group for further 
chain extension. 
The synthetic route to BEG is shown in Scheme 1. Esterification of GABA 
with isobutylene using the general procedure of Roeske71 produces the carboxy 
protected GABA ester, 1. Amidation of 1 with bromoacetyl bromide (2), followed 
by amination with excess ethylenediamine produces the ethylenediamine core of the 
-24-
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EDTA with one carboxyl arm in place, 3. Trialkylation of 3 with three equivalences 
of benzyl bromoacetate in the presence of diisopropylethylamine as base generates 
the t-butyl ester of BEG. BEG is formed by deprotection with trifl.uoroacetic 
acid in dichloromethane followed by silica gel chromatography. All compounds 
were characterized by high field 1H-NMR. BEG was also characterized by high 
resolution fast atom bombardment mass spectroscopy. 
The synthetic target is the 52 amino acid carboxy-terminal domain of Hin 
(139--+190) with EDTA- GABA covalently linked to the amino terminus as shown 
in figure 11. The coupling strategy used to attach BEG to the resin bound, 
protected HIN52 is shown in Scheme 2. The amino-terminal t-BOC protecting 
group was removed, and the peptide neutralized, using standard procedures (see 
experimental section). BEG was attached to the resin bound peptide by dicyclo-
hexylcarbodiimide (DCC) plus N-hyroxybenzotriazole (HOBt) mediated coupling 
in DMF. Ninhydrin analysis for primary amine indicated >99% reaction after 40 
hours. The slow coupling of BEG to the peptide-resin may be due to the age of 
the peptide. This intitial coupling was carried out on peptide-resin that had been 
stored dry at -20°C for approximately one year. In later studies BEG coupling 
to fresh peptide-resins was complete in $3 hours which is comparable to standard 
DCC/HOBt/DMF coupling reactions used in the peptide synthesis. After washing 
and drying, the peptide was deprotected and cleaved from the resin using anhy-
drous hydrogen fl.ouride in the presence of p-cresol and p-thiocresol scavengers. 
After removal of the HF under reduced pressure, the crude peptide mixture was 
precipitated and extensively washed with diethyl ether, redisolved in water and 
lyophilized affording EG52. Initial studies of EG52 were carried out using this 
crude peptide. 
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1 10 20 
a) • • • GRPRAINKHEQEQISRLLEKG 
30 5 0 • • 
HPRQQLAIIFGIGVSTLYRYFPASSIKKRMN 
b) 0 R 0 
HOI('N"'Y~~~v~YtOH 
o l o o R 51 
0 'j 0 n 
HO~NJOH Hin( 139-190) 
EG52 
Figure 11: (a) The 52 residue peptide is the carboxy-terminal domain of Hin, 
amino acids 139 to 190. Tentitive a helix assignments are underlined; helices a 2 
and a 3 are from protein sequence alignment with the DNA regulatory proteins 
in Table 1, a3 was assigned using the secondary structure predicting algorithm of 
Garnier.72 (b) The synthetic peptide EG52 . 
DNA Cleavage with EG52·Fe 
The sequence specific cleavage of DNA by EG52•Fe was investigated by anal-
ysis of the cleavage patterns produced on a 32P-endlabelled (both 5' and 3') DNA 
restriction fragment containing a shortened Hin inverting region of ~400 base pairs 
(the wild region is ~1kbp) . The assay is outlined in figure 12. 
Iron III was loaded into EG52 by mixing one equivalence of 500J,tM ferric 
ammonium sulfate dodecahydrate with 500J,tM EG52, followed by dilution to the 
appropriate concentration. EG52•Fe was added to a solution of 5' or 3' endlabelled 
DNA buffered to pH 7.8 containing 400J,tM tRNA as carrier. The cleavage reac-
-27-
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Figure 12: Outline of the high resolution DNA cleavage assay. 
tion was initiated by addition of d ithiothreitol (DTT) to a final concentration of 
5mM. The reactions were allowed to proceed for 40-60 minutes at 22°C and termi-
nated by ethanol precipitation. The 32P-labelled DNA products were analyzed by 
denaturing polyacrylamide gel electrophoresis followed by autoradiography. Den-
sitometric analysis of the gel autoradiogram and comparison of individual lanes 
with sequence marker lanes allowed assignment of DNA cleavage to nucleotide 
resolution as outlined in figure 12. 
The gel autoradiogram of EG52•Fe induced cleavage on the 400bp fragment 
from pMFB36 is shown in figure 13. Two cleavage loci are observed at hixL 
corresponding to one EG52•Fe per half-site. Controls show that neither HIN52 
(see lanes 2 and 17 in figure 13) nor Hin give detectable DNA cleavage under 
these conditions (iron II/III plus DTT). For comparison with the affinity cleaving 
data, footprinting of HIN52 with methidiumpropyl- EDTA•Fe (MPE•Fe)58•59 is 
included in figure 13. 
Histograms of MPE•Fe cleavage protection by HIN52 and cleavage sites for 
EG52•Fe are shown in figure 14. Two HIN52s bound the two half-sites of hixL 
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Figure 13: Autoradiogram of high resolution denaturing polyacrylamide gel of 
EG52• Fe cleavage of a 32P-endlabeled fragment (Xba I - Eco RI) from pMFB36.1 
Reaction conditions were 20mM NaCl, 20mM TRIS•HCl, pH 7.8, 400J,LM phosphate 
tRNA, 5mM DTT, and ~15,000cpm (~1ng) endlabelled DNA in a total volume of 
10J,Ll. Reactions were run for 40 minutes at 22°C for EG52•Fe and controls, and 
8 minutes for MPE•Fe footprinting lanes. Cleavage products were analyzed on 
an 8%, 1:20 crosslinked, 50% urea denaturing polyacrylamide wedge gel (0.2mm 
thick at the top and 0.6mm thick at the bottom). Lanes 1-9 and 10-18 contain 
5' and 3' endlabelled DNA respectively; lanes 1 and 18 are DNA controls; lanes 
2 and 17 minus EDTA controls (10J,LM HIN52, 10J.LM Fe(II)); lanes 3 and 16 are 
Maxam-Gilbert chemical sequencing G lanes; lanes 4 and 15 are MPE•Fe controls 
(10J.LM); lanes 5 and 14 are MPE•Fe (10J.LM) footprints in the presence of HIN52 
(10J.LM); lanes 6 and 13 are EG52•Fe at 0.5J.LM, lanes 7 and 12 at 1.5J,LM, lanes 8 
and 11 at 5J,LM and lanes 9 and 10 at 10J,LM. Concentrations of EG52 and HIN52 
are based on the weight of crude product. (Left) Marked are hixL, the secondary 
Hin binding site (Sec HIN) and the start of the bin gene. (Right) Cleavage data 
between the arrows is shown in figure 14. 
1 2 3 4 
~~-~ ~ . 
("" 
--
' • • 
I 
' -t -HI.\' -.: 
Start i 
~ 
.. - I Sec. HIS 
' 
• 
' ! ~ 
-IIixL - j 
. -- -• -- -
.; 
• ! 





5 6 7 8 9 10 11 12 13 14 15 16 17 18 
~-·-.-v-1 ;,~ 
-···--~- .• - . 
~ .. 
·· ~ . .. 
i 
a • • • • ~ s • • • I 
• --. • -• • z 
--
-• • 




. -• . -• 
% -• .. .. .. .. -
<= 
-31-
occupied by dimeric Hin.1 EG52• Fe produced two cleavage patterns on the symme-
try axis side of the indiviual half-sites. EG52•Fe appears to be similar to HIN521 
in that the two half-sites were not equally bound. The other major cleavage site 
(secondary Hin) which is also bound by Hin, is located just upstream from the 
initiation codon of the Hin gene and though the site is not required for Hin me-
diated recombination its location suggests it is involved in autoregulation of Hin 
expression.1 
The cleavage patterns on opposite strands of the DNA for EG52•Fe were 
shifted to the 3' side at all sites (figure 14) . This asymmetry, together with the 
model in figure 10, implies that the EDTA•Fe, and hence the amino terminus of 
the peptide, is located in or above the minor groove of the DNA. Positioning part 
of EG52 in the minor groove is consistent with the protection from methylation 
by both HIN52 and Hin at A(-6), A(-5) , A(-4) and A(4), A(5), A(6) of hixL, 
shown in figure 8. 
The gel in figure 13 was run using optimized conditions for EG52•Fe cleavage. 
These conditions were identified by studing the effects of various reaction conditions 
on the extent of DNA cleavage. The effect of salt concentration on the cleavage 
reaction was investigated at 2, 10, 20, 50, 200 amd 400mM added sodium chloride. 
The extent of cleavage is constant at $20mM and falls off sharply above 20mM 
giving -13 times more cleavage in the 2- 20mM range than at 400mM. This strong 
dependence on salt concentration is probably a result of the basic nature of EG52 
which is a +6 cation at neutral pH based on the peptide sequence. We have also 
found that inclusion of a polyanion carrier is critical for reducing the level of non-
specific cleavage which again is probably related to the high net positive charge 
of the peptide. Calf thymus DNA, tRNA and poly-rC are all effective as carriers 
-32-
Figure 14: The sequence left to right represents the cleavage data between the 
arrows in figure 13. (a) Boxes are the 26bp hixL binding site, 27bp secondary Hin 
binding site and the start of the hin gene. (b) Bars represent extent of protection 
from MPE•Fe cleavage in the presence of HIN52 (figure 13, lanes 5 and 14). (c) 
Arrows represent the extent of cleavage for EG52•Fe at lOJ.LM (figure 11 lanes 9 
and 10). (d) As in (c) except l.SJ.LM EG52•Fe (figure 13, lanes 7 and 12) . Extent 













































































































































































































































































































































































































































































































































































































































































































































with 400J.LM phosphate tRN A giving about three times greater specific cleavage 
with EG52•Fe than 100J.LM bp calf thymus DNA. 
The reaction time course was examined in the range of 5 to 80 minutes at 22°C 
and 5mM DTT. The initial rate of cleavage indicates an initial rate half-life of -10 
minutes. The cleavage reaction stops after 60-100 minutes. This is apparently due 
to inactivation (damage) of the EDTA and/ or peptide domains and has also been 
observed with small molecule-EDTA compounds. The effect of equilibration time 
of EG52•Fe with DNA prior to addition of DTT was examined at 0, 10, 20 and 
40 minutes (22°C). All equilibration times gave identical cleavage indicating that 
the equilibration rates are fast relative to the -10 minute initial cleavage rate. As 
with the salt and carrier effects this is probably a result of the basic nature of the 
peptide which facilitates a "one dimensional" search of the DNA for binding sites, 
similar to the fast equilibration of DNA binding proteins. 
Cleavage specificity as a function of temperature was examined at 0°C (120 
minute reaction), 22° (30min) and 37° (8min) and over this temperature range no 
differences in specificity were detected. The effect of different reducing and oxi-
dizing agents was also examined, compared to 5mM DTT and 1-4mM 02 (water 
solubility), 1mM sodium ascorbate was 1.5 times and 1mM ascorbate plus 1mM 
hydrogen peroxide was three times more effective. Ascorbate plus H202, and to 
a lesser extent ascorbate alone, tend to give a much higher degree of background 
cleavage and increases the total salt concentration significantly, so that in subse-
quent studies only DTT was used. 
After the initial report of the success of the EDTA coupling strategy 70 we ac-
quired the capability of purifying the synthetic peptides to homogeneity by reverse 
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phase HPLC. The peptides were purified on a preparative C4 reverse phase column 
using 0.1% trift.uoroacetic acid (TFA) in aqueous acetonitrile gradients. Individual 
fractions from the preparative runs were checked for purity by re-injection on a 
C4 analytical column and homogenous fractions were combined and lyophilized. 
The studies which follow were all carried out using the HPLC purified peptides. 
The purified peptides have all shown the same specificities as the crude peptides 
but have been approximately ten times more active. We have also changed our 
method of determining peptide solution concentrations. In initial studies concen-
trations were based on weight of crude peptide and the the molecular weight of 
the peptide amino acid sequence. In the studies which follow concentrations of 
purified peptides were determined by UV adsorption at 275nm using an extinction 
coefficient of 2800(M•cm) -l which is the expected extinction of a peptide con-
taining two tyrosines. Typically the UV concentration obtained in this manner 
is 10-30% lower than that based on weight of peptide. We attribute the differ-
ence to two factors. The HPLC purified and lyophilized peptides are obtained as 
the TFA salts and probably contain 10-15 TFA's per peptide {15-20% by weight) 
based on the number of basic side chains in the peptide sequence. Secondly, the 
lyophilized peptides are extremely hygroscopic and readily acquire a static charge 
making accurate weighing difficult. 
The robustness of the synthetic peptides has been somewhat surprising. No 
degradation of activity has been observed with lyophilized peptides stored at -20°C 
for 18 months, or for unbuffered solutions stored frozen, and after repeated freeze-
thaw cycles, for six months. Even EDTA•Fe(III) containing peptides in unbuffered 
solutions keep several weeks at -20°C with no apparent change in activity. 
-36-
To determine if the attachment of EDTA-GABA to HIN52 was significantly 
affecting the peptides' binding ability, we examined the HIN52 inhibition of 
EG52•Fe cleavage. Lanes 4 and 5 in figure 15 show DNA cleavage by 0.5JLM 
EG52•Fe at the standard assay conditions in the absence and presence of 0.5JLM 
HIN52, respectively. Densitometric analysis of cleavage at hixL and secondary 
binding sites indicates a 58(±10)% reduction in EG52•Fe cleavage in the presence 
of equimolar HIN52. This result indicates that the EDTA-GABA is not signifi-
cantly affecting the binding of the peptide at these binding sites. Even the loss of 
the positively charged amino terminus due to coupling of EDTA-GABA does not 
appear to affect DNA affinity. Interestingly, the weak cleavage by EG52•Fe at the 
tertiary site is unaffected by equimolar HIN52. 
As mentioned earlier, the 3' shift of the cleavage loci of EG52•Fe, as well as the 
dimethyl sulfate protection studies with HIN52 and Hin, indicate that the amino 
terminus of the peptide is interacting with the minor groove of hixL at A_6, A_5, 
A_4 and A4, As, A6. To further investigate this apparent minor-groove recognition 
event, the ability of a minor-groove binding small molecule to inhibit EG52•Fe 
induced DNA cleavage was examined. Distamycin A (DST) is a naturally occurring 
tripyrrole antibiotic which binds to A+T regions of double stranded DNA.60•61•73 
Figure 15 shows the autoradiogram ofEG52•Fe induced cleavage in the presence of 
DST, as well as MPE•Fe footprinting of DST and affinity cleaving by distamycin-
EDTA•Fe (DE).61 Histograms of the data in figure 15 are shown in figure 16. 
Distamycin binds tightly to both A+T tracks near the center of hixL; 
A_7A-6A-sA-4 and T 4T 5T 6T7Tg. Distamycin also binds to tracks of A+T just to 
the left of hixL, on either side of secondary Hin, and the end of the weak tertiary 
site. At high DST concentration (4JLM), EG52•Fe (0.5JLM) is strongly inhibited 
-37-
Figure 15: Autoradiogram of high resolution denaturing polyacrylamide gel of 
the 32P endlabelled -400bp fragment from pMFB36 (Ava I labelled, Eco RI sec-
ond cut) . Lanes 1, 3-+11, 16 and 18 are 51 labelled and lanes 2, 12-+15 and 17 
are 3' labelled DNA. Reaction conditions were 20mM TRIS•Cl, pH 8.0, 20mM 
NaCl, 400J.LM phosphate tRNA, 18kcpm/ lane radiolabelled DNA and SmM DTT. 
Reactions were run 1hr at 22°C for affinity cleaving lanes and 7 .Smin at 22°C for 
MPE•Fe footprinting lanes. All reactions were terminated by ethanol precipitation 
and analyzed on an 8% polyacrylamide, 1:20 crosslinked, 50% urea denaturing gel. 
Lanes 1 and 2 are 51 and 31 DNA controls, respectively. Lanes 3 and 18 are 5' and 
lane 15 3' Maxam-Gillbert chemical sequencing G marker lanes. Lanes 4-+8 are 
0 .5J.LM EG52•Fe cleavage reactions, lanes 9-+14 MPE•Fe (15J.LM) footprinting re-
actions. Lane 5 is EG52•Fe cleavage in the presence of 0 .5J.LM HIN52. Lanes 
6-+8 are EG52•Fe cleavage in the presence of 4, 2 and O.SJ.LM DST, respectively. 
Lanes 9 and 14 are MPE•Fe control lanes, 10 and 13 MPE•Fe footprints of 2J.LM 
DST and 11 and 12 0.5J.LM DST. Lanes 16 and 17 are affinity cleaving with 0.5J.LM 
distamycin- EDTA • Fe (DE). Concentrations of the pep tides were determined by 
UV adsorption at 275nm. 
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Figure 16: Histograms of the gel data in figure 15. The sequence left to right 
corresponds to the bottom of the gel to just above the secondary site. (Top) Brack-
ets mark the 26bp hixL site, 10bp tertiary site and 27bp secondary site. Arrows 
represent the extent of cleavage resulting in removal of the indicated base. Bars 
represent the extent of protection from MPE•Fe cleavage. The top histogram is 
5' cleavage by 0.5JLM EG52•Fe (figure 15, lane 4). The second histogram is 5' cleav-
age by 0.5JLM EG52•Fe in the presence of 2JLM DST (figure 15, lanes 7). The third 
histogram is 51 and 3' MPE•Fe footprints of 0.5JLM DST. The bottom histogram is 
51 and 31 cleavage by distamycin-EDTA•Fe (DE) at 2JLM, boxes represent binding 














































































































































































































































































































































































































































































































































































































































































































































at all sites except tertiary, at 4:1 DST-EG52•Fe cleavage is inhibited at hixL and 
secondary, but enhanced at the tertiary binding site, and at 1:1 DST-EG52•Fe 
cleavage is only slightly inhibited at hixL and not affected at the secondary and 
tertiary sites . 
DST binding at / near EG52 sites can be broken down into two classes; binding 
at the A tracks of hix half-sites (see figure 16), i.e. the region where the peptide 
appears to interact with the DNA minor groove, and binding at sites on the ends of 
hix-like halfsites such as at hixL IRL, both sides of secondary and at the tertiary 
site. At high concentrations DST binding to all of these sites inhibits EG52•Fe 
cleavage. As the DST concentration is lowered, cleavage appears to be less affected 
at sites where it binds on the end, away from the center of the sites, such as at the 
secondary and tertiary sites. In fact, at 4:1 DST- EG52, binding of DST appears 
to enhance EG52•Fe cleavage at the tertiary site. On the other hand, DST binding 
to the central A tracks of hix half-sites seems to have a greater inhibitory affect 
on EG52•Fe cleavage. At hixL IRR the DST site is only these A's. It appears 
then that the strongest inhibition of EG52•Fe cleavage occurs when the central A 
track of a hix half-site binding site is blocked with DST. 
To further investigate the effect of DST binding and to determine if EG52•Fe 
cleavage was being inhibited rather than peptide binding, the simultaneous binding 
of DST and HIN52 were examined by competitive footprinting with MPE•Fe and 
EDTA•Fe.74 Figure 17 shows densitometer scans of 51 footprinting lanes at hixL 
in the presence of HIN52 , DST and [HIN52 plus DST]. It is clear from figure 
17 that the footprint of DST in the presence of HIN52 is identical to that of 
DST alone and unlike HIN52 alone. The competitive footprinting and inhibition 
results indicate that DST competes for the same track of A's as is protected by 
-42-
the peptide in the minor groove, and that inhibition of EG52•Fe cleavage is due 
to inhibition of peptide binding and not simply inhibition of EDTA•Fe cleavage. 
The EDTA•Fe footprinting of HIN52 shown in figure 17 contains several un-
usually strongly protected bases. Analysis of the data in figure 17 (5' strand) 
along with 31 results (data not shown) indicates that the six strong protections of 
deoxyribose units in hixL by HIN52 are symmetrically related between the two 
half-sites as shown in figure 18. Strong protections from EDTA•Fe cleavage would 
imply either very close interaction, perhaps contact , between the peptide and the 
deoxyribose at that base position or, alternatively, an altered DNA sugar structure 
which makes the sugar less susceptible to attack. 
IRL IRR 
* ** 5~TTCTTGAAAACC~AGGTTTTTGATAA-~ 
3'- AAGAACTTTTGGTjTCCAAAAACT A TT-5' 
* * * 
hixL 
Figure 18: Asterisks indicate positions of hixL where the deoxyribose is strongly 
protected by HIN52 from cleavage by EDTA•Fe. 
DNA Double Strand Cleavage by EG52·Fe 
The ability of EG52•Fe to cause double strand cleavage of DNA containing 
the hixL site was investigated. Double strand cleavage of linearized plasmid DNA 
containing the hixL site cloned into pBR322 is shown in figure 19. EG52•Fe at 5 
and lOJ.LM revealed two strong and three weak double strand cleavage sites. One 
strong site maps to the hixL site. The other strong sites maps to a location in 
pBR322 that is a perfect match to the outer lObp of hixL IRR (5'-TTATCAAAAA-
3') . The three weaker sites map to regions of pBR322 near sequences with lower 
degrees of homology to a hix halfsite (compare figure 6 and the sequences in figure 
-43-
Figure 17: Densitometer scans of 5' MPE•Fe and EDTA•Fe competitive foot-
printing studies. Reactions conditions were 20mM TRIS•HCI, pH 8.0, 20mM NaCI, 
400JLM phosphate tRNA and 20kcpm 51 labelled DNA in 15JLl total volume. The 
left hand column (a) is 15JLM MPE•Fe footprints (5mM DTT, 7.5min at 22°C, no 
MPE•Fe equilibration) and the right hand column (b) 300JLM EDTA•Fe footprints 
(2mM ascorbate, 15min at 22°C). The top two panels are control reactions in the 
absence of peptide and DST. The hixL site is marked by a bracket. The second 
pair of panels are footprints of 3JLM HIN52. The third pair of panels are com-
petitive footprints of 3JLM HIN52 and 2JLM DST. The bottom pair of panels are 
2JLM DST footprints. All panels in a column are printed at identical scaling on 
both axis. Note the two unusualy strong protections by HIN52 from EDTA•Fe 
cleavage in the right-hand halfsite (IRR) of hixL. 
-44-








19). Identification of alternative DNA binding sites on large DNA fragments by 
gel electrophoresis is a useful feature of the affinity cleaving method for analyzing 
peptide-DNA recognition (see also Chen and Sigman57). 
Initial Binding Model 
Based on the amino acid sequence homology of Hin 160--+190 (HIN52 22--+43) 
with the regulatory proteins shown in Table 1, it seems likely that there is a helix-
turn-helix domain within the 52 amino acid synthetic peptide. The footprinting 
results and binding site homology suggest that the helix-turn-helix binds at the 
outer five base pairs on each end of a hix site. In addition, the cleavage data for 
EG52•Fe has revealed the nucleotide postition and groove identity of the NH2-
terminal residue of the peptide. Using this information it is possible to propose 
DNA binding models for the synthetic peptides and, by extension, the DNA recog-
nition domain of Hin binding to a hix site. 
If Hin recognizes the binding site via specific contacts in the major groove, 
possibly with a helix-turn-helix structure, then the combination of the cleavage 
pattern with EG52•Fe, and the footprinting results with HIN52, indicates that 
the amino-terminal end of the peptide (Gly-Ar~-Pro-Ar~-) must have at least the 
Gly-Ar~- portion in/above the minor groove. Therefore, there must be a peptide 
structure which extends over the DNA phosphodiester backbone to follow the mi-
nor groove toward the center of the dimeric binding site. The region C_2A_1A 1G2 
at the center of a hix site is believed to be the location of the recombination event. 
The central six base pairs not bound by the 52-residue peptide would then be avail-
able for the recombination activity of the other -140 residues of Hin. Therefore, 
the positions that are contacted by Hin in the major grooves are separated by one 
-46-
Figure 19: (Top) Double strand cleavage from the reaction of EG52•Fe and 
linearized plasmid pMS51575 analyzed on a nondenaturing agarose gel. A to E 
are fragments that resulted from one double strand break at five sites on pMS515. 
(Bottom) Locations of double strand breaks with Eco RI defined as the origin 
and the most probable recognition sequences are shown around the plasmid map 
along with the Eco RI, Ava I and Pvu I cleavage sites. Reaction conditions were 
40mM TRIS-acetate, pH 7.9, 5mM NaOAc, 5mM DTT, 50~-tM bp DNA in a total 
volume of 10~-tl, 1 hour at 22°C. The products were analyzed on a 1% nondenaturing 
agarose gel with subsequent ethidium bromide staining and photographed under 
UV transillumination. Lanes 1 to 3 contain Ava I linearized plasmid, lanes 5 to 
7 Pvu I linearized plasmid. Lane 4 consists of molecular weight markers of 4363, 
2118, 1565 and 680bp. Lanes 3 and 5 are EG52•Fe at 10~-tM, lanes 2 and 6 at 
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turn of the DNA helix. A similar model for 18 resolvase has been proposed.39 
Furthermore, the COOH-terminal end of Hin contains several positively charged 
residues (-Ly~-Ly~-Ar~-Met-Asn-C0~) similar to the amino-terminus of~ repres-
sor (N~-8er-Thr-Ly~-Ly~-Ly~-), which are believed to form an arm that wraps 
around the DNA following the major groove.76 The carboxy-terminal region of Hin 
may be positioned to fulfill a similar role. 
A binding model for the DNA recognition domain of Hin may involve three 
sets of interactions; (1) a helix-turn-helix domain binding in the major groove at 
the outer five base pairs on both ends of a hix site (51-TTCTT-3' and 5'-TTATC-3' for 
hixL), (2) a region that connects the helix- turn- helix domain to the other -140 
residues of Hin by following the adjacent minor groove sequence 51-AAA-3' toward 
the center of the hix site, and (3) a carboxy-terminal arm which follows the major 
groove. Two models which incorporate these features are shown in figure 20. 
The three a helices are based on the a 1-a2-a3 helices of Cro, and ~ and 434 
repressors . The a 3 helix is placed in the major groove. The two models differ 
in their orientation of the a 3 recognition helix relative to the C2 axis of the hix 
binding site. For one model, the helix orientation is based on the 434 repressor 
cocrystal, and in the other, on the complex of LAC repressor headpiece with a 
14bp LAC operator studied by two-dimensional nuclear magnetic resonance.41 
Since HIN31 contains the putative helix-turn-helix domain but does not bind 
to Hin recombination sites, 1 it would seem that the helix-turn-helix may be nee-
essary, but not sufficient, for binding in this system. Binding may require a third 
a helix and/or structures that bind DNA in the minor groove to hold the DNA-
binding helix-turn-helix in the proper configuration. 
-49-
Figure 20: Schematic representation of two models for EG52•Fe and, by exten-
sion, the DNA recognition domain of Hin binding to hixL . The sequence of hixL 
is shown along the 51 strand in the same direction as in figure 14. The psuedo- C2 
axis is indicated by a solid diamond. Putative a helices (see figure 11) are shown as 
cylinders with an arrow pointing from the NH2- to the COOH-terminus. The model 
on the left is based on the 434 repressor fragment-14bp operator cocrystal35 with 
the following changes; (i) 434 repressors a 4 helix is replaced with the ten residue 
carboxy teminus tail of Hin, (ii) the nine residue amino tail of EG52, which in-
cludes the EDTA, is added as an extension to the 434 repressor a 1 helix amino 
terminus. The model on the right represents the recognition helix orientation of 
the Lac repressor headpiece41, which is rotated 180° from the 434 operator com-
plex and Cro-OR3 model. This requires reorganization of the remaining helices 
in order to maintain the proper positioning of the amino terminus of the peptide. 
The a3 helix of Lac repressor is replaced by the carboxy-terminal tail of Hin. a 2 
of EG52 is reversed so that the amino-terminus of the a 1 helix is towards the C2 
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Extent of DNA Binding Domain 
The success of the EDTA- GABA attachment to the synthetic peptide allowed 
us to address several other issues regarding the sequence specific DNA binding 
domain of Hin. In particular, is the entire 52 amino acid sequence required for se-
quence specific binding or do shorter peptides contain all of the required elements? 
Conversely does the 52 amino acid sequence contain all of the important carboxy 
terminus DNA recognition residues? 
To investigate these two issues we, in collaboration with Dr. Suzanna Horvath 
and the Caltech microchemical facility, prepared a series of peptides which include 
shorter and longer versions of HIN52. Since it had already been shown that the 
31 residue carboxy terminus of Hin (HIN31) does not bind sequence specifically 
to DNA we chose peptides ranging in size from 33 to 60 amino acids, all from the 
carboxy terminus of Hin. In particular we prepared the 33, 37, 45, 49, 50, 51, 56 
and 60 amino acid carboxy-terminal sequences of Hin. We also prepared the 10 
amino acid amino terminus of HIN52 (Hin 139--+148). The complete amino acid 
sequences of these synthetic peptides, along with the 31mer and 52mer already 
described, are shown in figure 21. Two versions of each peptide were prepared, one 
with EDTA-GABA at the amino terminus and one without. 
All peptides were prepared as described for EG52 and HF cleaved. The 49, 
50, 51, 56 and 60mers, both with and without EDTA-GABA, were purified to 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































DNA Binding by 10n, 33, 37 and 45mers: These peptides showed no abil-
ity to sequence specifically cleave DNA. Even at 50J.LM EDTA-peptide concen-
trations, ~500 fold higher than the sequence specific cleavage detection limit for 
EG52 (O.lJ.LM), no specific cleavage was detected. Additionally HIN10n, HIN33, 
HIN37 and HIN45 at 50J.LM did not inhibit cleavage by 0.5J.LM EG52•Fe, or give 
detectable MPE•Fe footprints . 
The EDTA-GABA equipped 49, 50, 51, 56 and 60 residue peptides all showed 
sequence specific DNA cleavage ability and HIN49 through HIN60 gave MPE•Fe 
footprints. Figure 22 shows DNA cleavage by EG49•Fe --+ EG60•Fe and figure 
23 shows histograms of the sequence specific DNA cleavage. The sequence specific 
DNA binding abilities of HIN49 through HIN60 were examined by MPE•Fe 
footprinting. The high resolution gel autoradiogram for the MPE•Fe footprinting 
is shown in figure 24 and footprinting histograms in figure 25. 
DNA Binding by 56 and 60mers: Unlike EG52, both EG56 and EG60 
give very broad cleavage patterns at hixL which cover ~10 base pairs. However 
HIN56 and HIN60 give strong footprints at the same concentration as HIN52. 
The similar footprinting concentrations indicate that these three peptides have 
similar binding affinities. The 56 and 60mers also appear to have the same rela-
tive affinities for the secondary and tertiary sites as does the 52mer. It appears 
then that no additional DNA recognition elements are present in either the 56 or 
60mers. Furthermore, the very broad cleavage patterns obtained with EG56•Fe 
and EG60•Fe suggest that the peptide backbone (hence the EDTA•Fe) is not held 
as close to the DNA as it is for EG52•Fe. In Hin then, these residues (131--+138) 
-54-
Figure 22: Autoradiogram of a high resolution denaturing polyacrylamide gel of 
affinity cleaving reactions on a 32P-endlabeled fragment (Xba I - Eco RI) from 
pMFB36. 1 Reaction conditions were 20mM NaCl, 20mM TRIS•HCl, pH 8.0, 400J.LM 
tRNA, 5mM DTT, and :::::~15,000cpm (:::::~1ng) endlabelled DNA in a total volume of 
15J.Ll. Reactions were run for 60 minutes at 22°C and terminated by ethanol pre-
cipitation. Cleavage products were analyzed on an 8%, 1:20 crosslinked, 50% urea 
denaturing polyacrylamide gel. Lanes 1 through 8 contain 51 labelled and 9 through 
16 3' labelled DNA. Lanes 1 and 16 are DNA controls and 2 and 15 Maxam-Gilbert 
chemical sequencing marker lanes. Lanes 3 and 14 contain 10J.LM EG49•Fe, 4 and 
13 contain 10J.LM EG50•Fe, 5 and 12 contain 0.5J.LM EG51•Fe, 6 and 11 con-
tain 0.5J.LM EG52•Fe, 7 and 10 contain 2J.LM EG56•Fe and 8 and 9 contain 2J.LM 


































































































































































































































Figure 23: Histograms of the gel data in figure 22. The sequence left to right is 
the bottom of the gel to just above the secondary site in figure 22. (Top) Brackets 
mark hixL, tertiary and secondary sites. Arrow indicate extent of cleavage resulting 
in removal of the indicated base. Dots mark the EDTA•Fe location assigned using 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 24: Autoradiogram of high resolution denaturing polyacrylamide gel of 
MPE•Fe footprinting of HIN49, HIN50, HIN51, HIN52, HIN56 and HIN60 
on a 32P-endlabelled fragment (Xba I - Eco RI) from pMFB36.1 Reaction condi-
tions were 20mM NaCl, 20mM TRIS•HCl, pH 8.0, 400J.LM tRNA, 5mM DTT, 
and ~20kcpm (~1ng) endlabelled DNA in a total volume of 15J.Ll. Reactions 
were run (without MPE equilibration) for 7.5 minutes at 22°C and terminated by 
ethanol precipitation. Cleavage products were analyzed on an 8%, 1:20 crosslinked, 
50% urea denaturing polyacrylamide gel. Lanes 1 through 9 contain 5' labelled and 
10 through 18 3' labelled DNA. Lanes 1 and 18 are DNA controls and 2 and 17 
Maxam-Gilbert chemical sequencing marker lanes. Lanes 3 through 16 are foot-
printing reactions with 15J.LM MPE•Fe; Lanes 4 and 15 contain 20J.LM HIN49•Fe, 
5 and 14 contain 20J.LM HIN50•Fe, 6 and 13 contain 4J.LM HIN51•Fe, 7 and 12 
contain 2J.LM HIN52•Fe, 8 and 11 contain 2J.LM HIN56•Fe and 9 and 10 contain 
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Figure 25: Footprinting histograms of the gel data in figure 24. The sequence 
left to right is the bottom of the gel to just above the secondary site in figure 22. 
(Top) Brackets mark hixL, tertiary and secondary sites. Bars indicate extent of 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































may be part of the linking region between the sequence specific DNA binding 
carboxy-terminal domain and the recombination and oligomerization domains of 
the protein. 
DNA Binding by the Simer: The 51mer differs from the 52mer only in t he 
removal of one glycyl residue, 1% of the total mass and 2% of the peptide backbone. 
Both affinity cleaving with EG51 and MPE•Fe footprinting of HIN51 indicate 
essentially identical affinity and specificity. There is only a very small difference in 
apparent binding affinity, which changes from site to site, and is probably within 
experimental error (compare lanes 5 and 6 and lanes 11 and 12 in figure 22). 
DNA Binding by the 49 and SOmers: The SOmer differs from the 51mer 
only in the loss of an arginyl residue, 3% of the total mass and 2% of the peptide 
backbone. The 49mer is missing an additional prolyl residue. The sequence specific 
DNA binding ability of these two peptides is radically different than that of the 
51 and 52mers. For example, compare lanes 4 and 5 in figure 22. At hixL, even 
at 20 fold higher peptide concentration, specific cleavage has been completly lost . 
At the secondary site, cleavage with EG49 and EG50 is reduced by a factor of 
-20. The only binding site at which the 49 and SOmers have affinities comparable 
to the 51 and 52mers is the tertiary site. DNA cleavage with EG52•Fe at 10J.LM 
gives comparable cleavage at the tertiary site, as does EG49•Fe and EG50•Fe at 
that concentration (data not shown) . 
Footprinting of the HIN 49 and HIN 50 indicates that these pep tides only bind 
to the tertiary and secondary binding sites and not to hixL. The footprints indicate 
that the tertiary binding site extends to the right of the cleavage pattern. Reading 
right to left along the lower strand, 51-TTCTCATGGA-3'. The first five base pairs 
-63-
match the first five base pairs of the consensus hix half site, 5'-TT~TC-3' (see figure 
6) . The next two base pairs of the consensus half site are not conserved but the 
following 5'-AAA is strongly conserved and these are the three A's protected from 
dimethyl sulfate by Hin and the 52mer (see figure 8) . The corresponding bases in 
the tertiary site are 5'-GGA. The affinity cleaving patterns in figure 23 indicate the 
EDTA•Fe is located between the two G's for EG49•Fe and on the central G for 
EGSO•Fe. Therefore neither the 49mer nor the SOmer reaches the only conserved 
A in the tertiary site. 
The cleavage patterns for EG49•Fe through EG60•Fe are 3' shifted at all 
binding sites indicating that the EDTA•Fe of these six peptides are all located 
above the DNA minor groove. Furthermore the cleavage data at the two tertiary 
half-sites allows determination of the average EDTA•Fe position for each peptide. 
A plot of the average iron position versus peptide size is shown in figure 26. Note 
that the numbering of the base pairs has been reversed from the normal numbering 
of a hix site. The bases are numbered towards the C2 axis instead of away from 
it, starting with the first conserved base on the outside of a hix site. 
The plot in figure 26 indicates that each amino acid from 49 to 51 shifts the 
EDTA•Fe position by half a base pair. The 51 and 52mers place the EDTA•Fe 
at the same base position. The four additional amino acids of the 56mer shift 
the EDTA•Fe an additional base pair (0.25bpjamino acid). The effect of 4 more 
amino acids from 56 to 60mers is more difficult to define due to the diffuseness of 
the cleavage patterns. It appears however, that the four additional amino acids 
shift the EDTA•Fe location by half a base pair or less (-0.1bpjamino acid). 
Since the nitrogen-nitrogen seperation in an extended chain (i.e. (3 sheet) pro-

















• Secondary IRR site; 5'-TTCTCCTITAcatc-3' 
o Secondary IRL site; 5'-TTCTTCCTTAtctg-3' 
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48 49 50 51 52 53 54 55 56 57 58 59 60 61 
Peptide Length (excluding EDTA-GABA) 
Figure 26: Plot of average iron location for EG49•Fe, EGSO•Fe, EG51•Fe, 
EG52•Fe, EG56•Fe and EG60•Fe. Note that the numbering is from the outside 
of the site. 
the 49, 50, 51 and 52mer data indicates the backbone conformation of this region 
of the peptide is not that of an extended chain. If the peptide backbone was in 
an extended conformation the EDTA•Fe postion would have been shifted one base 
pair per additional amino acid residue instead of the observed -0.5bpjamino acid. 
Furthermore, a true extended conformation is excluded by the prolyl residue as the 
amino terminus of the 50mer. It appears then that the protein structure of this 
sub-domain is not that of a {3 sheet that follows the minor groove as described in 
the introductory discussion on potential types of protein-DNA interactions. Note 
that a double stranded, antiparallel {3 sheet is the only general protein structure 
-6S-
which has been proposed to potentially interact with the minor groove sequence 
specificaly. (An example of a (3 sheet interaction with the minor groove can be 
postulated for ..\ Cro, see figure 1). 
DNA Binding Affinities of the Synthetic Peptides 
The thermodynamics of HP1C purified HIN49, HIN50, HIN51, HIN52 , 
HIN56 and HIN60 binding to hix1 has been investigated by A. Glasglow et a/ .48 
DNA gel-mobility retardation assays 77•78 indicate the binding constants shown in 
Table 2. Gel-mobility retardation assays involve electrophoresis of a radiolabelled 
DNA fragment, in the presence of vary amounts of protein, on a nondenaturing 
polyacrylamide gel. The DNA•protein complex migrates through the gel more 
slowy than uncomplexed DNA. Table 2 also includes association constants for Hin, 
as well as "'/6 resolvase and its 43 amino acid chymotrypsin product. 
Table 2: Binding constants for HIN52, HIN56, HIN60, Hin, "'16 Resolvase and 
"'f6-43mer at 22°C. 
[NaCl] .6-Gassoc. 
Site Protein (mM) Ka.ssoc. (kcal/ mol) Technique 
hix1 HIN5248 20 7.1x106 -8.8 gel-mobility retardation 
hix1 HIN5648 20 l.Ox106 -7.7 gel-mobility retardation 
hix1 HIN6048 20 1.4x106 -7.9 gel-mobility retardation 
hix1 Hin79 100 2.Sx107 -10.2 DNase I footprinting 
II-1 "'!6 Resolv39 sot >S.Ox109 <-13.4 DNase I footprinting 
II-1 "'16 43mer39 sot 2.0x106 -8.S DNase I footprinting 
t 40mM N aCl + SmM MgCl2, 20°C. 
The gel-mobility retardation assays did not detect descrete binding of HIN49, 
HIN50 and HIN51 to hix1. However, both HIN51 and EG51 bind to hix1 as 
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revealed by footprinting and affinity cleaving assays. Furthermore the gel-mobility 
retardation assays indicate that HIN56 and HIN60 bind more weakly to hixL 
than does HIN52 (a factor of 7 between HIN52 and HIN60, t:..t:..G-l.lkcal/ mol, 
see Table 2) contrary to the apparently equivalent binding observed in the foot-
printing studies. The difference in the apparent bidning affinities, determined by 
gel-mobility retardation and footprinting or affinity cleaving, is perhaps due t o 
changes in the on/ off rates of the peptides. In particular the gel- mobility assay 
would be unreliable in systems where the binding rates were fast, since this would 
increase the likelihood of dissassociation of the DNA•protein complex during mi-
gration through the gel. 
It is also possible to extract estimates of the relative binding affinities of the 49 
through 60mers by comparison of the DNA cleavage with the EDTA•Fe equiped 
peptides. Table 3 lists relative cleavage efficiencies (RCE) and estimated t:..t:..G's for 
EG49, EG50 and EG51 relative to EG52 . Table 3 is divided into two sections. 
The upper section shows the RCE's between the indicated peptide at a particular 
site relative to EG52•Fe cleavage at the same site. The lower portion shows RCE's 
between the indicated peptide at a particular site relative to EG5 2• Fe at the best 
binding site (hixL IRR) . The RCE's are valid if the efficiency of EDTA•Fe cleavage 
is the same for these peptides and is independent of the sequence being cleaved, 
i.e. observed cleavage efficence is only dependent on the peptide binding constant. 
This analysis was not extended to EG56•Fe and EG60•Fe since the EDTA•Fe 
moeities do not seem as tightly held to the DNA, and as a result, the EDTA•Fe 
cleavage efficience is certainly reduced. 
A number of interesting comparisons can be made based on the data in Table 3. 
First, the relative affinities for EG52 at the five sites is hixL IRR~hixL IRL> Sec 
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Table 3: Relative cleavage efficiencies (RCE) for EG51, EG50 and EG49 versus 
EG52 at hix type binding sites. 
-EG52--EG51--EG50--EG49-
Site Sequence a RCEb-AAGcRCEb-AAGcRCEb-AAGcRCEb-AAGc 
Relative to EG52 at the same site: 
hixL IRL ggTTCTTGAAAAcca 0.69 -0.22 0.0027 -3.5 0.0011 -4.0 
hixL IRR ctTTATCAAAAAcct 1.1 0.06 0.0068 -2.9 0.0065 -3.0 
Sec IRL aaTTCTTCCTTAtct 1.1 0 .05 0.11 -1.3 0.087 -1.4 
Sec IRR ttTTCTCCTTTAcat 1.2 0.10 0.052 -1.7 0.032 -2.0 
Tertiary ttTTCTCATGGAgga 0.80 -0.13 0.59 -0.3 0.48 -0.4 
Relative to EG52 at hixL IRR: 
hixL IRL ggTTCTTGAAAAcca 0.92 -0.05 0 .64 -0.27 0.0025 -3.5 0.0010 -4.0 
.hixL IRR ctTTATCAAAAAcct 1.1 0 .06 0.0068 -2.9 0.0065 -3.0 
Sec IRL aaTTCTTCCTTAtct 0.27 -0.77 0.29 -0.72 0.029 -2.1 0.023 -2.2 
Sec IRR ttTTCTCCTTTAcat 0.68 -0.22 0 .82 -0.12 0.036 -2.0 0.022 -2.2 
Tertiary ttTTCTCATGGAgga 0.035 -2.0 0 .058 -1.7 0 .043 -1.8 0.034 -2.0 
a. Sequence (51--+31) towards the psuedo-C2 axis. 
b. Relative cleavage efficency. Cleavage for a given compound at a particular site (A:~pound) is 
the sum of the integrated peak areas over the cleavage loci on both strands. RCE is the ratio 
of cleavage for two compounds corrected for differences in concentration. For example RCE for 
EGSl at hixL IRR versus EG52 at the same site is; 
RCE = (A~i~l~nn) • [EG52] 
[EG51] (A~~l1nn) 
c. Calculated using AAG = RT ln(Kd K2 ) (T=22°C) and assuming RCE = Kd K2 , in kcal/mol. 
IRR>Sec IRL>>Tertiary, with the hix sites 1.5 to 3.7 times better than the two 
secondary sites and 30 times better than the tertiary site. Secondly, EG51 is 
essentially identical to EG52 both in differentiating between the five sites in and 
overall binding affinities. Thirdly, EG50 and EG49 are similar to each other 
but show inverted relative affinities compared to EG52, Tertiary:::::Sec IRR:::::Sec 
IRL>hixL IRR:::::hixL IRL. Binding by EG49 and EG50 is reduced 150 to 1000 
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fold (AAG=3-4kcal/ mol) at hixL relative to EG52. However at the tertiary site, 
EG49 and EG50 binding is reduced only by a factor of two relative to EG52. 
Comparisons such as those listed above lead to two conclusions; (1) Since the 
first five base pairs of all five binding sites match the consensus half site (figure 6 
and Table 3), the following two base pairs are not conserved in the consensus and 
the last 3bp of the consensus half-site are apparently not contacted by these pep-
tides (see EDTA•Fe locations in figures 23 and 26), the remaining three consenus 
base pairs (5'-AAA, numbers 4, 5 and 6 from the C 2 axis) constitute the signifi-
cant differences between the sites. Furthermore, the binding of EG52 is directly 
correlated with the extent of deviation from the 5'-AAA consensus; 5'-AAA>5'-
TTA>>5'-GGA. These are also the three A's protected from dimethyl sulfate by 
Hin (figure 8). (2) As the peptide is shortened from the amino terminus by removal 
of glycine, arginine and proline (EG51, EG50 and EG49 respectively) the effect 
of the 5'-AAA sequence on peptide binding changes from an enhancing to a desta-
bilizing contribution to binding. For instance, EG49 and EG50 prefer the tertiary 
and secondary sites (5'-GGA and 5'-TTA) over hixL (5'-AAA) by a factor of 4-30 
depending on the site. The EDTA•Fe cleavage patterns indicate that EG49 and 
EG50 do not even reach the A•T base pair nearest the C 2 axis, and perhaps the 
one before it as well. 
It appears then that the Bnal Arginine in the peptide, perhaps in conjunction 
with the following residues, not only specifically recognizes the 5'-AAA sequence 
via the minor groove, but also changes the DNA conformation in such a way that 
the peptide interaction at the outer Bve base pairs of a hix half-site is enhanced. 
The amino terminus sequence of the 52mer; N~-Gly-Ar~-Pro-Ar~-, appears 
to contain the element which recognizes the 5'-AAA track of a hix half-site. A 
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search of the GenBank protein sequence library ( -2000 protein entries, -500,000 
amino acids) found 70 occurrences of Art-Pro-Art, 5 occurences of Art-Pro-Art-
EB E9 E9 E9 
Gly and 4 occurences of Gly-Arg-Pro-Arg. Of the 70 occurrences of Arg-Pro-Arg, 
11 (16%) were in protamines. Protamines are small (-30 amino acids) arginine 
rich peptides associated with DNA packaging and there was a very high correla-
tion with the Art-Pro-Art sequence located at the exact center of the peptide 
sequence. Nine (13%) of the Art-Pro-Art were in Actins, proteins associated 
with muscular and other mechanical movements of the cell. These appear to be 
unrelated to DNA binding. Of the remaining 50 proteins, at least 14 (;:::::20%) are 
DNA binding proteins and include the regulatory proteins; Arabinose Operon reg-
ulatory protein (both E. Coli and Salmonella Typhimurium), Galactose repressor 
(E. Coli), 434 Cro and 434 repressor. Other DNA binding proteins were, GAG's 
(three proteins), genome polyproteins (two proteins), kinase-related transforming 
proteins (three proteins), large T antigen (mouse polyomavirus) and the human 
chromasomal protein HMG-1 . All four of the occurrences of Gly-Art-Pro-Art are 
in DNA binding proteins; three in kinase-related transforming proteins (fgr-feline, 
mht and raf-murine) and one in HMG-1. It can be hypothesized that all of these 
proteins use the (Gly)-Art-Pro-Art sequence to recognize A•T base pairs in the 
minor groove. 
Two of the Art-Pro-Art containing proteins deserve special mention. 434 re-
pressor contains Lys4~-Arg4~-Pro42-Arg4~ near the carboxy terminus of the DNA 
binding helix of its helix-turn-helix domain (the small loop between a3-a4 in fig-
ure 3). This sequence interacts with the 3' strand (ATA) of the DNA binding site. 
Ethylation of these three phosphates also interferes with repressor binding. 80 It is 
difficult to draw detailed conclusions from the 3.2-4.5A resolution cocrystal, but 
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it appears that the peptide backbone crosses over the DNA phosphate backbone 
with the carboxy terminus in the major groove, Arg4~ and Pro42 interacting with 
the DNA backbone at the crossover point and, perhaps, Arg4~ interacting in the 
minor groove.34 Anderson et al. point out that an Arg4~-Ala mutant still pref-
erentially binds to the wild type DNA sequence arguing against a specific minor 
groove contact by Arg4~. This implies that the Art-Pro-Art sequence is recogniz-
ing the DNA conformation rather than a specific hydrogen bonding pattern in the 
minor groove. They further point out that the minor groove is 2.5A narrower than 
idealized B-form DNA at base pairs 6, 7, 8 and 9 (the center of the 14bp operator), 
and therefore Arg4~ could have significant electrostatic attractions with the phos-
phates on the other side of the minor groove (phosphates 5 and 6 in figure 3). The 
Anderson model then, involves specific recognition by Art-Pro-Art of a sequence 
specific DNA conformation which is characterized by a narrower minor groove. 
The narrow minor groove at the center of the operator also appears important 
in correctly positioning the the two protein monomers for proper protein-protein 
contact. 34•81 
Interestingly, if the interaction between the Art-Pro-Art sequence and DNA 
observed in the repressor-DNA cocrystal were applied directly to EG52, the 
EDTA•Fe would be positioned in the DNA major groove. 
The other DNA binding protein containing Art-Pro-Art deserving special 
mention is the mammalian High Mobility Group-1 protein (HMG-1, also called 
a-protein). HMG-1 contains two palindromic sequence of Pro-Art-Gly-Art-Pro 
as well as a Gly-Art-Pro-Art sequence.82 Ethylation and methylation interference 
studies indicate that HMG-1 binds to stretches of five or more A•T base pairs in 
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the DNA minor groove.83 Solomon et al. speculate that the minor groove recogni-
tion is primarily a result of the unique DNA conformation of stretches of five or 
more A•T base pairs, i.e. a narrower minor groove.83 
The DNA cleaving ability of EG49•Fe, EGSO•Fe, EG51•Fe and EG52•Fe, 
binding affinities of HIN49, HINSO, HIN51 and HIN52 and dimethyl sulfate 
studies with Hin, along with the proceeding discussion, indicate that the Art-Pro-
Art amino terminus sequence of the 52mer is responsible for recognizing, via the 
minor groove, the conserved 5'-AAA in a hix half-site. It appears from the protein 
homologies for Hin, Gin, Pin and Cin (see figure 7) that there are perhaps three 
protein sequences which are capable of recognizing the same DNA sequence from 
the minor groove. These amino acids sequences are shown in figure 27. 
Figure 27: Protein sequences which apparently recognize three or more A•T base 
pairs from the minor groove. Note that this alignment differs slightly from the one 
in figure 7 in that Hin and Gin have been shifted right one residue. 
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It appears from the amino acid sequences shown in figure 27 that the conserved 
element is an Art-Pro-(Ar~/Ly~) sequence which occurs in all but Gin. The 
variation in amino acid sequence suggest that there is either more than one mode 
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of recognition or that the common Art-Pro-(Art/Ly~) sequence is competent at 
recognition of 5'-AAA in the minor groove. The mode of recognition may be based 
on the minor groove width at runs of four or more A•T base pairs and not on 
specific hydrogen bonds in the minor groove. The Art-Pro-(Art/Ly~) sequence 
may act as a "molecular caliper" which "measures" the minor groove width by 
ionic interactions accross the two phosphate backbones. The central proline would 
be required for this type of interaction due to the unique (and limited) back bone 
torsional angles of the pyrrolidine moeity which would uniquely fix the positively 
charged first and third residues. 
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Location of Carboxy Terminus 
The results with the 49 through 60 series of peptides identified the location of 
the amino termini of these peptides when bound to DNA. The two models shown 
in figure 20, which are based on the assumption of an helix-turn-helix domain in 
the major groove, differ significantly in their positioning of the 10 amino acids at 
the carboxy terminus. The amino acid sequence homology between the carboxy 
terminus of Hin and the amino terminus of .A repressor suggest that these 10 amino 
acids may form an arm which wraps around the DNA following the major groove. 
In order to test the "arm" hypothesis , as well as to differentiate between the two 
models, a strategy for incorporating BEG at any position in a synthetic peptide 
was developed. 
It was decided to replace Methionine-189 (Hin numbering), the next to last 
residue from the carboxy teminus, with a lysine residue which had been modi-
fied by covalent attachment of EDTA-GABA to the lysyl-Nf amino group. The 
target compounds were the 52mer with Nf-(EDTA-GABA)-Lysyl at position 51 
(EG*52), a double EDTA- GABA peptide ((EG)252), as well as a peptide equiv-
alent to EGSO (which did not cleave at hix half sites); EG*SO. Figure 28 shows 
the complete amino acid sequence of these three peptides as well as the points of 
EDTA-GABA attachment. 
The synthetic route to the EG* compounds is shown in Scheme 3. Starting 
with PAM-Asn resin, Nf-FMOC-Na-tBOC-L-Lysine was coupled to the Asn resin 
in place of the normal Hin methionine-189 residue. Incorporation of Nf-FMOC-
Na-tBOC-L-Lysine allowed the Nf amino group to be deprotected (piperidine in 























































































































































































































































































































































































































































resin. BEG was then coupled to the free lysyl N€ amino via DCC/ HOBt mediated 
coupling in DMF. Ninhydrin analysis indicated 99.8% reaction after 100 minutes. 
The lysyl No:-tBOC was then removed and the next amino acid (Arg-TOS) was 
coupled to the peptide-resin using the standard procedures. The remainder of the 
synthesis was carried out as described for the previous peptides. At the 52mer 
stage a portion of the peptide-resin was again coupled to BEG to give the double 
EDTA-GABA peptide; (EGh52. During the synthesis, samples of 3mer, 30mer, 
SOmer and 52mer were removed, subjected to HF cleavage, and purified by HPLC. 
The 3mer, Arg-N€-(EDTA-GABA)-Lys-Asn, was characterized by high field NMR 
and high resolution FAB mass spectroscopy, both of which were consistent with the 
target structure. The 30mer was also characterized by NMR which indicated that 
the EDTA-GABA was still present in the peptide at that stage of the synthesis. 
DNA Cleavage with EG*50·Fe, EG*52·Fe and (EGh52·2Fe 
The ability of the carboxy-terminal EDTA-GABA peptides to cleave DNA 
was investigated by high resolution gel electrophoresis of 32P - endlabelled DNA 
fragments as described earlier for EG52•Fe. The autoradiogram of DNA cleavage 
by EG*50•Fe, EG*52•Fe and (EGh52•2Fe is shown in figure 29 and cleavage 
histograms in figure 30. 
DNA cleavage with EG*52•Fe gives three very broad cleavage patterns at hixL. 
(EG h52•2Fe gives a cleavage pattern which is identical to the sum of the EG52• Fe 
and EG*52•Fe patterns. The fact that (EGh52•2Fe gives the EG52•Fe pattern 
superimosed on the EG*52•Fe pattern leads to two conclusions; (1) The synthetic 
method used to incoporate EDTA- GABA at the carboxy terminus was succesful 
and the primary structure of both EG*52 and (EGh52 is correct. (2) Since 
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Figure 29: Autoradiogram of a high resolution denaturing polyacrylamide gel of 
affinity cleaving reactions on a 32P-endlabeled fragment (Xba I - Eco RI) from 
pMFB36.1 Reaction conditions were 20mM NaCl, 20mM TRIS•HCl, pH 8.0, 400J.LM 
tRNA, 5mM DTT, and ~15,000cpm (~1ng) endlabelled DNA in a total volume of 
15J.Ll. Reactions were run for 60 minutes at 22°C and terminated by ethanol pre-
cipitation. Cleavage products were analyzed on an 8%, 1:20 crosslinked, 50% urea 
denaturing polyacrylamide gel. Lanes 1 through 8 contain 51 labelled and 9 through 
16 3' labelled DNA. Lanes 1 and 16 are DNA controls and 2 and 15 Max:am-Gilbert 
chemical sequencing marker lanes. Lanes 3 and 14 contain 0.5J.LM EG52•Fe, 4 and 
13 contain 2.5J.LM EG*52•Fe, 5 and 12 contain 0.5J.LM EG*52•Fe, 6 and 11 contain 
2.5J.LM (EG }252•2Fe, 7 and 10 contain 0.5J.LM (EG }252•2Fe and 8 and 9 contain 
10J.LM EG*50•Fe. (Left) Brackets mark hixR, secondary, tertiary and hixL bind-
ing sites. 
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hix L tertiary 
. llll 1111 . . +H . 
5' TTT A TTGG:T TC TTGAAAAC CA:AGG TTTTTGA T AA:AG CAA TC c:rc CA TGAGAA: 
3' AAA T AAC C·AAGAAC TTT T GG T·TC CAAAAAC T A TT·TC G T T AGG·AGG TACT C T T · . rrp . lftl . tttt . 
O.SJ.'M 
EG*52 ~~:~~!~~~~~ ~~~~:~~U~~ .:.~!!!!~ . ~~·~ 
~TTTATTG~TTCTTGAAAACCA:AGGTTTTTGATAA:AGCAATCC~CCATGAGAA : 
3' AAA T AAC C·AAGAAC TTTTGGT·T C CAAAAAC TAT T·T C G T T AGG·AGG TACT C T T · 
tttttttt tttttt~t tttt~tt ttt~tttt . 
(~~~.. ~nuwuJllhdllll uU!u ~uw~ 
~TTTATTG~TTCTTGAAAACCA:AGGTTTTTGATAAAGCAATCC~CCATGAGAA: 
~AAATAAC~AAGAACTTTTGGT~CCAAAAACTATT~CGTTAGG~GGTACTCTT· 
tttf:ttt trrrrttnrr ttttttt tttttt . 
Figure 30: Histograms of the gel data in figure 29. The sequence left to right is 
the bottom of the gel to just above the tertiary site in figure 29. (Top) Brackets 
mark hixL and tertiary binding sites. Arrows indicate extent of cleavage resulting 
in removal of the indicated base. 
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(EG)z52•2Fe gives the EG52•Fe pattern as a subset of its total cleavage pattern, 
inorporation of EDTA-GABA at the carboxy terminus has not grossly altered the 
DNA binding ability of the 52mer. The carboxy-terminal EDTA-GABA has, how-
ever, lowered the binding affinity of the 52mer somewhat. Comparison of the extent 
of cleavage of EG52•Fe with the portion of the (EG)z52•2Fe pattern apparently 
due to the amino-terminal EDTA-GABA indicates that the cleavage efficiency has 
been reduced by a factor of five. Assuming the reduction of cleavage efficiency is due 
to a reduced binding constant, the ~~Gassoc for (EG)z52•2Fe relative to EG52•Fe 
would be -1kcal/mol. The reduced binding affinity of (EG)z52•2Fe could result 
from three factors; (1) addition of one negative charge due to EDTA•Fe (either 
EDTA - 3·Fe+2 or EDTA - 3·Fe+3•0Ir), (2) loss of a contact made by the methion-
ine residue in the wild amino acid sequence to either the DNA or the peptide or 
(3) an incorrect steric, hydrogen bonding or hydrophobic interaction between the 
EDTA-GABA•Fe and the DNA or peptide. 
Assuming that the observed EG*52•Fe cleavage occurs in the same DNA bind-
ing conformation as the EG52•Fe cleavage and not some other binding mode, two 
conclusions can be made about the location of the carboxy terminus of the 52mer 
relative to the DNA binding site; (1) As with EG56•Fe and EG60•Fe the broad 
cleavage pattern implies that the EDTA•Fe, and hence the carboxy terminus of the 
peptide, is not held close to the DNA. (2) Though the cleavage patterns are broad 
they are clearly 31 shifted implying cleavage is occurring from the minor groove. 
This indicates that the carboxy-terminal domain of the peptide does not form an 
arm which wraps around the DNA following the major groove as proposed in the 
intial binding models. 
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In retrospect, though the sequence homology between then amino--terminal 
arm of >.. repressor and the carboxy terminus of Hin is a strong one, the fact is that 
the carboxy-terminal domains of Hin, Gin, Pin and Cin are not conserved. (see 
figure 7). Since these four proteins almost certainly have the same DNA binding 
structure, the lack of sequence homology between the six carboxy-terminal residues 
of Hin argues against a significant contribution to binding by these residues. 
In summary, the EG* results indicate that the synthetic strategy used to incor-
porate EDTA-GABA at the carboxy terminus of the 52mer peptide was successful. 
Furthermore, the observed cleavage patterns rule out the possibility of a carboxy-
terminal arm that wraps around the DNA following the major groove, and instead 
indicate that this domain is not intimately associated with the DNA. The EG* 
results do not however, preclude a helix-turn-helix domain as shown in the ini-
tial models, nor do they specifically differentiate between the two binding helix 
orientations. 
Revised DNA Binding Model 
The EG* results indicate that the binding models shown in figure 20 require 
revision. The original models were based on a helix-turn-helix domain and a 
carboxy-terminal arm in the major grove and the minor groove location of the 
amino terminus. The EG* results indicate that the carboxy terminus is posi-
tioned in such a way that the diffusable oxidant generated by EDTA•Fe does not 
have direct access to the DNA backbone. Inspection of the structure of >.. Cro 
(figure 1) indicates that Cro has a peptide backbone which turns after leaving the 
carboxy terminus of the recognition helix and runs back along the DNA backbone, 
turns again and forms a f3 sheet with itself, then crosses over the DNA phosphate 
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backbone and runs along the minor groove. In dimeric .\ Cro, the peptide chain 
forms an antiparallel f3 sheet with the equivalent strand from the other monomer 
above the minor groove (see figures 1 and 31) . If the 10 amino acid carboxy t er-
m inus of Hin follows a similar path, the carboxy terminus is located above, and 
somewhat between, helices 1 and 2 as shown in figure 31. The interaction between 
the carboxy terminus and the DNA or remainder of the protein is not required for 
DNA binding. This model is consistent with the broad and weak cleavage pattern 
observed with EG*52•Fe if the binding of the three a helices protects the ma-
jor groove directly below the carboxy- terminal EDTA•Fe. With the major groove 
protected from cleavage by the peptide, the only cleavage that is observed is that 
which results from diffusion away from the major groove binding site and into the 
minor grooves above and below. It is interesting to note that the two regions of 
Hin 139-+190 that deviate most from the Hin/ Gin/Pin/Cin protein consensus are 
the six carboxy-terminal residues and residues near the amino terminus of the pu-
tative a 1 helix (see figure 7) . The revised model suggests that these two regions 
may interact . 
The results with EG49 through EG60 allow refinement of the amino terminus 
of the model. The affinity cleaving studies indicate a minor groove recognition of 
the A4A5A6 sequence with a protein structure which is neither a f3 sheet or an 
a helix. Additionally, amino acid locations can be specified for the amino terminal 
residues of the 49, 50, 51 and 52mers within the minor groove and for the amino-
terminal residues of the 56 and 60mers located away from the DNA. 
5' 3' 
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(N) ·-· 135 131 
Figure 31: Revised binding model of the interaction between the synthetic pep-
tides (and by extension, Hin) and a hix half-site. The left hand drawing shows the 
approximate course of the peptide backbone and the location of the three helices. 
The DNA sequence shown along the 51 strand is that of hixL IRL and the solid 
diamond marks the psuedo-C2 axis. The numbers along the peptide indicate the 
approximate locations of peptide alpha-carbons (Hin numbering) relative to the 
DNA. The wavy backbone near the amino terminus represents a specific interac-
tion with the minor groove. Residue 142, the second Arg of the Arg-Pro-Arg 
sequence, interacts with A5 and A6 in the minor groove. Residue 141 is the pro-
line. Residue 140 is the first Arg in the tripeptide sequence and interacts with 
the phosphate on the 5' strand between C3 and A4. The right hand drawing is 
a spacefilling model of HIN52. The peptide atoms are highlighted. The Argl40 
interaction with the phosphate is visible at the top of the peptide. In the space-
filling model only non-hydrogen and hetero-hydrogen atoms are shown. Shown on 
the fol~owing page are stereo drawings of this complex. The upper drawing shows 
hixL and the HIN52 alpha-carbon trace. The lower drawing includes all peptide 
atoms except hydrogens bonded to carbons. In the lower drawing the interaction 




It has been shown that attachment of EDTA at a specific amino acid in a 
synthetic DNA binding peptide creates a peptide which not only reports its binding 
sites on DNA but also the groove identity and nucleotide position of the modified 
amino acid. The methods required for placement of the EDTA at any position(s) 
in the peptide sequence have been described. The EDTA attachment strategy 
has been used to investigate the sequence specific DNA binding domain of Hin 
recombinase and has helped to identify a unique, sequence specific DNA recognition 
which occurs in the minor groove. Furthermore, the EDTA•Fe equipped peptides 
are competent at double strand cleavage. This is useful for identifying alternate 
DNA binding sites on large pieces of DNA. The method of conversion of either 
the amino terminus or a single lysyl side chain to a non-standard one is general 
and should allow the construction of other synthetic peptides capable of delivering 
a reporter function (not necessarily EDTA•Fe) to a target molecule. The target 
molecules could themselves be proteins or other types of macromolecules. 
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Materials and Methods 
Nuclear magnetic resonance spectra were recorded on a JEOL JNM-GX 400 
(
1H=399.65) and are reported in parts per million downfield from tetramethylsi-
lane. Ultraviolet-visible spectra were recorded on a Beckman Model25 spectropho-
tometer, a Cary Model 219 spectrophotometer or a Hewlett-Packard Model 8451A 
spectrophotometer. Mass spectra were recorded using fast atom bombardment 
(FAB) techniques at the Midwest Center for Mass Spectrometry at the University 
of Nebraska. 
Agarose gels stained with ethidium bromide were photographed with Polaroid 
type 55 film and the negatives were scanned at 485nm on an LKB Ultroscan XL 
densitometer. Autoradiography of dried polyacrylamide gels with radiolabelled 
DNA was carried out at room temperature on Kodak X-Omat AR film. Dithiothre-
itol (DTT) was purchased from Boehringer Mannheim. All water used in biological 
reactions and dilutions was deionized and distilled using a Corning Mega-Pure sys-
tem. Aqueous (a32P) dATP and dCTP, triethylammonium salts, 3000 Ci/mmol, 
were from Amersham and aqueous ( , 32P)ATP, 5000-9000 Ci/mmol, was from ICN. 
Nucleotide triphosphates were from Pharmacia. All enzymes were from Boehringer 
Mannheim except the Klenow fragment of DNA polymerase I which was from New 
England Biolabs. Calf thymus DNA from Sigma was sonicated, deproteinized, and 
extensively dialyzed. 84 tRN A from Sigma was deproteinized by phenol extraction 
prior to use. Plasmids pMFB36 and pMS515 were gifts from Melvin Simon and 
were prepared using standard procedures.85 
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BEG Synthesis 
All reagents were commercial grades and used without further purification ex-
cept: dimethyl formamide (DMF), pumped in vacuo until there was no odor of 
amines and stored over 4A molecular sieves, and diaminoethane distilled from 
sodium hydroxide under argon. TLC's were performed on EM reagents silica gel 
plates (with UV indicator) and visualized by both UV and iodine staining; sol-
vent systems were (A) 12% concentrated ammonium hydroxide in methanol, (B) 
3% methanol in dichloromethane, (C) 3% concentrated ammonium hydroxide in 
methanol and (D) 6% methanol in dichloromethane. Chromatography was carried 
out with EM Reagents silica gel 60 (230- 400 mesh). All non-aqueous reactions 
were run under argon with rigorous exclusion of water unless otherwise noted. 
Initial attempts to prepare BEG via mono-saponification of the copper II 
chelate of EDTA tetrabenzyl ester similar to the preparation of the EDTA tri-
ethyl ester from tetra ethyl ester86 were unsuccesful due to the low solubility of 
the Cu-EDTA tetrabenzyl ester in the aqueous ethanol saponification mixture. 
Attempted mono-hydrogenation (H2, palladium on carbon) was also unsuccesful. 
EDTA Tetrabenzyl Ester: To a solution of 2.9g (lOmmol) EDTA and 5.5g 
(40mmol, 4eq.) freshly powdered potassium carbonate in 50ml hexamethyl phos-
phoramide (HMPA) was added 14.2g (80mmol, Seq.) benzyl bromide. The mixture 
was held at 90°C for 22hrs, cooled to room temperature, diluted with 60ml wa-
ter and extracted with diethyl ether (2x200ml). The combined ether layers were 
washed with O.lN sodium hydroxide (2x60ml), water (60ml) and saturated NaCl 
(60ml), dried (Na2S04) and the ether removed under reduced pressure. The crude 
product was recrystallized from 20mll:l diethyl ether/ petroleum ether (30-60°) at 
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-20°C and from 150m! diethyl ether at -20°C giving 4.9g (75%) EDTA tetraben-
zyl ester as white needles . MP = 67.2- 68.0°C , NMR (CDCI3) 87.33 (m, 20H), 
5.10 (s, 8H), 3.63 (s, 8H), 2.90 (s, 4H). 
t-Butyl---y-aminobutyrate (1): To a cold solution of 20ml concentrated sulfuric 
acid and 200ml dry dioxane (prepared cold) in a 500ml Parr bottle was added 
12g (116mmol) --y-aminobutyric acid. The mixture was cooled to -70C in a dry 
ice/ acetone bath and approximately lOOm! of isobutylene was condensed in. The 
bottle was stoppered and shaken on a Parr- rocker (no connection to H2 tank!) a t 
room temperature. After 6hrs the bottle was removed (caution, the bottle is under 
pressure) , cooled in ice, poured into cold ether (500ml) plus 250m! cold SN sodium 
hydroxide and extracted. The aqueous layer was extracted with 2x200ml ether. 
The combined ether extracts were washed with lN sodium hydroxide (2x200ml), 
dried (Na2S04) and the ether and bulk of the dioxane removed by carefull roto-
vaping at 35C. The crude product was distilled at 35C and 40-SOJ,Lm vacuum to a 
-70C trap giving 5.6g (30%) 1 as a colorless liquid which contains ca. 5% (wht) 
dioxane. NMR (CDCI3) 62.72 (t, 2H, j=7Hz) , 2.27 {t, 2H, j=7Hz) , 1.73 (p, 2H, 
j=7Hz) , 1.45 {s, 9H), 1.14 (broads, 2H). TLC{A) Rf 0.56. 
t-Butyl---y-aminobutyrate bromoacetamide(2): To a solution of 9 .5g { 47mmol, 
l.Seq) of bromoacetyl bromide in 175m! dichloromethane at -SOC was slowly added 
a cold solution of Sg (47mmol, l.Seq) triethylamine, 70mg dimethylaminopyridine 
and 4.7g (30mmol, leq) 1 in 50ml dichloromethane. The addition funnel was 
rinsed with 20ml dichloromethane. After lhr at -SOC the flask and cooling bath 
were allowed to warm to room temperature over 2 hours. The dichloromethane 
was removed in vacuo at 25C, and the residue taken up in 800ml ether and ex-
tracted with cold O.lN sodium hydroxide (2x100ml) , cold O.lN hydrochloric acid 
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(lOOml) and cold water (50ml). Drying (MgS04) and removal of solvents gave 
8.lg (97%) 2 as a light yellow liquid. The product can be chromatographed with 
3% methanol-dichloromethane. 2 does not keep very well and should be stored 
cold under nitrogen. NMR (CDCI3) 86.8 (broads, lH), 3.88 (s, 2H), 3.33 (q, 2H, 
j=6Hz), 2.23 (t, 2H, j=7Hz), 1.84 (p, 2H, j=7Hz), 1.46 (s, 9H). TLC(B) Rf 0.35. 
3: To 27ml (~40eq.) freshly distilled 1,2-diaminoethane at lOC was slowly added 
1.6g (5.8mmol) 2 in 2ml dimethylformamide. The solution was stirred for lhr at 
lOC and 2hr at 22C. Excess diaminoethane was removed by distillation under high 
vacuum at 25C and the crude product chromatographed with 5% concentrated 
ammonium hydroxide in methanol to give l.lg (75%) 3 as a yellow oil. 3 does 
not keep very well and should be stored cold under nitrogen. NMR (CDC13) 87.27 
(broads, lH), 3.30 (q, 2H, j=7Hz), 3.28 (s, 2H), 2.82 (t, 2H, j=6Hz), 2.66 (t, 2H, 
j=6Hz), 2.27 (t, 2H, j=7Hz), 1.81 (p, 2H, j=7Hz), 1.68 (broads, 3H). 1.46 (s, 9H). 
TLC (C) Rf 0.33. 
BEG-tBu: To a solution of 400mg (1.54mmol) 3 and 632mg (4.9mmol, 3.2eq.) 
diisopropylethylamine in 20ml DMF was slowly added a solution of 1.18g (4.9mmol, 
3.2eq) 97% benzyl bromoacetate in lOml DMF. The mixture was stirred lhr at 
room temperature and 15hrs at 35C. The DMF was removed in vacuo at 35C and 
the crude product taken up in lOOml diethyl ether, washed with water (3x50ml) and 
saturated sodium chloride (50ml), dried (Na2S04) and the ether removed under 
reduced pressure. Chromatography with 3% methanol in dichloromethane gave 
890mg (81 %) BEG-tBu as a yellow oil. BEG-tBu can also be chromatographed 
with 25% ethyl acetate/dichloromethane plus 0.5% water. The column must be 
completely equilibrated with solvent. NMR (CDC13) 68.07 (t, lH, j=6.0Hz), 7.33 
(m, ISH), 5.11 (s, 6H), 3.58 (s, 4H), 3.40 (s, 2H), 3.27 (s, 2H), 3.23 (q, 2H,j=6.7Hz), 
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2.80 (t, 2H, j=5.1Hz), 2.75 (t, 2H, j=5.1Hz), 2.22 (t, 2H, j = 7.5Hz), 1.76 (p, 2H, 
j = 7.5Hz), 1.42 (s, 9H). TLC(B) Rf 0.25. 
BEG: To a solution of 310mg (4401-'mol) BEG-tBu in 3ml dichloromethane was 
added 2ml trifluoroacetic acid with vigorous stirring. The mixture was stirred for 
30min at room temperature, the solvents removed under vacuum at room temper-
ature and the residue taken up in 100ml ethyl acetate. The solution was extracted 
with cold saturated sodium bicarbonate (2x150ml, if the mixture emulsifies allow 
it to sit overnight at 4C), saturated sodium chloride (150ml) followed by drying 
(Na2S04, do not use MgS04) and ether removal under reduced pressure giving 
230mg (78%) BEG as a light yellow oil. If needed, BEG can be chromatographed 
on a well equilibrated silica column using 8% methanol in dichloromethane with 
~0.8% water (saturated) . BEG does not keep very well and should be stored 
under vacuum. NMR (D6-DMSO+TFA) 88.50 (t, 1H, j=6.0Hz), 7.37 (m, 15H), 
5.23 (s, 2H), 5.12 (s, 4H), 4.40 (s, 2H), 4.08 (s, 2H), 3.76 (s, 4H), 3.39 (t, 2H, 
j=7.0Hz), 3.16 (m, 4H), 2.26 (t, 2H, j=7.3Hz) , 1.68 (p, 2H, j=7.1Hz). TLC(D) Rf 
0 .32. FAB-MS; expected M• +H=648.2920, observed=648.2914 (error=1ppm). 
Peptide Synthesis 
Peptides in the HIN31 to HIN60 series were prepared by the California In-
stitute of Technology Microchemical Facility under the direction of Dr. Suzanna 
J . Horvath.1 The general procedure is described below. Reagents, used without 
further purification, were: Burdick and Jackson HPLC grade DMF, Mallincrodt 
"Ar analytical grade" DCM, BOC-L-amino acids (with the exception of Na-BOC-
Nim_DNP-L-histidine which was from Fluka), PAM-Asn resin and 2M DCC/ DCM 
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from Peninsula Laboratories. Diisopropyl ethyl amine was from Aldrich (98%). A 
Peninisula Laboratories reactor and wrist-shaker were used for the synthesis. 
In the general procedure described below ''wash" refers to a flow wash, i.e. the 
wash solvent is added with the reactor connected to a source of vacuum so that 
the solvent passes imediately through the reactor. In general, the peptide/ resin 
mixture was not drained completely. Instead, the solution was drained only until it 
was level with the top of the resin. This avoids drawing air through the resin which, 
particularly when the resin is wet with with DCM or TFA/DCM, can condense 
considerable moisture on the peptide. 
Abbreviations: 
DMF = dimethylformamide 
DCC= N,N1-dicycloheylcarbodiimide 
DCM = dichloromethane 
DIPEA = diisopropyl ethyl a.mine 
HOBt = N-hydroxybenzotriazole 
TOS = tosylate 
OBzl = benzyl ester 
Bzl = benzyl ether 
Cl-Z = p-chlorobenzyloxy carbonyl 
Br-Z = p-bromobenzyloxy carbonyl 
DNP = 2,4-dinitrophenyl 
BOC = t-butyloxycarbonyl 












The ninhydrin assay does not work with N-terminal secondary amino acids (ie., 
proline) and is unreliable with N-termiminal tryptophanes. 
Reagents: 
.£1. 40g 100% phenol in lOml absolute ethanol. 
B . 0.2mM potassium cyanide in pyridine (pyridine is distilled from ninhydrin) . 
C. 500mg ninhydrin in lOml absolute ethanol. 
D . O.SM tetraethylammonium chloride in DCM. 
Procedure: 
1. Remove ~Smg peptide/resin from reactor. 
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2. Wash well with DCM and 1:1 methanol/ DCM on a sintered glass funnel. 
3. Allow to dry on funnel -3min. 
4. Accurately weigh the sample into a small test tube and add: 
a . 2 drops .,1. 
b . 4 drops IJ... 
c. 3 drops G. 
5. Heat at 100°C, 5min. 
6. Cool to room temperature. 
7. If there is substantial color in the beads filter through a pasteur pipet plugged with 
glass wool and wash with 60% ethanol (2x200.A), 2x200A D, and 2x200A 60% ethanol. 
8. Dilute with 60% ethanol to 3ml. 
9 . Mix thoroughly and measure O .D. at 570nm versus 60% ethanol blank; 
COUPLING CYCLE:88 
I . DCM Flow Wash (-5 vessel volumes) . 
IT. 65% TFA/DCM tBOC Removal; 
A. 1min 
B . 15min. 
ill. DCM Flow Wash, -10 vessel volumes. 
IV. 10% DIPEA/DCM Neutralization (also rinse the reactor cap); 
A. 1min 
B . DCM flow wash, -4 vessel volumes. 
C. 1min 
D. DCM flow wash, -10 vessel volumes. 
V . Coupling Cycles; 
A. Symmetric Anhydride (SA), all residues except Asn, Gin and Arg. 
1. Add a solution of 2mmol BOC-AA in 2ml DCM (may need a little DMF to get 
completely into solution). 
2. Add 1mmol DCC/2ml DCM, add DCM until inversion wets everything. 
3. After 10min do a ninhydrin test and add DMF to reactor until 2/3 - 3/4 full. 
If the coupling passes the ninhydrin test go to step I. 
4. After 30min take another ninhydrin. If ninhydrin still less than -99.6% early 
in the synthesis or -99% later, then recouple. 
-93-
Preformed Symmetric Anhydride (PSA) Recouple: 
a. DMF flow wash, 5 vessel volumes. 
b . 10% DIPEA/ DMF neutralization (prepare fresh), 1min. 
c. DMF flow wash, 10 vessel volumes. 
d . If removing DCM from PSA then DMF wash 5min. 
e. PSA preparation: 
1. Dissolve 4eq. AA in minimum DCM. 
u . Add 2eq. DCC/ DCM, stir 5min. 
m. Filter to remove DCU (strip DCM) . Add to reactor. 
1v. Fill reactor with DMF. 
v. Ninhydrin test at 30min. 
B. DCC/HOBt Coupling for Arg-TOS, Gin and Asn: 
1. 2mmol HOBt in 2ml DMF. 
2. Add 2mmol DCC in 4ml DCM. 
3. Add 2mmol AA in 2ml DMF. 
4. Add to resin, top reactor off with DMF. 
5. Ninhydrin at 30-45 minutes. If needed, this reaction can proceed 
for up to 2 hours. 
6 . If needed, recouple Gln or Asn with the same procedure 
(recouple Arg using PSA): 
a. DMF wash, 5 vessel volumes. 
b. 10% DIPEA/DMF wash (prepared fresh), 1min. 
c. DMF wash, 10 vessel volumes. 
d . Recouple as above to a 1hr ninhydrin, then a 2hr ninhydrin. 
DNP Removal: 
Resin Bound Peptide: 
1. 20% 2-mercaptoethanol, 10% DIPEA in DMF, 2x30min. 
2. DMF wash, 5 vessel volumes. 
Residual DNP Removal (after HF cleavage): 
1. Peptide at 10-20mg/ml in 4M guanidine-HCI, 50mM TRIS, pH 8.5, 20% thioethanol. 
2. 50°C, 1hr. 
Optional Small Molecule Removal: 
Mini G-10 Sephadex column, elute with 5% HOAc. 
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HF Cleavage: 
1. Remove terminal t-BOC, wash, neutralize with DIPEA/ DCM as above, wash well 
with DCM then 1:1 methanol/DCM. 
2. Vacuum dry, 30min. 
3. For a 100mg peptide/resin sample add: 
a . 0.5ml p-thiocresol (works best if this is added first) . 
b . 0.5ml p-cresol. 
4 . Cool to -70° C and condense in 10ml HF. 
5. Stir 1hr at 0°C. 
6. Remove HF under reduced pressure. 
7. Add, with stirring, 20ml diethyl ether to precipitate the peptide. 
8. Filter, wash the precipitated peptide well with ether (20~50ml) on the funnel. 
9. Wash crude peptide through funnel with DD water or 5% HOAc. 
10. Freeze and lyophilize. 
Peptide Purification 
All peptides described in this report were purified by reverse phase HPLC 
on a Beckman lnstuments HPLC using a 421A controller, 165 dual wavelength 
UV /VIS detector, two 114M analytical pumps and a Spectra Physics SP8780XR 
auto-injector controlled by the 421A controller. 
HPLC: 
Analytic: 
column: Vydac C4, 210x4mm analytic column. 
flow: 0. 7ml/min 
temperature: 37°C 
solvent A : 0.1% TFA/water 
solvent B: 0.1% TFA/60% acetonitrile/ water 
gradient: O% to 100% B in 60min 
detection: UV at 215nm (peptide) 2AUFS 
UV at 254nm (aromatics) 0.2AUFS 
sample: ~200ttg in water, 5% HOAc or A for crude material, 
~30ttg for purified material. 
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Sample straight from 5% HOAc after HF or after residual DNP removal. 
Prep: 
column: Vydac C4 , 210x25mm semiprep column. 
flow: 3.0ml/min 
temperature: 37°C 
solvent A: 0.1% TFA/water 
solvent B: 0.1% TFA/60% acetonitrile/water 
gradient: O% to 100% B in 240min 
detection: UV at 215nm (peptide) 2AUFS 
UV at 254nm (aromatics) 2AUFS 
sample: Up to 200mg in water, 5% HOAc, A or DNP mixture. 
After residual DNP removal load the entire solution in line as solvent A. Run 
solvent A until initial large peak is almost completely off then start gradient and 
fraction collection. Re-inject (analytical column) 20-100J.Ll samples of each fraction, 
pool good fractions and lyophilize. 
BEG Coupling to Resin Bound Peptides. 
The general procedure for the preparation of the N-terminal EDTA-GABA 
peptides was as follows.70 A -100mg sample of peptide/resin {loading -100J,Lmolj g, 
total peptide -10J,Lmol) was placed in a 12x80mm reactor, and the resin was swollen 
in DCM for 15 minutes. The resin was washed with DCM {5x), the terminal t-BOC 
was removed and the resin neutralized as described above. BEG {125mg, 194J,Lmol, 
20eq.) and 50mg {330J,Lmol, 34eq.) N-hydroxybenoztriazole monohydrate was dis-
solved in 2ml DMF and 42mg {203J,Lmol, 21eq.) DCC was added. The solution was 
stirred 15 minutes at room temperature and added to the peptide/resin along with 
sufficient DMF to fill the reactor 2/3 full. Ninhydrin assays were used to follow the 
reaction and typically indicated :2:97% reaction after 3-4 hours. The peptide/resin 
was then washed with DMF {4x) followed by DNP removal (see above). The final 
washes of the peptide/resin were; DMF {4x), 1:1 DCM/DMF {2x), DCM {4x) and 
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1:1 Methanol/ DCM (4x) . Though there is no terminal t-BOC group remaining , 
a final wash with TFA/ DCM helps to remove any remaining exogenous materials . 
The peptide/ resin is then dried under vacuum and subjected to HF cleavage as 
described earlier. The crude peptide is then treated for residual DNP and purified 
by preparative HP1C (see above) . Typically 3- 6mg (5-10% theoretical) of purified 
peptide was obtain after HP1C. 
EG*50, EG*52 and (EGh52 Synthesis 
The peptides with N€- (EDTA-GABA)-1-lysine near the C terminus were pre-
pared using the same peptide synthesis protocol described earlier except for the 
* incorporation of 1ys. Reagents were the same except; "Biograde" TFA from Halo-
carbon Inc. and N€-FMOC-Na-t-BOC-1-lysine (1y;) which was from Chemical 
Dynamics Corp. 
The synthesis was started with SOOJ.Lmol PAM-Asn-t-BOC resm (670J.Lmol 
amine/g). The peptide/resin, after DCM swelling and washing, gave a background 
ninhydrin of 1.9J.Lmol/g (99.7% t-BOC protected) , standard t-BOC removal gave 
a ninhydrin of llOJ.Lmol/ g . It may be advantageous at this point to determine 
free amine concentration using a picric acid titration to avoid the uncertanties of 
variable ninhydrin yields on very small peptides.87 The N€-FMOC-Na-t-BOC-1-
lysine was coupled to the peptide/ resin using the standard SA procedure and gave 
a ninhydrin value of 1.6J.Lmol/g (99.8%) . The peptide/resin was washed with DCM 
(Sx) and DMF (Sx). The FMOC group was removed with 20% piperidine/ DMF89 
(1min and 10min treatments) and gave a ninhydrin value of 370J.Lmolj g. 
BEG (1.3g, 2mmol, -3eq.) was activated with 460mg (3mmol, -4.5eq.) HOBt 
and 412mg (2mmol) DCC in 4ml DMF for 30min and added to the reactor with 
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DMF. BEG coupling, as monitored by ninhydrin analysis, was 7.7J.Lmolj g (98.4%) 
after 45min and l.1J.Lmolj g (99.8%) after 100min. The peptide/ resin was then 
washed with DMF (5x) and DCM (5x), the Na-t-BOC removed and the resin 
neutralized using the standard procedures. The deprotected peptide/ resin gave a 
ninhydrin value of 320J.Lmol/ g. 
Arg-TOS was coupled to the peptide/ resin using the standard HOBt procedure 
and gave a ninhydrin value of 1.9J.Lmol/ g (99.5%) after 30min. At this point a small 
sample of peptide/ resin was removed, HF cleaved and purified by HPLC to afford 
EG*3. High resolution fast atom bombardment (FAB) mass spectra; calculated 
M*-H+ = 776.390, observed= 776.391, difference= 1.3ppm. The 400MHz NMR of 
EG*3 in 10% TFA/ D6- DMSO, with partial peak assignments, is shown in figure 
32. 
Though it did not appear to be necessary in this synthesis, it may be advan-
* tagous to "cap" the peptide after the BEG coupling to Lys and the subsequent 
amino acid coupling with acetic anhydride or acetyl imidazole90 to minimize po-
tential side chain elongation during the remainder of the synthesis. 
The synthesis was continued to the 30mer stage at which time a sample of 
EG*30 was removed, HF cleaved and purified by HPLC. The 400MHz NMR of 
EG*30 in (10% TFA/ D6- DMSO) is shown in figure 33. Integration indicates that 
the expected amount of EDTA-GABA is still present in the peptide at this stage 
of the synthesis. 
The synthesis was then continued to the SOmer stage, where another small 
sample was removed (EG*50), and to the 52mer stage (EG*52) . Finally, another 






































































































































































Table 4: Synthesis record for EG*52. 
cycle ninydrin % 
number AA type couples jl-mol/g yield comments 
1 Asn 1 "1.9" "99.7" background ninhydrin 
2 Lys* SA 1 1.6 99.8 
2.5 BEG HOBt 1 1.1 99.8 
3 Arg HOBt 1 1.9 99.5 60mg sample EG*3 
4 Lys SA 1 1.2 99.7 
5 Lys SA 1 0.6 99.8 
6 lle SA 1 0.6 99.8 
7 Ser SA 1 1.3 99.5 
8 Ser SA 1 1.9 99.3 
9 Ala SA 1 1.5 99.4 
10 Pro SA/PSA 3 1.9 99.3 
11 Phe SA/PSA 2 0.7 99.7 
12 Tyr SA/PSA 2 0.6 99.8 
13 Arg HOBt/PSA 2 0.7 99.7 
14 Tyr SA§~SA 2 1.0 99.5 
15 Leu 1 1.0 99.5 
16 Thr SA/PSA 2 2.0 98.9 
17 Ser SA/PSA 2 1.8 99.0 
18 Val SA/PSA 2 1.5 99.2 
19 Gly SA/PSA 2 1.6 99.1 
20 lle SA/PSA 2 1.6 99.1 
21 Gly SA 1 1.6 99.1 
22 Phe SA/PSA 2 1.6 99.0 
23 lle SA/PSA 2 2.5 98.5 
24 lle SA/PSA 3 2.5 98.5 
25 Ala SA/PSA 2 1.8 98.8 
26 Leu SA/PSA 2 1.8 98.8 
27 Gln HOBt 2 2.3 98.5 
28 Gln HOBt 2 2.2 98.6 
29 Arg HOBt/PSA 3 1.5 99.0 
30 Pro SA/PSA 2 2.5 98.2 97mg sample EG*30 
31 His SA/PSA 2 "1.5" "98.9" background ninhydrin 
32 Gly SA 1 1.0 99.3 
33 Lys SA/PSA 2 1.8 98.6 
34 Glu SA§~SA 2 1.3 99.0 
35 Leu 1 1.5 98.8 
36 Leu SA 1 1.4 98.8 
37 Arg HOBt/PSA 2 1.4 98.8 
38 Ser SA/PSA 2 2.3 98.0 
39 lle SA/PSA 2 1.8 98.4 
40 Gln HOBt 2 1.2 98.9 
41 Glu SA/PSA 2 1.8 98.4 
42 Gln HOBt 2 1.4 98.7 
43 Glu SA§~SA 2 1.6 98.5 
44 His 1 1.6 98.4 
45 Lys SA/PSA 2 1.8 98.2 
46 Asn HOBt 2 1.1 98.8 
47 Ile SA/PSA 2 1.4 98.6 
48 Ala SA/PSA 2 2.4 97.5 
49 Arg HOBt/PSA 2 2.0 97.8 
50 Pro SA 1 2.6 97.2 30mg sample EG*SO 
51 Arg HOBt/PSA 2 "1.0" "98.8" background ninhydrin 
52 Gly SA 1 1.4 98.4 EG*52 
53 BEG HOBt 1 3.5 96.1 (EG)252 
average % yield = 98.9±0.6 
0.98952 = 57% 
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peptides were all subjected to DNP removal, HF deprotection, residual DNP re-
moval and purified by HPLC using the standard procedures. Table 4 contains the 
complete ninhydrin and coupling procedure record for the synthesis. 
Plasmid Preparation 
The following procedure was used to prepare both pMFB3691 and pBR322 (strain 
HB101). 
Cell Growth: 





SOX V-B salts 
50 ml autoclaved thymine (1mg/ml) 
H20 to give -980 ml total volume 
Autoclave on wet cycle, allow to cool to r.t., add: 
20 ml Sterile (autoclaved) 20% (w/v) D-glucose 
2 ml Ampicillin (25mg/ml, filtered sterile 0.45J.lM) 
1 ml Thiamine·HCl (1mg/ml, filtered sterile 0.45J.lM) 
Inoculate 11 of VB minimal with 4ml of an overnight culture of bacteria in 1-broth and 50J.lg/ml 
ampicillin (to keep selective pressure on, increases the yield of plasmid) . Shake at 37°C at 200rpm. 
Amplify when O.D.590nm = 0.6-0.9 (best to amplify at higher O.D.) Amplify by adding 2ml 
Chloromycetin sodium succinate (100mg/ml) per 11 of broth (final concentration= 200J.lg/ml) 
Chloromycetin sodium succinate = Chloroamphenical (Cm) and the 100mg/ml solution is 
made by adding 10ml of sterile H20 (via syringe) to a 1g vial of Cm and shaking until it has 
completely dissolved. 
Amplify for 12-17 hours at 37°C with shaking. 
Harvest Cells: 
Chill 21 flasks on ice bath with frequent agitation 
Load chilled cells into 500 ml bottles, balance with double pan balance. 
Spin at 5000 rpm, 4°C for 201, discard supernatants and wipe bottles dry. 
Lysis: 
Resuspend cell pellet in minimum volume ( 4-6ml) of: 
25% Sucrose 
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50mM Tris pH 8 
Transfer resuspended cells to a 70Ti (polycarbonate) tube and add: 
1.6mllysozyme (5mg/ml prepared just before use) 
-Let sit 51 on ice with occasional stirring 
5ml 0.5M EDTA pH 8 
-Let sit 51 on ice with occasional stirring 





Tris pH 8 
EDTA pH 8 
Solution to almost fill tube - (air bubble good for agitation) 
Shake vigorously (!!) until the lysates "clear" 
Looks like shampoo that's been shaken, usually 2G-30sec is O.K . 
Try to avoid clumping of lysates 
Balance tubes to ±O.Olg, load into Ti70 rotor 
Spin 30Krpm, 4°C for 301 
Pour off supernatants into 50ml polypropylene centrifuge tube 
** Avoid gluey junk near cell debris ** 
A~d 350>. of 2mg/ml RNase A (DNase free as in Maniatis), incubate 201 at 37°C 
Add 1/3 volume (-6-7ml) of 30% PEG 8000/1.5M NaCl to each tube, shake to mix and incubate 
0.5-8hr on ice (longer times give better yields) . 
Centrifuge PEG/NaCl mixture: 201 at 6Krpm, 4°C, discard supernatants 
Resuspend pellet in 2-5ml cold lOX TE using a glass rod 
CsCl spins: 
lOOmM Tris pH 8 
lOmM EDTA pH 8 
Set up 1st CsCl isopycnic banding run: 
(use lx40ml quick seal tube per 500ml of original broth) 
59.52g CsCl (ultrapure) 
+ Pellets in lOX TE 
+ 3.2ml ethidium bromide (lOmg/ml) 
+ lX TE buffer to give a final weight of : 124.00g 
This equals 80ml of 48% (w/w) CsCl and has a p -1.55. 
Stir to dissolve CsCl 
Load into VTi50 quickseal tubes, balance to ±O.Olg and seal 
Run in VTi50 rotor at 42Krpm, l7°C for 20hr. 
Vent tube at top with an 18G needle and pull lower (plasmid) band (using UV illumination) by 
puncturing quick seal tube -1 em below band with an 18G needle and lOml syringe. Keep needle 
bevel up and protect DNA from excessive exposure to UV light. 
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Thansfer bands into VTi65 tubes, fill tubes with CsCl filling solution (p = 1.55, 
400J.Lg/ ml ethidium bromide) . 
Balance tubes to ±0.01 g, seal and load into VTi65.2 Rotor. 
Spin at 55Krpm, 17°C for 12hr. 
Extract plasmid (lower) band as before, but use a 3ml syringe. 
Extract ethidium bromide with 1X TE saturated isoamyl alcohol: 
about 12-15 extractions of 1 volume each are needed 
(DNA is in bottom layer) 
check for EtBr removal with UV light 
Dialyze plasmid versus 1X Reaction Buffer (40mM This acetate, pH 7.9, 5mM sodium 
acetate) at 4 °C. 
High Resolution DNA Studies 
Preparation of Specifically Labelled DNA Fragments. Endlabelling was 
carried out in a similar way for each fragment . The following is a description of 
the procedure for the labelling and isolation of the -400bp fragment from pMFB36. 
Superhelical pMFB36 plasmid DNA was digested with the restriction endonuclease 
Xba I, then labeled at the 31 end with (a32P)dATP using the Klenow fragment of 
DNA polymerase I. A second digest with restriction endonuclease Eco RI yielded 
the 31 labeled -400bp fragment. Cleavage of pMFB36 with Xba I and successive 
treatment with calf alkaline phosphatase {CAP) , (132P)ATP and T4 polynucleotide 
kinase, and Eco RI yielded the 51 labelled fragments. The restriction fragments were 
isolated by non-denaturing polyacrylamide gel electrophoresis. Guanine specific 
chemical cleavage lanes were carried out according to Maxam and Gilbert.92 The 
specific reaction procedures and conditions are outlined below. 
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3' and 5' Labelling of -400bp Fragment of pMFB36 
General Procedures 
Ethanol Precipitation: 




For fragments larger than lkb spin at 17krpm for lOmin at 4°C. 
For smaller fragments spin 20min at 4°C. 
Discard supernatants 
Ethanol Re-precipitation: 




Centrifuge as above. 
Discard supernatants 
Phenol Extraction: 
lvol Phenol saturated with lx TE 
Vortex lmin 
Centrifuge 20sec 
Discard LOWER layer 
Ether Extraction: 
-3vol H20 saturated ether 
Vortex lmin 
Centrifuge 20sec 
Discard UPPER layer 
Choroform Extraction: 
lvol 24:1 CHC13 /i-amyl alcohol 
Vortex lmin 
Centrifuge 20sec 
Discard LOWER layer 
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Xba I Digest of 15J.Lg pMFB36: 
lOO.A pMFB36 (150J.Lg/ml) 
20.A lOx Xba I buffer 
78.A DD H20 
2.A Xba I (20u/ .A) 
200.A 37°, ~3hr 
Phenol extract 2x. 
Ether extract 3x. 
Etanol precipitate 2x. 
70% Ethanol wash. 
3' Labelling: 
15J.Lg Xba I'd pMFB36 
6.A DD H20 
S.A lOx Rae III buffer 
5,\ 66mM DTT (lOmg/ml) 
25.A dTTP+dGTP+dCTP (S.A, lOmM) 
lO.A a-32P dATP 
4.A polymerase ( 5u/ .A) 
50,\ 25°, 20m in 
1.A dATP (lOmM) 
1.A dTTP (lOmM) 
1.A dGTP (lOmM) 
1.A dCTP (lOmM) 
54.A 25°, lOmin 
CAPing for 5' labelling: 
15J.Lg Xba I'd pMFB36 
80.A DD H20 
lO.A lOx CAP Buffer 
10-\ CAP ( lu.A) 
lOO.A 37°, 30 min 
Phenol Extract 2x. 
Chloroform Extract. 
Ether Extract 3x. 
Ethanol Precipitate 2x. 
70% Ethanol Wash. 
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5' Labelling: 
15~g Xba I'd & CAP'd pMFB36 
34.A DD H20 
S.A lOx Kinase buff 
5.A 66mM DTT (lOmg/ml) 
-4.A 1-32P dATP 
2>. Kinase (NBL, 2u/ >.) 
SO.A 37°, 45 min 
Ethanol precipitate 2x. 
70% Ethanol wash. 
Eco RI Digest: 
15~g labelled DNA 
4l.A DD H20 
S.A lOx Eco RI buffer 
4.A Eco RI (20u/.A) 
SO .A 37°, 1-3hr 
Ethanol precipitate 2x. 
70% Ethanol wash. 
Resuspend in S.A ficol buffer. 
Prep Polyacrylamide Gel (5%, 1:30): 
Plug (10%, 1:30): 
2.5g acrylamide 
85mg bisacrylamide 
30mg ammonia persulfate 
5ml 5x TBE 
to 25ml with DD H20 
Stir -30min, millipore filter, add 40>. TEMED and pour plug. 
Gel (5%, 1:30): 
4.0g acrylamide 
136mg bisacrylamide 
48mg ammonia persulfate 
16ml Sx TBE 
to 80ml with DD H20 
Stir -30min, millipore filter, add 40>. TEMED, pour gel, let stand ~2 hours. 
Load labelled nucleotides and electrophorese at 240V until BPB 
reaches the bottom of the gel. 
Excise bands after 3min autoradiogram, smash ployacrylamide fragments 
between parafilm and transfer to eppendorf tubes. 
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500.>. elution buffer: 
0 .25% sodium dodecyl sulfate 
1mM disodium EDTA 
10mM magnesium chloride 
500mM ammonium acetate 
Seal with parafilm, 1(}-20hrs, 37° shaking incubator. 
Centrifuge through a quick-sep column (0.45J.tm CA, 15min). 
600.>. Phenol extract, spin Smin over phenol. 
Dry butanol extract until volume -200.>.. 
Ethanol precipitate 2x. 
70% Ethanol wash. 
Vacuum dry. 
Resuspend in DD H20 at -18kcpmf.A. 
Maxam-Gilbert G-Reaction: 
Start Buffer: 
500.>. 100mM sodium cacodylate (pH 8.0) 
100.>. 100mM magnesium chloride 
10.>. 100mM disodium EDTA 
390.>. DD H 20 
1000.>. 
Stop Buffer: 
94.>. 4N sodium acetate 
18.>. thioethanol 
126.>. DD H20 
12.>. tRNA (2mg/ml) 
250.>. 
G Reaction: 
200.>. Start Buffer 
5.>. 32P labelled DNA 
205.>. 
1.>. dimethyl sulfate 
20°, 20sec 
Stop: 
50>. stop buffer, vortex 
750.>. ethanol, invert Sx 
centrifuge 20min at 4°C 
Discard supernatants 
Ethanol re-precipitate. 
70% Ethanol wash. 
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lOO.A 1M Piperidine (99.A piperidine+ 900.A DD H20) 
90°, 30 min 
freeze , lyophilize 
SO.A DD H20 
freeze, lyophilize 
lO.A DD H20 
freeze, lyophilize 
Resuspend in formamide loading buffer at ~9kcpmj.A. 
Affinity Cleavage Reactions 
The concentration of each peptide compound was determined spectroscopically 
assuming an extinction coefficient of 2800M-1 at 275nm (two tyrosines). Peptide-
EDTA•Fe(III) solutions were prepared by mixing 0.5mM solutions of peptide-
EDTA and freshly prepared Fe(NH4)(S04h•12H20 followed by dilution to the 
appropriate concentration. The cleavage reactions were run with ~18kcpm of 32P-
endlabelled restriction fragment made up to a total concentration of 400J.LM phos-
phate tRNA (final concentration). To 9J.Ll of 32P-DNA/tRNA/buffer solution, 3J.Ll 
of peptide-EDTA•Fe(III) complex was added. Cleavage was initiated by the ad-
clition of 3J.Ll of a 25mM dithiothreitol (DTT) solution to the reaction mixture to 
give a total reaction volume of 15J.Ll and a final concentration of 5mM DTT. The 
reaction buffer was prepared to 20mM TRIS•HCl (pH 8.0) and 20mM sodium chlo-
ride. The reactions were typically run for one hour at room temperature and were 
terminated by ethanol precipitation. 
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Footprinting Reactions 
The footprinting reactions were run m a buffer of pH 8.0 containing 20mM 
TRIS•HCl and 20m.M sodium chloride and were made up to a final tRNA phosphate 
concentration of 400,uM. The footprinting reagents, MPE•Fe(III) and EDTA•Fe-
(111) , were prepared by mixing at 1mM with one equivalent of Fe(NH4)(S04)z and 
diluting immediately. To a 6,ul solution of DNA and buffer, 3J.Ll of the molecule to be 
footprinted at an appropriate concentration was added. Next, 3,ul of footprinting 
reagent (10,uM MPE•Fe(III) or 1.5m.M EDTA•Fe(III)) was added. The cleavage 
reaction was initiated by the addition of 3,ul of 15m.M DTT or 10mM sodium 
ascorbate to give final concentrations of 3m.M DTT and 2m.M sodium ascorbate, 
respectively. MPE Footprinting reactions were allowed to continue for 7min at 
room temperature, and EDTA reactions for 20min at room temperature. Both 
were terminated by ethanol precipitation. 
High Resolution Gels 
The precipitated reactions were suspended in 4,ul of 1X TBE, 80% (voljvol) 
formamide at pH 8.3 containing bromophenol blue and xylene cylanol tracking 
dyes. Recrystalization of the formamide is important to remove any traces of 
formic acid which may cause depurination upon heat denaturation. Storing the 
TBE/forma:mide loading buffer for extended periods of time results in the forma-
tion of trace formic acid. However, the dyejformamide mixture alone appears to 
be stable when frozen. Gel buffer (TBE) consisted of 89mM TRIS base, 89mM 
boric acid and 2m.M Na2EDTA, pH 8.3. The gels were either 0.4mm thick, 40cm 
long or wedge-shaped 0.2-0.6mm thick, 40cm long and were 5-8% polyacrylamide 
(1:20 crosslinked), 50% urea. The gels were pre-electrophoresed for 30 minutes 
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and then the samples were heat denatured at 95° for 2min, cooled to 0°, loaded 
onto the gel, and electrophoresed at 35mA (1400-1700V). For the ~400bp fragment 
from pMFB36, gels were typically run until the xylene cylanol tracking dye was 
llOmm from the bottom of the gel. The gels were dried using a BIO-RAD Model 
483 Slab Gel Dryer. They were then exposed to Kodak X-Omat photographic film 
at -70° with a duPont Cronex Lighting Plus intensification screen for 8-12 hours. 
The gels were subsequently re-exposed at room temperature without an intensi-
fication screen. The time for the second exposure was determined by assuming 
the intensification screen decreased the exposure time by a factor of ten. The gel 
was scanned and the data were recorded as a plot of absorbance versus distance 
scanned, quantitated and converted into histogram form. 
Double Strand Cleavage 
DNA Preparation. pMS515 is a pBR322 based plasmid which contains a 150bp 
insert containing hixL cloned in at the CJa I site.91 The plasmid was linearized 
separately with Pvu I and Ava I, phenol extracted (2x), ether extracted (3x) and 
ethanol precipitated (2x). The concentration of digested plasmid was adjusted by 
normalizing the UV adsorptions at 270nm. 
Agarose Gels The DNA cleaving reactions were carried out as described for 
the high resolution gels except the reaction buffer was 40mM TRIS-acetate, 5mM 
sodium acetate, pH 7.9. The reactions were initiated by the addition of a DTT 
solution and carried out at 22°C for 2 hours. The final reaction volumes were 
typically 15..\ and to this reaction mixture was added 2..\ lOX ficol loading buffer. 








to 15 mL 
The samples were loaded onto a vertical 4mm thick, 1% agarose gel and elec-
trophoresed versus 40mM TRIS-acetate, pH 7 .9, lOOJLM N a2EDTA at 120V until 
the bromophenol blue tracking dye reached the bottom of the gel. The DNA 
was visualized by staining with ethidium bromide (0.25JLg/ mL) followed by a 30 
minute running water de-stain. The gel was then photographed with Polaroid type 
55 positive/ negative film under UV trans-illumination. 
The molecular weight marker lane for the radiolabeled DNA was produced by 
individual digestions of pBR322 with Rsa I and Eco RI. The general digestion pro-
cedure was as described in the labelling procedures. After digestion, the reactions 
were ethanol precipitated and combined to produce the molecular weight marker 
lane. The molecular weights of-the fragments in the final marker lane mixture are; 
4363, 2118, 1565 and 680bp. 
Negatives of the gel photographs were scanned with an LKB densitometer 
and quantitated with the accompanying data analysis software. The molecular 
weights of the DNA fragments from the cleavage reactions were determined by 
comparison of the mobility of the bands observed with the mobility of the molecular 
weight standard. To obtain greater accuracy in molecular weight determination, 
some cleavage reactions were spiked with the molecular weight standard. This 
allowed direct comparison of the mobilities of the reaction fragments with the 
molecular weight standard and avoided error introduced by lane to lane variations 
in electrophoretic mobility. 
Because each double strand cleavage event produces two fragments of DNA 
which sum to the fragments original size, the cleavage of linearized plasmid DNA 
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should produce a symmetrical banding pattern. Therefore the bands resulting from 
cleavage at each site can be paired so that they sum to 4663 (the size of pMS515) . 
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CHAPTER II: 
Distamycin-Actinomycin Hybrid Affinity Cleaving Molecules 
One approach to the design of sequence specific DNA binding molecules 
that read large sequences of DNA, is to couple DNA binding units of similar 
or diverse base pair specificities. The natural product distamycin is a tris-N-
methylpyrrolecarboxamide tripeptide that binds in the minor groove of DNA at 
A•T rich sequences that are five base pairs in size. The natural product acti-
nomycin D, which consists of an aromatic phenoxazone coupled to two identical 
cyclic pentapeptide lactones is an intercalator which binds four base pairs with a 
preference for 51-NGCN-31 sequences. The synthesis of hybrids of distamycin and 
actinomycin, bis(distamycin)phenoxazone is described, where the cyclic pentapep-
tides of actinomycin are replaced by the tripeptide of distamycin. The synthetic 
hybrid DNA binding molecule should have the following capabilities; (1) bind by 
intercalation to a 51-GC sequence, (2) bind in the minor groove to the adjacent 
A+T region on both sides of the central GC, and (3) cleave the DNA to facilitate 
identification of binding sites. 
Before discussing the design and analysis of the hybrid molecules, we will ex-
amine small molecule/DNA interactions in general, as well as the two natural 
products. 
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Small Molecule-DNA Interactions 
Minor Groove Binding: The interaction of a small molecule with the minor 
groove of DNA can be broken down into several types of interactions including: 
1. Electrostatic interaction of charged molecules with the polyanion phos-
phate backbone.1 
2. Hydrophobic interactions with the sugar portion of the backbone.2 
3. Hydrogen bonding with the nitrogens and oxygens of the bases. 
Of these three types of interactions, the third would be expected to be the 
most sensitive to the base sequence at the binding site. Figure 1 shows A•T and 
G•C base pairs as viewed down the duplex axis. Potential minor groove hydrogen 
bond acceptor sites for an A•T base pair are the adenine N(3) and thymine 0(2). 
The G•C base pair is significantly different when viewed from the minor groove, 
primarily due to the amino function at guanine C(2). The cytosine 0(2) and 
guanine N(3) are still hydrogen bond acceptors, but the minor groove is partially 
blocked by the amino group at guanine C(2), which is potentially both a donor 
and an acceptor site. Interestingly, if the guanine amino function is removed, 
i.e. guanine is substituted by inosine, the I•C base pair is qualitatively the same as 
the A•T base pair when viewed from the minor groove. In synthetic DNA's, the 
substitution of inosine for guanine gives a structure which behaves more like an 
A•T than a G•C base pair with respect to resistance to forming A-form DNA.
3 
For a small molecule to hydrogen bond to the bases in the minor groove , it 
must first displace the spine of hydration, particularly in A+ T regions. The dif-
ference in hydrogen bond enthalpies between the water•DNA complex and small 
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Figu re 1: A•T and G•C base pairs. 
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molecule• DNA complex (AAH) may be quite small, even positive. However, if sev-
eral waters are displaced by a single small molecule, then the entropic contribution 
to AAG, hence the binding constant, could be substantial. 
Intercalative Binding: There are many small molecules containing planar aro-
matic ring systems which can be inserted between adjacent base pairs of duplex 
DNA in a process called intercalation.4 The classical intercalation model, based 
on model building studies , involved extending the B-form double helix with sim-
ple bond rotations to create a space for insertion of a planar aromatic molecule of 
approximately 3.4A thickness.5 This intercalation model has the following features : 
1. The rod-like structure, hydrogen bonding and covalent bonding of B-
form DNA is retained. 
2. Separation between two adjacent base pairs is approximately doubled, 
from 3.4A to -6.8A, creating space for intercalation of an aromatic 
ring. 
3. An unwinding of the double helix is required, (unwinding was estimated 
at 36°) 5 leaving adjacent base pairs positioned more directly over each 
other. 
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4. The intercalator is inserted into the opening parallel to the adjacent 
bases in such a way as to fill the space as fully as possible. 
Extensive studies aimed at verifying the preceding model have been carried 
out in the last 20 years. In particular, ambiguities in the determination of un-
winding angles based on viscosity and sedimentation coefficients have been largely 
eliminated with the development of methods employing superhelical closed circular 
(plasmid) DNA's.6'7 Unwinding angles (per intercalation) determined on plasmid 
DNA's have ranged from a high of 26° for ethidium and related phenanthridines,8 
to a low of 10° for anthracyclines.9 
Evidence has also been found for a nonclassical intercalation event.4 Asymmet-
ric distribution of bulky substituents around an intercalator, as well as a small or 
bent aromatic system, can cause asymmetric unwinding of the two strands. If the 
unwinding angle of the two strands is not equal, the resulting complex has a bend 
in the helix.lO,ll 
An important part of the driving force for intercalation appears to be trans-
fer of the hydrophobic intercalator from the aqueous medium to the hydrophobic 
intercalation cavity. Although the kinetics of intercalation are slowed down by 
bulky substituents on both sides of the aromatic nucleus, binding constants are 
frequently not affected. 12 For example, tetra-meso-pyridylporphyrins are known 
to intercalate readily, even though the pyridine rings seem far to bulky to pass 
through the intercalation cavity. Apparently, the DNA duplex denatures, i.e. the 
strands separate, and the bulky substituents are passed through the denatured 





The thermodynamics of intercalation are generally dependent on the ionic 
strength of the solution. For charged intercalators, it appears that much of the ob-
served free energy of intercalation at low ionic strength, calculated from observed 
binding constants, is due primarily to cation release from the phosphate backbone, 
and not to any especially favorable interaction between the intercalator and DNA.4 
Most mono-intercalators studied to date have exhibited from slight to quite 
pronounced specificity for G•C base pairs.4 Sequence specificity appears to be due 
to stacking interactions and/ or interaction of pendant groups, i.e. groups not part 
of the aromatic system, in the major or minor grooves adjacent to the intercalation 
site. 
Distamycin A 
Distamycin A (DST) IS a naturally occurring basic oligopeptide antibiotic 
isolated from Strepomyces Distallicus.14 It shows antifungal, antimitotic and 
anti(DNA)viral activities,15 and is used clinically as a topical ointment in the 
treatment of chickenpox, herpes zoster and eruptions resulting from smallpox vac-
cinations. 
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Extensive studies have been carried out on DST, including total synthesis16 
and numerous homologs. 17 An x-ray crystal structure of the related dipyrrole 
netropsin (NET) (as the sulfate salt) indicates that the majority of the molecule 
is essentially flat, with a pronounced curvature in the pyrrolef peptide backbone. 
The amide nitrogens are on the concave side and carbonyl and methyl groups on 
the convex side. 18 
NET 






+N~ 0 I 
DST 
Numerous studies of the DST•DNA interaction have appeared. The following 
1s a brief synopsis of some of the relevant data. Equilibrium binding constants, 
obtained from sedimentation data, indicate a binding constant for preferred sites 
of 2.4x109M-1 (1 DST:8 base pairs) as well as ..... 1Q6M-1 (1:3) for a weaker binding 
process. 19 DST binding to double stranded DNA increases the thermal denatura-
tion temperature of the DNA19 and causes a bathocromatic shift in the DST ad-
sorption spectra, 15 as well as cotton effects in the circular dichroism spectra. 20 
Binding site size, determined by a number of techniques, shows DST to bind to a 
six base pair length of DNA for preferred sites.21 
Binding is non-intercalative22•23 and methylation (minor and major groove) 
d I I . ( . ) d" . d" b" d" . th . 24 25 an g ycosy at10n maJor groove stu 1es m 1cate m mg m e mmor groove. ' 
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Sequence specificity appears to be for A+T rich regions of DNA,24 with a minimal 
number of A/T switches, 5'-AAAAAA > 5'-ATATAT) .26 Structural studies indicate 
that the basic N-methylpyrrole oligopeptide antibiotics bind in the minor groove 
of A+T rich regions of DNA, with both specific and non-specific interactions. The 
amide hydrogens are involved in hydrogen bonding with the 0 (2) of thymine and/ or 
N(3) of adenine, and contribute to the sequence specific binding component.17 
Electrostatic interaction of the positively charged end group(s) of the antibiotic 
and the polyanion backbone of the DNA contribute to the non-specific interaction. 
There also appears to be a significant entropic (from release of bound water) and 
hydrophobic contribution to the free energy of binding. Conformational changes 
in the DNA caused by G•C base pairs, and/or steric interactions with N(2) of 
guanine, substantialy reduce the affinity for G+C rich regions of DNA, though 
I+C rich synthetic DNA's have high affinity for DST.27 
NMR studies of an oligonucleotide-netropsin complex confirm the groove and 
sequence specificity, hydrogen bonding contacts and increased resistance to thermal 
denaturation required by the preceding model for N-methylpyrrole oligopeptide 
binding to DNA.28•29 Additionally, the x-ray crystal structure of a complex be-
tween netropsin and a 14bp oligonucleotide further confirms the groove, hydrogen 
bonding and hydrophobic interactions.30•31 
. . . h I d MPE F 32 33 d ffi 't 1 . 34- 36 Footprmtmg, with bot D N ase an - e, ' an a m y c eavmg 
methodologies have been applied to DST binding to heterogenous DNA. Both 
studies confirm the A+ T sequence specificity, as well as giving a more direct de-
. . f h b' d' ' t . h' h . . 11 fi b . 32•33 termmatwn o t e m mg SI e size, w IC 1s nomma y ve ase pairs. 
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Actinomycin D 
Actinomycin D (ACT)(D= C 1= X 1=I1) is a red, crystalline antibiotic isolated 
from the culture of Streptomyces. It consists of a planar aromatic system (phe-
noxazone) coupled to two identical cyclic pentapeptide lactones. Numerous total 
syntheses of ACT have been reported37- 40 as well as many derivatives.41•42 
ACT exhibits some antibacterial activity, especially against Gram ( +) bacte-
ria such as B. Subtilis, and has also been shown to inhibit replication of double 
stranded DNA viruses, although RNA viruses are unaffected.43 Studies on the in-
teraction of ACT with DNA have been extensive.41•42 Spectrophotometric2 and 
equilibrium dialysis44 studies of ACT binding to both natural and synthetic DNA's 
have indicated an apparent binding constant of 0.6-3.3x106M-1 and a binding site 
size of 4.5-6 base pairs.2 In a classic study, Muller and Crothers determined the 
kinetics of ACT binding to heterogenous DNA.2 The data indicated at least five 
different DNA•ACT complexes present during the course of the reaction and at 
equilibrium. Based on the observed kinetics and the effect of chemical modifica-
tion of actinomycin C3 (C3 differs from D in that both D-valine residues in the 
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cyclic peptides are replaced by D-alloisoleucine)45, the binding mechanism shown 
in scheme 1 was proposed. The first two steps are very fast (k1~1.5x104Msites-1 , 
k2~5sec-1), the third and forth slower (k3~k4~0.2sec- 1) and the final two very slow 
(ks~k6~0.002sec-1 ). The slowness of the last two steps was attributed to the rup-
ture of an internal hydrogen bond in each of the peptide rings. The kinetic data 
allows the determination of an intrinsic binding constant for actinomycin c3 of 
I 1/~,1 I CFP AD, QGJ 
AD: i '~/ i AD, i H D A 
AD4 
Scheme 1: Schematic drawing for the proposed mechanism for the reaction of 
ACT with DNA.2 The reaction begins at the left with DNA (D) and actimomycin 
(A); the DNA base pairs are represented by horizontal lines, as is the actinomycin 
chromophore. The actinomycin peptide rings are viewed from the edge; it is sup-
posed that their faces interact with each other in solution. In complex ADl> the 
chromophore has been inserted between the base pairs, and in complex AD2 the 
peptide rings reorient themselves to interact more favorably but non-specificly with 
the DNA backbones; the rings are viewed from their faces. In complex AD3 and 
AD4, one or the other of the peptide rings undergoes a conformational change 
which adapts it to interact specifically with the DNA, and in form ADs both rings 
have been so rearranged. At equilibrium, only AD3, AD4 and ADs are present in 
significant amounts, with about half the complex present as ADs. 
· ( ) 46 d dG4 1 48 X-ray crystal structures for 1:2 complexes of ACT w1th d GpC an ' 
show an intercalative like structure and specific hydrogen bonds from the guanine 
2-amino group to the carbonyl oxygen of the L-threonine residue, as well as two 
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hydrogen bonds between the D-valine residues of the peptide rings. Further evi-
dence for an intercalative mode of binding comes from changes in superhelicity of 
,PX174 RF DNA on binding ACT, giving an unwinding angle of 26° (analytical 
ultracentrifugation).22 As an intercalator, ACT is unusual in several respects:4 
1. It is one of the few known intercalators which is uncharged.2 
2. Its binding constant is nearly ionic strength independent. 
3. It exhibits unusually slow kinetics for an intercalator. 
4 . .6.H of binding to DNA is positive, +2kcal/mol.49•50 
5. It has a large negative temperature coefficient of solubility m water 
(128 mg/ml at 1°C, 0.8mg/ml at 20°C)33 which may be related to the 
large entropic contribution to binding.51 
6. Based on light scattering experiments52 and a 2:1 co-crystal structure 
with d(GpC),46 ACT may also crosslink DNA (non-covalently). 
Sequence preference is for nucleotides with 2-amino functions such as guanine or 
diaminpurine though there are exceptions.48 The alternation of purine and pyrimi-
dine also appears important.44 ACT affinity for repeating homopolymers has been 
determined; 5'-GC>GGG>GT,GTT>GA,GAA,GTA>GAT-3'.44 Stacking interac-
tions also appear to be important in determining ACT's sequence specificity. The 
dipole moments of a G•C base pair are expected to interact favorably with the 
charge distribution in the phenoxazone ring system:2 •53 
NMR has provided additional data on preferred stacking interactions. Studies 
with dinucleotides suggest that the quinoid portion of the phenoxazone ring sys-
tem prefers to stack with guanine, while the benzoid portion binds adenine and 
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guanine equally well. 54•55 It has been suggested that stacking interactions are more 
responsible for sequence specificity than is hydrogen bonding between the peptide 
and guanine 2-amino function. 54•55 
As noted earlier, ACT is unique in that AH of binding is +2kcal/ mol. This 
implies a large contribution from entropy effects resulting from release of partially 
bound water molecules associated with the peptide rings and/ or DNA.55 The AH 
of binding for actinomine at low binding densities is ~-7 kcal/mol (Kapp:::::l06M-1).2 
H+ H+ 
/'N............... /'N ............... 
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It is unclear however, how much of the difference between ACT and actinomine is 
due to the removal of the peptides from ACT and how much is due to the addition 
of two positive charges in actinomine. Unlike ACT, actinomine binding is highly 
dependent on the ionic strength of the solution.4 
ACT-DNA interactions have also been studied on heterogenous DNA using 
MPE-Fe and DNase I footprinting methods.32•33 The footprinting results agree 
well with the homopolymer binding studies, and further indicate a preference for 
51- GC-31 flanked by A•T base pairs as an optimal site. 56 Figure 2 shows footprinting 









































































































































































































































Simultaneous DST and ACT Binding 
Given the radically different binding modes of ACT and DST (intercalation 
versus minor groove binding) the question still remains whether the DNA helix can 
accommodate both of these ligands within close proximity, despite their unique 
distortions to the DNA structure. Fortunately, there is sound literature evidence 
indicating that proximal binding of the two ligands is possible. 
Spectral titration, circular dichroism and methylation studies on the effect 
of ACT binding to DST-DNA complexes indicate that binding of ACT does 
not give rise to appreciable dissociation of DST at normal binding densities.25 A 
reasonable, but not theoretically rigorous, treatment of spectral titration data for 
the simultaneous binding of ACT and NET indicates that adjacent binding is 
possible and that each ligand's total neighbor exclusion is consistent with its van 
der Waals radius. 24 This implies that longer range effects are small enough to not 
significantly affect the adjacent binding of another ligand, even if the ligand has a 
different binding mode. 
An NMR study of simultaneous NET and ACT binding to a synthetic do-
decamer, 51-CGCGAATTCGCG-3', provides further evidence for adjacent binding 
on a defined sequence.60 Analyses of changes in chemical shift and half-life of the 
guanine H(l) and thymine H(3) imino resonances, as well as of backbone phos-
phorous shifts, indicate that two 40and a NET can simultaneously bind to the 
dodecamer as shown in figure 3. 
Of further interest is the observation that the binding of two 40destablizes 
the A+ T core of the dodecamer (lowers melting temperature and decreases imino 
proton half lives from 56 to ~28msec). NET binding, however, stabilizes the same 
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ACT DST ACT 
Figure 3: Simultaneous binding of two ACT's and one DST to a 14bp oligonu-
cleotide. 
region (imino half live increases from 56 to 165msec) and causes small chemical shift 
differences in the adjacent G+C regions. Simultaneous binding of both antibiotics 
(two 40and one NET) gives results which are very nearly equal to the sum of the 
independent effects. For example dA•dT core imino proton half lives increase from 
56 to 130msec (~tl/2=+74) as compared to ~t 1;2 's of +109 msec for just NET or 
-28msec for two ACT's. 
The preceding discussion indicates that intercalation of ACT and minor groove 
binding of DSTin close proximity are indeed possible even though the two bind-
ing modes exert different constraints on the duplex DNA structure. The final 
remaining question then is, whether an intercalator and a minor groove binder 
can be covalently linked in such a way that the sequence specificity and the abil-
ity to simultaneously bind both moeities is retained. During the course of the 
work described here, Krivtsova and coworkers have reported the synthesis of a 
series of hybrid molecules, called distactins, which have one, two and three N-
methylpyrrolecarboxamides directly attached to the 1,9 positions of the phenoxa-
zone chromophore.61 From spectrophotometry, viscometry and flow birefringence 
studies they concluded that the distactin containing three N-methylpyrrole rings 
is bound to DNA only on the outside of the double helix through the peptide frag-
ments, and that intercalation of the phenoxazone does not take place. Distactins 
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with one or two N-methylpyrroles appear to have both intercalation and groove 
binding modes. 
BEDP: Design and Synthesis62 
Based on the preceding discussion of ACT binding and the apparent sources 
of G•C specificity two important points emerge: stacking interaction of adjacent 
G•C base pairs with the phenoxazone ring system contributes to specificity, as does 
the hydrogen bond between the guanine 2-amino and the carbonyl oxygen of the 
peptide L-threonine residue. The smallest portion of ACT which may still retain 




The phenoxazone ring system is completely retained. The threonine residue is 
replaced with glycine to simplify the structure while retaining the amide carbonyl 
function with a similar spatial arrangement. The rest of the cyclic peptide lactones 
are removed. The remaining question then, is how to couple the intercalator with 
the affinity cleaving molecule EDTA-distamycin (ED) without affecting both their 
abilities to bind to DNA. 
A combination of model building and judicous use of Occam's Razor60 sug-
gest that a reasonable first generation target structure involves direct coupling 
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of the intercalator (shown above) and groove binding moieties giving bis(EDTA-
distamycin-glycyl)phenoxazone (BEDP) . For comparison, the iron chelates of 
EDTA-distamycin35 and bis(EDTA-distamycin)fumaramide63 (BEDF) will also 
be included (see figure 4) . 
It is hoped that the hybrid of ACT and DST will bind to a DNA sequence 
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Figure 5: Stylized drawing of the DNA binding model of a hybrid DST-
intercalator molecule showing the targeted hydrogen bonding pattern. 
Synthesis 
The synthetic route to bis(EDTA-distamycin-glycyl)phenoxazone (BEDP) 
1s shown in Scheme 2. Compound 1 was prepared in eight steps (27% over-
all) from N-methylpyrrole-2-carboxylic acid using a modification of a published 










Figure 4: The iron chelates of EDTA-distamycin (ED), bis(EDT A-distamycin)-
fumaramide (BEDF) and bis(EDTA-distamycin-glycyl)phenoxazone (BEDP). 
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protected 3,31-diamino-N-methyldipropylamine (7) afforded 2 in 79% yield. The 
protected aromatic precursor to the phenoxazone ring system ( 4 b) was prepared 
in three steps from the commercially available 2-nitro-3-hydroxy-4-methylbenzoic 
acid in 83% overall yield. Catalytic hydrogenation of 2 and subsequent condensa-
tion with the carbonyldiimidazole adduct of 4b gave 5a in 48% yield. Deprotection 
of 5a to afford 5b (93%) and condensation with excess carbonyldiimidazole acti-
vated EDTA-triethyl ester afforded 6a in 95% yield. Saponification of 6a, catalytic 
hydrogenation of 6b and subsequent oxidative coupling with potassium ferricyanide 
in 1:1 methanol/phosphate buffer (pH 7.1) followed by chromatography on Am-
berlite XAD-2 gave the red-orange hexazwitterion of BEDP in 60% yield. 
Affinity Cleaving Assays 
The DNA cleavage efficiency of BEDP•Fe(II) was investigated by monitoring 
the conversion of supercoiled pBR32264 plasmid DNA (form I) to open circular 
(form II) and to linear form (form III) (Table 1). One single strand scission con-
verts form I to form II. In the presence of 0 2 and dithiothreitol (DTT), 0.1J.LM 
concentration of BEDP•2Fe(II) converts form I to 82% form II and 18% form III. 
The sequence and site size of the DNA binding sites were examined by analysis 
of DNA cleavage on 32P end-labelled DNA restriction fragments by denaturing 
polyacrylamide gel electrophoresis as shown in figure 6. A 517 base pair Rsa I-
Eco RI restriction fragment (base pairs 3848 to 4362) from plasmid pBR322 DNA 
was labelled separately with 32p on the 51 and 31 ends. The DNA fragments were 
allowed to react with BEDP•2Fe(II) (5J.LM concentration) at BEDP /DNA base 
pair ratio of 0.05 in the presence of DTT (5mM) for two hours (37°C, pH 7.9). The 
DNA cleavage sites were visualized by high resolution gel electrophoresis (figure 7). 
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Scheme 2: Synthetic route to BEDP. 
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Table 1: Cleavage a of pBR322 by BEDP•2Fe(II). 
BEDP•2Fe(II) % %low mw 
(J.LM) Ib II III linear DNA 
1.0 0 15 28 58 
0.1 0 82 18 0 
0.01 58 39 3 0 
0.001 86 14 0 0 
a. 10J.LM bp, buffer (40mM TRIS, 5mM NaOAc, pH 7.9), 5mM DTT. Reactions 
were run 1hr at 25°C, BEDP•2Fe(II) annealed with pBR322 5min at 65°C prior 
to addition of DTT. 
b. Corrected for decreased stainability of form I DNA. 
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high resolution gel 
Figure 6: Scheme for the affinity cleaving method. (Left) A molecule equipped 
with two EDTA functions gives two cleavage loci which are asymmetric on opposite 
strands of a 32p end-labelled restriction fragment. Lengths of arrows indicate 
frequencey of cleavage. (Center) Cleavage patterns visualized on the autoradiogram 
of a high resolution denaturing polyacrylamide gel. (Right) Assignment of binding 
site boundaries based on the model of Schultz et al. 35•36 
From densitometric analysis of the autoradiogram (lower half of figure 7), the DNA 
cleavage patterns reveal a major cleavage site flanking the ten base pair sequence, 
51- TATAGGTTAA-3' (figure 8). One interpretation of the data suggests that the 
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tripyrroles are binding simultaneously at A•T rich sequences, four base pairs in 
size, flanking a central 5'-GG-3' phenoxazone binding site. Although not proven, 
this is consistent with the groove binder-intercalator-groove binder mode. 
However, at two other sites (middle of the autoradiogram) single cleavage loci 
are observed. One interpretation of this data is that only one tripyrrole or possibly 
a tripyrrole-phenoxazone (groove binding-intercalation) is binding at these sites. 
The absence of two cleavage loci prohibits the assignment of binding location and 
site size. 
From the histograms and binding locations illustrated in figure 8 we see that the 
tripyrrole EDTA-distamycin (ED) binds the five base pair site, 5'-TTTTT-3'. The 
octaamide, bis(EDTA-distamycin)fumaramide (BEDF), binds the same location 
but of larger site size, 5'-ATTTTTATA-31• In contrast, bis(EDTA-distamycin-
glycyl)phenoxa.zone (BEDP) shzfts the binding location to a sequence that is ten 
base pairs in size, 5'-TATAGGTTAA-3'. Although we present no data here on 
whether the phenoxazone is intercalating, the apparent binding site size of ten base 
pairs and the binding sequence of four A•T flanking both sides of a GG sequence 
suggest that this may be a site where the hybrid molecule is binding in a simulta-
neous (though not necessarily equal) groove binding-intercalation-groove binding 
mode. This is in contrast to the corresponding distactin studied by Krivtsova et 
al. 61 The molecules have in common a tris-N-methylpyrrole covalently tethered to 
the 1,9 positions of the phenoxazone. However, the distactins61 are directly cou-
pled whereas BEDP described here has a glycine tether which acts as a hinge and 
preserves the postulated critical carbonyl recognition functional group. 
Because there are 524,800 unique sequences of double helical DNA that are ten 
base pairs in size, it is likely that we have not yet identified the optimal 10 base pair 
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Figure 7: Autoradiogram of 3' (lanes 1- 5) and 51 (lanes 6- 10) 32P end-labelled 
517bp DNA restriction fragment on a high resolution denaturing wedge gel. 
Lanes 1 and 6, intact DNA; lanes 2 and 7, Maxam-Gilbert G reaction; lanes 3 
and 8, ED•Fe(II), 5J.L.M; lanes 4 and 9, BEDF•2Fe(II), 1J.L.M; lanes 5 and 10, 
BEDP•2Fe(II), 5J.L.M. Bottom to the middle of the gel is the sequence left to right 
in figure 8. 
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recogntion site for bis( distamycin- glycyl)phenoxazone. The data presented here 
only suggests that 10 base pair recognition may be possible with this molecule . 
Indeed, this is not an obvious result when one considers that actinomycin, which 
most likely unwinds flanking sequences (by intercalation), and distamycin, which 
most likely binds B form DNA, could present a potentially incompatible situation. 
We also see in figure 8 that the single cleavage loci at the other sites suggest 
that simultaneous groove binding of the tripyrroles is not occurring at these sites. 
Perhaps, at these sites, there is intercalation of the phenoxazone with sequence 
dependent distortions on both sides of the intercalation site. This leaves only one 
site compatible with tripyrrole binding. 
Second Generation Hybrid 
The results with BEDP suggest that though simultaneous groove binding and 
intercalation occur at some sites, at other sites this is not the case. Furthermore, 
the observation by Kristova et al ., that the directly coupled tripyrrole-phenoxazone 
only binds the tripyrrole units and not the phenoxazone suggests that the nature of 
the linker between the phenoxazone and tripryrrole unit is of critical importance. 
Re-analysis of the binding model in figure 5 indicates that in essence, BEDP uses 
a pyrrole unit as a linker function to connect the glycyl-phenoxazone to a dipyr-
role unit. The glycyl unit is not a linker since its carbonyl oxygen was designed 
to interact, via a specific hydrogen bond, with the guanine 2-amino group. If the 
glycyl carbonyl is directed into the DNA minor groove, the amide hydrogen of the 
amino terminus tripyrrole unit must be directed out of the minor groove. This 
orientation of the amide unit is reversed relative to the normal DST binding con-
formation and is problematic in two ways. First, the carbonyl recognition element 
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is shifted by one backbone bond relative to the normal pyrrole carboxamide NH 
recognition element. Secondly, the carboxamide orientation is rotated 180° relative 
to the orientation observed in both the NET and NET•DNA crystal structures. 
This rotated carboxamide is presumably a higher energy conformation. These two 
problems indicate that BEDP must assume a higher energy conformation in order 
to adopt the targeted binding conformation. Furthermore, if the glycyl carbony l 
does assume the proper configuration, then the amino-terminal pyrrole unit must 
be forced out of register compared to the normal DST-like binding. Since a pyrrole 
is a rigid unit, it would be difficult for the two remaining pyrroles to get back into 
proper register with the DNA minor groove. 
The preceding discussion suggests that the amino terminus pyrrole is acting 
as an excessively rigid linker function, and, additionally, is biasing the glycyl car-
bonyl towards an incorrect conformation. Therefore, we have redesigned the hybrid 
molecule in an attempt to remove these difficulties. Replacement of the amino t er-
minus pyrrole unit with a 1-aminobutyric acid (GABA) linker should minimize 
these problems. Once the pyrrole unit is removed, the incorrect biasing of the gly-
cyl carbonyl should no longer be a problem. Additionally, the increased flexibility 
of GABA should facilitate the proper registering of the two remaining pyrroles 
within the minor groove. The second generation hybrid is formally related to the 
dipyrrole NET; bis(EDTA- netropsin-glycyl-GABA)phenoxazone (BENP). 
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Synthesis of BENP 
The synthetic route to bis(EDTA-netropsin-glycyl-GABA)phenoxazone is 
shown in Scheme 3. N,N'-Carbonyldiimidazole mediated coupling of the dipyrrole 
nitro acid 8, with mono-tBOC protected 3,3'-diamino-N-methyldipropylamine (7) 
afforded 9 in 71% yield. Catalytic hydrogenation of 9 and subsequent condensation 
with the carbonyldiimidazole adduct of 10a gave 11a in 44% yield. Deprotection 
of 11a to 11b (95%) and condensation with excess carbonyldiimidazole activated 
EDTA-triethyl ester afforded 12a in 78% yield. Saponification of 12a, catalytic 
hydrogenation of 12b and subsequent oxidative coupling with potassium ferri-
cyanide in 1:1 methanol/phosphate buffer (pH 7.1), followed by chromatography 
on Chellex-100, gave the red-orange hexazwitterion of BENP in 71% yield. 
DNA Cleavage with BENP·2Fe 
The sequence specific DNA cleavage ability of BENP•2Fe was examined 
on a 517bp 32P end-labelled restriction fragment from pBR322 as described for 
BEDP•2Fe. Figure 9 is the autoradiogram and figure 10 the histograms for 
the cleavage reaction. For comparison, BEDF•2Fe and the original hybrid, 
BEDP•2Fe, are included in figures 9 and 10. The binding sites for BENP•2Fe 
are different than those for both BEDP•2Fe and BEDF•2Fe. The left-hand-
most BEDP site (5'-TATAGGTTAA, figure 10), the possible minor groove-
intercalation-minor groove site, is lost with the redesigned BENP. Instead, 
BENP binds nearly the same site as BEDF in this region. The strong cleav-
age on the left hand end of this site indicates that one dipyrrole unit is tightly 
binding in the DNA minor groove, and is shifted right -1bp relative to BEDF. 
The broad cleavage pattern on the right hand end of this site implies that the other 
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dypyrrole unit is not binding tightly in the minor groove. BEDP•2Fe gives two 
ambigous cleavage loci (center of the histogram in figure 10). With BENP•2Fe, 
the left hand locus is also observed, though it appears to be less tightly bound, 
and the right hand one is lost. 
The most intriguing binding/ cleavage sites are the ones just below the arrow 
m figure 9 and on the right hand side of the histograms in figure 10. In this 
region BEDF binds the 8bp site 51-TTATTTTT-3'. The original hybrid molecule, 
BEDP, apparently has overlapping binding sites in this region, giving at least four 
cleavage loci. The DNA cleavage patterns do not lend themselves to anaylsis of 
binding sites. It appears, however, that part of the BEDP•2Fe cleavage pattern in 
this region is similar to that of BEDF•2Fe. BENP•2Fe, on the other hand, gives 
a much less ambigous cleavage pattern in this region. It appears that there are two 
ajoining lObp binding sites; 5'-ATTTGTTTAT-3' and 5'-TTTTCTAAAT-3', and 
that the very strong cleavage between the sites is due to the combined cleavage 
of two EDTA•Fe's, one from each binding site. It appears that the redesigned 
hybrid, BENP, is indeed more specific than the original hybrid molecule. However, 
BENP still appears to have monomeric and/or dimeric binding modes, though to 
a lesser extent. The two strong 10bp binding sites both include a single guanine 
residue at either the fifth or sixth base pair, i.e. stradling the center of the site. 
The inclusion of a single guanine at the center of the site, and the ± 4bp binding 
site shift relative to the fumaramide linked tripyrrole compound (BEDF), both 
suggest that at these two sites, binding may be minor groove-intercalation-minor 
groove as designed. It is also interesting to note that the cleavage pattern for 
BEDP•2Fe at this 20bp region is essentially the sum of the cleavage patterns for 
BEDF•2Fe and BENP•2Fe. This indicates that the original hybrid exhibits some 
of the DNA binding modes of both BENP and BEDF. 
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Figure 9: Autoradiogram of 51 (lanes 1- 5) and 3' (lanes 6-10) 32P end-labelled 
517bp DNA restriction fragment on a high resolution denaturing wedge gel. Re-
action conditions were end-labelled restriction fragment (~18,000cpm), lOOJJ.M 
bp calf thymus DNA, 20mM TRIS•acetate pH 7.9 and 5mM DTT. BEDF•2Fe , 
BEDP•2Fe and BENP•2Fe were equilibrated with the DNA for two hours at 
37°C prior to the addition of DTT. Reactions were run two hours at 37°C and 
terminated by ethanol precipitaion. The 32P end-labelled products were analyzed 
on an 8%, 1:20 crosslinked 50% urea denaturing polyacrylamide wedge gel (0.2mm 
thick at the top and 0.4mm thick at the bottom). Lanes 1 and 10 are intact DNA; 
lanes 2 and 9, Maxam-Gilbert G reaction; lanes 3 and 8 BEDF•2Fe(II), 0.5JLM; 
lanes 4 and 7 BENP•2Fe(II), 0.5JJ.M; lanes 5 and 6 BEDP•2Fe(II), 1JJ.M. Bottom 
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Does the Phenoxazone Intercalate? 
The two strong cleavage sites observed for BENP, 5'-ATTTGTTTAT-3' and 5'-
TTTTCTAAAT-3', suggest that both of the dipyrrolecarboxamide units are bind-
ing in the DNA minor groove and that the phenoxazone is intercalating. To de-
termine if the phenoxazone is still competent at intercalation, the UV / VIS spectra 
of BENP•2Fe was examined in the presence and absence of calf thymus DNA. 
When bound (intercalated) to DNA, the ACT phenoxazone visible adsorption at 
445nm undergoes a -20nm red shift with 30% decrease in extinction.2•65 Simi-
larly, NET binding to DNA also induces a red shift and hypochromic effect in the 
NET UV adsorption at 296nm. 
Figure 11 shows the UV /VIS spectra of 5J.LM BENP•2Fe(III) in the absence 
and presence of 5mM bp calf thymus DNA (1:1000). In the presence of calf thymus 
DNA, the phenoxazone adsorption undergoes a 25nm bathochromic shift and re-
duction in extinction. The adsorption for the dipyrroles at 296nm also undergoes 
a red shift (-14nm) and reduction in extinction. These two observations indicate 
that the phenoxazone is still able to intercalate, and that the dipyrrolecarboxamide 
units bind to the DNA in a manner similar to NET. Though the UV / VIS results 
do not specifically indicate simultaneous binding of all three domains of BENP, 
they do indicate that both the dipyrrole units and phenoxazone are still competent 
at their respective binding modes. 
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Figure 11: UV /VIS spectra of 5J.LM BENP•2Fe(III) in the absence (curve a) and 
presence of 5mM bp calf thymus DNA (curve b). The spectra of 5mM bp calf 
thymus DNA has been subtracted from curve b which is the source of the noise 
below 300nm. The adsorption around 450nm is due to the phenoxazone moeity 
and the one near 300nm is due to the dipyrroles. 
Double Strand Cleavage with BENP·2Fe 
Since there are 524,800 unique 10 base pair DNA sequences, it is possible that 
we have not examined the best binding sites for BEDP and BENP. However, since 
both hybrids contain two chelators, they should at least be reasonably competent 
at double strand cleavage. Double strand cleavage on larger DNA fragments should 
allow the searching of a large number of potential binding sites, as well as giving an 
indication of the overall specificity of the two hybrids. To examine their abilities to 
cause double strand cleavage, BEDP•2Fe and BENP•2Fe were allowed to react 
with 32p end-labelled linearized pBR322 ( 4363 base pairs) under standard reaction 
conditions. The 32p labelled reaction products were analyzed by non-denaturing 
polyacrylamide gel electrophoresis followed by autoradiography (figure 12). 
The DNA double strand cleavage caused by 0.5J.LM BEDF•2Fe gives one strong 
-152-
Figure 12: Non-denaturing agarose gel autoradiogram of DNA double strand 
cleavage. pBR322 was linearized with Sty I and 32P end-labelled at only one 
3' end. DNA cleavage conditions were the same as in figure 9. Lane 1 is a DNA 
control, lane 2 is a molecular weight marker ( 4364, 3371, 2994, 2368, 19998, 1768, 
1372, 995 and 666 base pairs top to bottom), lanes 3 and 4 are BENP•2Fe cleavage 
reactions at 0.4 and 0.2J.LM, respectively. Lanes 6 and 7 are BEDP•2Fe cleavage 
reactions at 1.0 and 0.4J.LM, respectively. Lane 8 is 0.4J.LM BEDF•2Fe cleavage 
reaction. 
-153-
BENP BEDP BEDF 
..... 
~ ~ ~ ~ ~ I:: ;;; ....::.:: :::i.. :::i.. :::i.. :::i.. ...... ..... --c ro "'<:1' N 0 ~ ~ 
u 6 0 0 - 0 c 1 2 3 4 5 6 7 






















































































































































































































































































































I -VI ~ I 
-155-
and three weaker sites.63 The two cleavage sites near the top of the gel in figure 
12 map to the two binding sites observed in the high resolution studies on the 
517bp fragment (see figure 9). The strongest site in figure 13 maps to a region 
of pBR322 (3235 relative to Eco RI) which includes the longest run of A•T base 
pairs in the plasmid; 15bp, 5'-TTTTAAATTAAAAAT-3'. BEDP•2Fe (0.4J.LM) 
gives more than 12 detectable bands, as well significant background cleavage under 
the same conditions. The strongest BEDP•2Fe cleavage also maps to the 3235 
site of pBR322. In contrast to BEDP•2Fe, 0.4J,tM BENP•2Fe gives only three 
cleavage bands, one of which is subtantially reduced by decreasing the BENP•2Fe 
concentration to 0.2J.LM. The higher site on the gel in figure 12 maps to the double 
binding site on the 517bp fragment observed in the high resolution studies (just 
below the arrow in figure 9 and right hand side of figure 10). The major double 
strand cleavage site for BENP•2Fe maps to the same region of pBR322, as do the 
major sites for BEDP•2Fe and BEDF•2Fe (3235). The broadness of the major 
cleavage band suggests that it may result from cleavage at more than one binding 
site in close (~40bp) proximity. It is clear from figure 12 that the redesigned hybrid 
(BENP) is significantly more specific than the original hybrid molecule BEDP. 
BENP·DNA Binding Model 
The observed facility of BENP•2Fe mediated double strand cleavage, in con-
junction with the changes in the UV /VIS spectra in the presence of DNA, suggest 
that at least some binding events involve both minor groove binding of the two 
dipyrrolecarboxamides, and, simultaneously, intercalation of the phenoxazone moe-
ity. The results of model building studies of this interaction are shown in figure 
14. A model of BENP, without the metal chelates, was docked to a 10 base 
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pair B form DNA of sequence 5'-ATTTGTTTAT-3'. This sequence is one of the 
two strong binding sites observed in the high resolution DNA cleavage studies. 
The modeling studies indicate that the dipyrrolecarboxamide units are capable 
of interacting with a sequence of the form (A/T) 4 similar to that observed in the 
NET•dodecamer complex crystal structure. The modeling studies further indicate 
that the flexability of the GABA linker is required for proper orientation of the 
dipyrrolecarboxamide units relative to the intercalated phenoxazone. Interestingly, 
the model indicates that though BENP is nearly C2 symmetric, the interactions of 
the phenoxazone carbonyls, glycyls and GABA portions of BENP with the DNA 
are highly asymmetric . This asymmetry appears to be caused by the asymmetry 
of the DNA binding site and leads to different conformations of the phenoxazone 
carbonyls and glycyl moeities. However, the remaining amides of both dipyrrole-
carboxamide domains are still properly positioned in the minor groove. 
CONCLUSION 
The design, synthesis and testing of two DNA binding molecules that are hy-
brids of the natural products, distamycin/netropsin and actinomycin have been 
described. These molecules are hybrids in two other senses as well. They address 
the issue of where one can mix (and match) groove binders with intercalators, and 
they address the issue of whether one can couple A•T 'words' with G•C 'words'. 
We have found that bis(distamycin-glycyl)phenoxazone will apparently bind 10 
base pairs of DNA of general sequence (A•T)4 (G•Ch(A•T) 4 . However, not all sites 
allow simultaneous binding of the groove binders, suggesting that the extent and 
nature of the distortion of the sequences flanking the intercalator may be sequence 
dependent. Additionally, double strand cleavage of a 4363bp DNA fragment with 
Figure 14: Model of bis(netropsin-glycyl-GABA)phenoxazone bound to a 10 
base pair psuedo-B form DNA. (Top) Stereo drawing of the complex. (Bottom, 
left to right) Spacefilling models of the DNA with an empty intercalation pocket , 
BENP and the complex. In both models only heteroatom hydrogens are included. 
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BEDP shows a large number of weak cleavage sites , indicating that its sequence 
specific DNA binding is not optimized. A second generation hybrid, bis(netropsin-
glycyl-GABA)phenoxazone, has shown improved sequence specific DNA binding 
ability and highly efficient and specific DNA double strand cleavage ability. 
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Experimental 
See the experimental section for Chapter I for general comments and procedures 
used in the preparation of 32P end-labelled restriction fragments. The following 
procedure for the preparation of nitro acid 1 is a modification of a published 
procedure17•66 which is easier for large scale preps and gives a higher overall yield. 
N-Methyl-4-nitropyrrole-2-carboxylic acid, la:17•66 A solution of 100g 
(0.71mmol) N-methylpyrrole-2-carboxylic acid (Aldrich, 97+%) in 600ml acetic 
anhydride was cooled to -25°C in dry ice/ acetone. A solution of 80ml concentrated 
nitric acid in 380ml acetic anhydride (prepared cold) was slowly added over 75 
minutes with vigorous mechanical stirring and without allowing the temperature 
to rise above -20°C. After the addition was completed, the mixture was stirred an 
additional 3 hours at -25°C and one hour at --10°C. The resulting black solution 
was poured (carefully) into one liter of ice and stirred for two hours at room 
temperature. The solution (2.61) was refrigerated (-20°C) overnight during which 
time brown crystals formed. The crystals were removed by filtration and washed 
with water until the washes were colorless. Drying under vacuum at 40°C gave 
60.6g (50%) la as light brown needles. NMR analysis indicated 97% 4-nitro and 
3% 5-nitro products. Recrystallization from 300ml of 1:1 acetic acid/water at -20°C 
followed by filtration, water washing and vacuum drying gave 57.4g (48%) la as a 
light tan material which was pure by NMR (NMR detection limit of 5-nitro acid and 
starting material is less than 1%): NMR (D6-DMSO) 6 8.25 (d, 1H, j=2Hz), 7.25 
(d, 1H, j=2Hz), 3.9 (s, 3H) . The supernatants from the original reaction mixture 
were extracted with dichloromethane (3x600ml), dried (Na2S04) and stripped, 
giving 50g of material, which was recrystalized as described above. NMR analysis 
of the tan colored product {28g, 23%) indicated 60% 5-nitro acid, 39% 4-nitro acid 
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and 1% starting material by weight. Further recrystallizations removed starting 
material, but the 6:2 ratio of 5- and 4-nitro acid products remained constant. Pure 
N-methyl-4-nitropyrrole-2-carbo:xylic acid methyl ester, 1b, can be obtained from 
this mixture by esterification followed by chromatography on alumina. 17•66 
N-Methyl-4-nitropyrrole-2-carboxylic acid methyl ester, 1b:17•66 To a 
cold solution of 17ml concentrated sulphuric acid and 175ml methanol were added 
17.1g (O.lOmmol) nitro acid. The solution was refluxed for 15 hours, then cooled 
to 0°C. The product was removed by filtration , washed with 5% sodium bicar-
bonate and water and dried in vacuo, giving 14.6g (79%) 1b as off-white needles: 
NMR (CDC13) 8 7.1 (d, 1H, j=5Hz), 6.85 (d, lH, j=5Hz),4.3 (s, 3H), 3.85 (s, 
3H) . Concentration of the supernatants afforded 1.5g (8 .8%) recovery of start ing 
material. 
N-Methyl-4-(N-methyl-4-nitropyrrole-2-carboxamide)-pyrrole-2-carbox-
ylic acid methyl ester, 1c:17•66 In 200ml dry dimethyl formamide (DMF) was 
dissolved 14.6g (79.4mmol) nitro ester 1b. Palladium on charcoal (1.5g) was added 
and the mixture hydrogenated under 1 atm hydrogen for 3 hours. The catalyst 
was removed by filtration through celite, giving a transparent black solution to 
which 20ml (0.2mol) triethylamine were added. N-methyl-pyrrole-2-carboxyl chlo-
ride (prepared by refluxing 14.8g (87mmol) nitro acid 1a in 50ml thionyl chloride 
for two hours, followed by vacuum distillation of the excess thionyl chloride) in 
50ml DMF was added to the filtered hydrogenation mixture and stirred overnight . 
Ice water ( 400ml) was added, the solution stirred for 20 minutes at room temper-
ature and cooled to 0°C. The product was filtered , washed with 10% bicarbonate, 
water and cold methanol and dried in vacuo . Trituration with diethyl ether and 
redrying removed the last traces of DMF giving 22g (90%) of light yellow-green 
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nitro ester lc: NMR (D6-DMSO) 8 10.3 (s, 1H), 8.2 (d, 1H, j=1.5Hz), 7.6 (d, 1H, 
j=2.0Hz), 7.5 (d, 1H,j=l.5Hz), 6.9 (d, 1H,j=l.5Hz), 4.0 (s, 3H), 3.85 (s, 3H), 3.75 
(s , 3H). 
N- Me thy 1-4- [N- me thy 1-4- (N- me thy 1-4-nitropyrrole-2-car boxamide) -
pyrrole-2-carboxamide]-pyrrole-2-carboxylic acid methyl ester, ld:17,66 
Nitro ester lc (21g, 69mmol) was dissolved in 200ml DMF with 1g palladium on 
charcoal and hydrogenated under 1 atm hydrogen for 24 hours. The catalyst was 
removed by filtration through celite and 26g triethylamine was added to the black 
solution. N-methyl-4-nitropyrrole-2-carboxyl chloride (from 12.5g, 73mmol, la) 
in 75ml DMF was added and the solution stirred overnight. The product was 
removed by filtration and washed with 10% bicarbonate, water, cold methanol and 
ether followed by drying in vacuo. The light yellow-green solid was finely ground 
and digested in 1400ml boiling methanol for 15 minutes. Cooling to 0°C, filtering, 
washing (methanol and ether) and vacuum drying gave 22.5g (77%) of ld as yellow 
crystals: NMR (D6-DMSO) 810.35 (s, 1H), 10.00 (s, 1H), 8.2 (d, 1H, j=l.5Hz), 
7.60 (d, 1H, j=l.5Hz),7.50 (d, 1H, j=1.5Hz), 7.05 (s, 1H, j=1.5Hz), 6.9 (d, 1H, 
j=l.5Hz), 4.0 (s, 3H), 3.83 (s, 3H), 3.75 (s, 3H). 
N -Methyl-4- [N -methyl-4- (N -methyl-4-nitropyrrole-2-carboxamide) 
-pyrrole-2-carboxamide]-pyrrole-2-carboxylic acid, 1:17,66 A solution 
of 1.6g ( 41mmol) sodium hydroxide in 70ml water was added to a suspension of 
2.0g (4.7mmol) ld in 70ml ethanol. The mixture was refiuxed 3 hours and the 
ethanol removed on a rotovap. The aqueous solution was diluted to 200ml with 
water and then slowly acidified with 6N hydrochloric acid to pH 1. The product 
was removed by filtration and washed with cold 1:1 methanol/ water and acetone. 
Vacuum drying gave 1.8g (93%) of yellow solid 1: NMR (D6-DMSO) 8 3.84 (s, 3H), 
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3.87 (s, 3H), 3.97 (s, 3H), 6.85 (d, 1H, j=1.5Hz), 7.10 (d, 1H, j=l.5Hz), 7.25 (d, 
1H,j=l.5Hz), 7.26 (d, 1H,j= l.5Hz), 7.45 (d, 1H,j=l.5Hz), 7.65 (d, 1H,j=l.5Hz), 
8.2 (d, 1H, j=l.5Hz), 9.95 (s, 1H), 10.35 (s, 1H); UV/VIS (H20) 391 (€=35,600), 
236nm. 
3- (t- Butylcarbamide)- 31 - diamino- N- methyldipropylamine, 7: To 5g 
(34mmol) 3,3'-diamino-N-methyldipropylamine (Aldrich) were added 1.9g (8.7 
mmol) di-t-butyldicarbonate (Fluka) and the mixture held at 50°C for one hour. 
\ 
The mixture was diluted with 30ml water and extracted with dichloromethane 
(3x30ml) . The organic layer was stripped and the crude product chromatagraphed 
with 12% concentrated aqueous ammonium in methanol. Drying in vacuo gave 
0.7lg (34%) 7 as a colorless liquid which was pure by TLC: NMR (CDC13) {; 5.75 
(broad singlet, 1H) 3.13 (p, 2H,j=6Hz), 2.73 (t, 2H,j=6Hz), 2.37 (t, 4H,j=6.8Hz), 
2.17 (s, 3H) , 1.7 (m, 6H), 1.49 (s, 9H). 
Nitro-tripyrrolecarboxamide-linker- t- boc, 2: To a cold (0°C) solution of 
1.16g (2.8 mmol) 1 and 0.91g (6.7mmol) N-hydroxybenzotriazole monohydrate in 
50ml DMF were added 0.69g (3.4mmol) dicyclohexylcarbodiimide. The mixture 
was allowed to warm to room temperature overnight with stirring. A solution 
of 0.72g (2.9mmol) 7 in 5ml DMF was added and stirring continued for 15 hours. 
Dicyclohexylurea was removed by filtration followed by removal of DMF in vacuo at 
40°C. After triturating with ether (3x) , the crude product was chromatagraphed 
with 0.25% concentrated aqueous ammonia in methanol, giving 1.4g (79%) 2 as a 
yellow solid: NMR (D6-DMSO) {; 10.25 (s, 1H), 9.90 (s, 1H), 8.14 (d, 1H, j=l.5Hz) , 
8.00 (m, 1H), 7.57 (d, 1H, j=1.5Hz), 7.22 (d, 1H, j=1.5Hz) , 7.19 (d, 1H, j=1.5Hz), 
7.02 (d, 1H, j=l.5Hz), 6.80 (d, lH, j =1.5Hz) , 6.7 (m, 1H), 3.92 (s, 3H), 3.83 (s, 
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3H), 3.78 (s, 3H), 3.2 (m, 4H), 3.25 (m, 4H), 2.12 (s, 3H), 1.6 (m, 4H), 1.37 (s, 
9H) . 
2-Nitro-3-benzyloxy-4-methylbenzoic acid, 3:67 A solution of 13.8g (0.25mol) 
freshly powdered pottassium hydroxide in 50ml DMSO was stirred for 5 minutes 
followed by the addition of 5g (25mmol) 2-nitro-3-hydroxy-4-methylbenzoic acid 
(Aldrich) and 12ml (96mmol) a:-chlorotoluene (Aldrich). After stirring for three 
hours, 190ml of water was added and the mixture extracted with ether (2x100ml) 
to remove excess a:-chlorotoluene. The aqueous layer was acidified to pH 1 with 
concentrated hydrocloric acid and extracted with ether (2x100ml). These ether 
extracts were washed with a 50% brine solution (4x50ml), dried (Na2S04) and 
stripped. Drying in vacuum gave 7.1g (97%) 3 as a light yellow solid: NMR 
(CDC13) 6 8.2 (broad singlet, 1H), 8.8 (d, 1H, j=7.5Hz), 7.4 (m, 7H), 4.91 (s, 2H), 
2.33 (s, 3H) . 
2-Nitro-3-benzyloxyl-4-methylbenzamide glycine methyl ester, 4a:68 A 
solution of 7.0g (24mmol) 3 and 4.4g (27mmol) acydiimidazole in 60ml DMF was 
stirred for 24 hours under a dry atmosphere. N-ethylmorpholine (3.4g, 27mmol) 
and 3.4g (27mmol) glycine methyl ester hydrochloride were added and stirring 
continued for 12 hours. The reaction mixture was diluted with 600ml chloroform 
and extracted with 2.5% sodium bicarbonate (3x150ml), 5% hydrochloric acid 
(2x150ml), water (3x150ml) and saturated sodium chloride (150ml). The organic 
layer was dried (Na2S04), and the chloroform removed on a rotovap. Drying in 
vacuo gave 8.0g {91%) 4a as a cream colored solid which was pure by TLC: NMR 
(CDC13) 6 7.33 (m,7H), 6.74 (t, 1H, j=5Hz), 4.89 (s, 2H), 4.06 (d, 2H, j=5Hz), 
3.74 (s, 3H), 2.31 (s, 3H). 
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Glycine-2-nitro-3-benzyloxy-4-rnethylbenzarnide, 4b: To a solution of 
7.5g (21mmol) 4a in 250ml methanol were added 100ml of 1N lithium hydroxide 
and the mixture was stirred at room temperature for 2 hours. The methanol was 
removed on a rotovap followed by dilution with 150ml water and slow acidification 
with 6N hydrochloric acid to pH 1. The product was removed by filtration and 
washed with 0.1N hydrochloric acid and ether, followed by vacuum drying. The 
6.8g of crude product were digested in 250ml boiling chloroform then allowed to 
stand at 5°C overnight. Filtration followed by vacuum drying gave 6.5g (90%) 4b 
as marble white crystals: NMR (D6-DMSO) 8 12.7 (s, 1H), 9.12 (t, 1H, j=6Hz), 
7.59 (s, 2H), 7.41 (s, 5H), 4.94 (s, 2H), 3.86 (d, 2H, j=6Hz), 2.37 (s, 3H). 
1/2-Phenox-tripyrrolecarboxarnide-linker- t- hoc, 5a: A solution of 1.16g 
(1.81mmol) 2 and 0.2g palladium on charcoal in 3ml DMF was hydrogenated under 
one atmosphere hydrogen for 20 hours, followed by removal of the catalyst by 
filtration through celite. A solution of 0.65g (1.9mmol) 4b and 0.34g (2.1mmol) 
acydiimidazole in 0.7ml DMF, after stirring for one hour, was added to the filtered 
hydrogenation mixture and stirred overnight. DMF was removed in vacuo at room 
temperature and the crude product triturated with ether (3x). The product was 
chromatographed twice with 30% methanol in dichloromethane (at ~5ml/min from 
a 40x150mm column), giving 0.82g ( 48%) 5a as a bright yellow solid which was 
pure by TLC: NMR (D6-DMSO) 8 10.01 (s, 1H), 9.96 (s, 1H), 9.91 (s, 1H), 9.12 
(t, lH, j=5.8Hz), 8.06 (t, 1H, j=5.6Hz),7.65 (s, 2H), 7.45 (m, 5H), 7.27 (d, 1H, 
j=l.OHz), 7.20 (s, 2H), 7.06 (d, 1H, j=1.1hz), 6.96 (d, 1H, 1.2Hz), 6.86 (d, 1H, 
j=l.3Hz), 6.82 (t, 1H, j=4.8Hz), 5.00 (s, 2H), 4.01 (d,2H, j=4.3Hz), 3.87 (s, 6H), 
3.82 (s, 3H), 3.21 (q, 2H,j=5.8Hz), 2.96 (q, 2H,j=5.8Hz), 2.53 (s, 3H), 2.32 (m, 
4H), 2.16 (s, 3H), 1.64 (p, 2H, j=6.8Hz), 1.54 (p, 2H, j=6.7Hz), 1.39 (s, 9H). 
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1/2- Phenox- tripyrrolecarboxamide -linker, 5b: To a solution of 725mg 
(0. 77mmol) Sa in 15 ml dichloromethane was added 10ml trifluoracetic acid. After 
10 minutes, the mixture was slowly diluted with 75ml of ether which precipitated 
the di-trifluoracetic acid salt of 5b. The crude product was chromatographed with 
12% concentrated ammonia in methanol giving 605mg (93%) of 5b as a light yellow 
solid: NMR (D6-DMSO) S 10.21 (s, 1H), 9.95 (s, 1H), 9.90 (s, 1H), 9.2 (broad sin-
glet, 1H), 8.05 (t, 1H, j=6Hz), 7.65 (d, 1H, j=9Hz), 7.60 (d, 1H, j=9Hz), 7.42,(m, 
5H), 7.25 (d, 1H, l.OHz), 7.19 (s, 2H), 7.05 (d, 1H, j=1Hz), 6.94 (d, 1H, j=1Hz), 
6.83 (d, 1H, j=1Hz), 4.97 (s, 2H), 3.98 (s, 2H), 3.86 (s, 6H), 3.80 (s, 3H), 3.18 (m, 
2H), 2.56 (broad singlet, 2H), 2.43 (s, 3H), 2.31 (m, 4H), 2.13 (s, 3H), 1.62 (p, 2H, 
j=8Hz), 1.48 (p, 2H, j=7Hz). 
1/2-Phenox-tripyrrolecarboxamide-EDTA triethyl ester, 6a: A solution 
of 900mg (2.4 mmol) ethylendiamine tetraacetic acid triethyl ester69 and 410mg 
(2.5mmol) acydiimidazole in 3ml DMF was stirred under a dry atmosphere for 
one hour, followed by the addition of 466mg (0.56mmol) 5b in 0.5ml DMF. After 
stirring for 15 hours, the DMF was removed in vacuo at room temperature and the 
product triturated with ether (4x). Column chromatography with 1% concentrated 
aqueous ammonia in methanol afforded 630mg (95%) 6a as a yellow solid: NMR 
(D6-DMSO) S 9.97 (s, 1H), 9.90 (s, 1H), 9.87 (s, 1H), 9.08 (t, 1H, j=5Hz), 8.00 (t, 
1H, j=4Hz), 7.95 (t, 1H, j=5Hz), 7.64 (d, 1H, j=10Hz), 7.62 (d, 1H, j=10Hz), 7.41 
(m, 5H), 7.24 (d, 1H, j=l.5Hz), 7.16 (s, 2H), 7.03 (d, 1H, j=L5Hz), 6.93 (d, 1H, 
j=l.5Hz), 7.84 (d, 1H, j=l.5Hz), 4.96 (s, 2H), 4.05 (q, 6H, j=7Hz), 3.97 (s, 2H), 
3.85 (s, 6H), 3.79 (s, 3H), 3.50 (s, 6H), 3.12 (q, 2H,j=6.7Hz), 2.72 (t, 2H,j=6.3Hz), 
2.67 (t, 2H, j=6.3Hz), 2.42 (s, 3H), 2.31 (t, 2H, j=8.3Hz), 2.29 (t, 2H, j=8.3Hz), 
2.13 (s, 3H), 1.62 (p, 2H, j=7Hz), 1.56 (p, 2H, j=7Hz), 1.17 (t, 9H, j=7Hz). 
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1/2-Phenox-tripyrrolecarboxamide-EDTA, 6b: To a solution of 200mg 
(167 J.Lmol) 6a in 5ml of methanol was added 1.5ml of 1M lithium hydroxide and 
the mixture was allowed to stir in the dark at room temperature for 4 hours. The 
solvents were removed under reduced pressure and the product chromatagraphed 
on silica gel with 2% concentrated aqueous ammonia in methanol affording 170mg 
(91 %) 6b as a light yellow solid. NMR (1:10 trifluoroacetic acid/D6-DMSO) 8 10.00 
(s, 1H), 9.96 (s, 1H), 9.94 (s, 1H), 9.42 (bs, 1H), 9.13 (t, 1H, j=6Hz), 8.53 (t, 1H, 
j=6Hz), 8.22 (bs, 1H), 7.67 ( d, 1H, j=8Hz), 7.61 (d, 1H, j=8Hz), 7.44 (m, 4H), 7.41 
(m, lH), 7.25 (d, 1H, j=1.3Hz), 7.20 (s, 2H), 7.12 (d, 1H, j=l.3Hz), 7.01 (d, 1H, 
j=l.7Hz), 6.99 (d, 1H, j=l.3Hz), 4.99 (s, 2H), 4.07 (s, 2H), 4.01 (d, 2H, j=5Hz), 
3.98 (s, 2H), 3.94 (s, 2H), 3.88 (s, 9H), 3.85 (s, 4H), 3.36 (m, 2H), 3.30 (m, 4H), 
3.25 (q, 2H,j=6Hz), 3.08 (m, 2H), 2.81 (d, 3H,j=4Hz), 2.45 (s, 3H), 1.90 (m, 4H). 
BEDP: A mixture of 120mg (108J.Lmol) 6b and 30mg 5% palladium on carbon 
in 10ml methanol was hydrogenated under one atmosphere hydrogen in the dark 
for three hours. Under an argon atmosphere the catalyst was removed by filtra-
tion through celite and the celite was washed with 2ml methanol. The solution 
was diluted with 12ml of 67mM phosphate buffer (pH 7.1) and 89mg (270J.Lmol, 
2.5eq) potassium ferricyanide in 1ml phosphate buffer was added. The solution 
was stirred for two minutes during which time it turned deep red-orange char-
acteristic of the phenoxazone moeity. The solution was allowed to stand for two 
hours, followed by removal of solvents under reduced pressure. The crude prod-
uct was dissolved in minimal water and loaded on an Amberlite XAD-2 (Kodak) 
column. The column was washed with water (150ml), 3% EDTA-Na2 {500ml) 
and water {11). BEDP was eluted with 50% aqueous methanol. The solvents 
were removed in vacuo, the product was triturated with 2ml methanol and dried; 
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67mg (68%) BEDP as a red-orange solid. UV / VIS (H20) 438nm (phenoxazone), 
305nm (pyrroles), 235nm; €305 / €438=3.0, expected €305 / €438=3.0. NMR (1:10 t ri-
fl.ouroacetic acid/ D6-DMSO) {; 10.02 (s, lH), 9.93 (s, 3H), 9.90 (s, lH), 9.83 (s, 
lH), 9.44 (bs, 2H), 9.08 (t , lH, j=6Hz) , 8.59 (t, 2H, j = 5Hz) , 8.24 (bs, lH) , 8.10 
(bs, 2H), 7.72 (d, lH, j = 8Hz), 7.46 (d, lH, j=8Hz) , 7.25 (s, lH), 7.23 (s, lH), 7.20 
(s, 4H), 7.17 (s, lH), 7.15 (s, lH), 7.07 (s, 2H), 7.02 (s, 2H), 4.44 (s, 8H), 4.03 
(s, 4H) , 4.00 (s, 8H), 3.88 (m, 18H), 3.57 (s, 3H), 3.52 (q, 6H, j=7Hz) , 3.48 (m , 
6H), 3.34 (bs, 4H), 3.29 (q, 6H, j=7Hz), 3.21 (m, 4H), 3.14 (m, 4H), 2.84 (d, 6H, 
j=4Hz), 2.56 (s, 3H), 2.20 (s, 3H) , 1.95 (m, 8H) . 
N -Methyl-4- (N -methyl-4-nitropyrrole- 2-carboxamide) -pyrrole- 2-car-
boxylic acid, 8: To a suspension of 2g (6.5mmol) le in 80ml ethanol was added 
a solution of 1.5g (37.5mmol) sodium hydroxide in 80ml water and the mixture re-
fl.uxed for 3.5hr. The solution was cooled and concentrated to lOOm! under vaccum. 
After acidification with 6N HCl, the product was removed by filtration, washed 
with water and dried to give 1.99g (104%) 8 as a yellow-green solid. NMR (D6-
DMSO) 810.24 (s, lH), 8.16 (d, j=2Hz, lH) , 7.56 (d, j=2Hz, lH), 7.41 (s, lH), 
6.83 (d, j=2Hz, lH), 3.94 (s, 3H), 3.83 (s, 3H). 
9: To a cold (0°C) solution of 300mg (1.03mmol) 8, 277mg (l.lmmol, l.leq) 7 
and 303mg (2.3mmol, 2.2eq) N-hyroxybenzotriazole monohydrate in lOml DMF 
was added 254mg (1.2mmol, 1.2eq) N,N'-dicyclohexylcarbodiimide. The solu-
tion was allowed to warm to room temperature over 16hrs. Dicyclohexylurea 
was removed by filtration and the solvents removed under vacuum at 30-40°C . 
The crude product was triturated with diethyl ether (3x) and dried. Chro-
matography with 0.3% concentrated aqueous ammonium hydroxide, 15% methanol 
in dichloromethane followed by re-chromatography of the mixed fractions with 
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0.5% concentrated aqueous ammonium hydroxide in methanol, afforded 381mg 
(71 %) 9 as a yellow solid which was pure by TLC. NMR (D6-DMSO) 810.25 (s, 
1H), 8.18 (d, j=l.7Hz, 1H), 8.13 (bs, 1H), 7.59 (d, j=2.2Hz, 1H), 7.21 (d, j=l.7Hz, 
lH), 6.85 (bs, 2H), 3.96 (s, 3H), 3.82 (s, 3H), 3.35 (m, 4H), 3.22 (m, 2H), 2.95 (t, 
j=5.6Hz, 2H), 1.71 (bs, 2H), 1.62 (bs, 2H), 1.37 (s, 9H). 
1-Aminobutyric acid methyl ester hydrochloride: 1-Aminobutyric acid (5g, 
49mmol) was suspended in 75ml methanol and hydrogen chloride was bubbled 
through the solution for three hours. The methanol was removed on a rotovap 
followed by 12 hours in vacuo. The crude product was recrystalized from 1:2 
methanol/ether at -20°C. The extremely hydroscopic product was removed by 
filtration, washed with ether, and quickly transferred to a flask for vacuum drying, 
which gave 6.3g (86%) as white crystals which were pure by TLC: NMR (D6-
DMSO) S 8.22 (broad singlet, 3H), 3.60 (s, 3H), 2.75 (broad multiplet, 2H), 2.42 
(t, 2H, j=7Hz), 1.81 (p, 2H, j=7Hz). 
1/2-Phenox-GLY-GABA-methyl ester, lOa: In 100ml dimethoxyethane were 
placed 6g (17.4mmol) 4b and 2.55g (19.2mmol) N-hydroxysuccinamide monohy-
drate. The solution was cooled to 0°C, 4.3g(21mmol) dicyclohexylcarbodiimide was 
added, and the solution allowed to warm to room temperature overnight with stir-
ring. Dicyclohexyl urea was removed by filtration 2.7g (18mmol) 1-aminobutyric 
acid methyl ester hydrochloride and 6ml N-ethylmorpholine was added. After 
stirring for four hours, the reaction mixture was diluted with 200ml water and 
extracted with chloroform (2x50ml). The organic layer was washed with 2.5% hi-
car bonate ( 2x50ml), brine ( 1x50ml) and dried (N azS 0 4). Removal of the chloro-
form in vacuo followed by chromatography with 4% methanol in dichloromethane 
afforded 3.8g (48%) lOa which was pure by TLC: NMR (CDCl3) b 7.59 (t, 1H, 
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j=5.8Hz), 7.39 {s, 7H), 7.01 (t, 1H, j=6Hz), 4.98 (s, 2H), 4.09 {d, 2H, j=5.8Hz) , 
3.64 {s, 3H), 3.31 {q, 2H, j=6Hz), 2.4 {m, 5H), 1.84 {p, 2H, j=7Hz). 
1/2-Phenox-GLY-GABA acid, lOb: A solution of 3.7g{8.4mmol) lOa and 
72ml of 1N lithium hydroxide in 200m} methanol was stirred in the dark at room 
temperature for two hours. The methanol was removed on a rotovap, 100ml water 
were added and the solution slowly acidified with 6N hydrochloric acid to pH 1. 
The aqueous solution was extracted with ethyl acetate {3x50ml). The combined 
organic layers were washed with 0.2N hydrochloric acid (50ml) and brine (50ml). 
The ethyl acetate was removed in vacuo giving 3.2g (90%) lOb as a cotton candy 
like solid: NMR (DMOS-D6) o 8.89 (t, 1H, j=6Hz), 7.83 (t, 1H, j=6Hz), 7.56 (s, 
2H), 7.40 (3, 5H), 4.92 (s, 2H), 3.77 (d, 2H, j=6Hz), 3.09 (q, 2H, j=7Hz), 2.40 (s, 
3H), 2.18 (t, 2H, j=7Hz), 1.61 (p, 2H, j=7Hz). 
lla: A solution of 300mg (580J.Lmol) 9 and 30mg 5% palladium on carbon in 
3ml DMF was hydrogenated under 1Atm hydrogen in the dark for 48hrs at 10°C. 
The catalyst was removed by filtration through celite and the celite washed with 
DMF (3x1ml). A solution of 372mg (870J.Lmol, 1.5eq) lOa and 154mg (950J.Lmol, 
1.1eq relative to lOa) carbonyldiimidazole in 5ml DMF was stirred 6hr at room 
temperature, filtered, and added to the filtered hydrogenation mixture . The re-
sulting solution was stirred overnight in the dark followed by removal of solvent 
under reduced pressure at 35°C. The crude product was chromatographed twice 
with 0.25% concentrated aqueous ammonium hydroxide in methanol and once with 
30% methanol in dichloromethane giving 232mg (44%) lla as a yellow solid which 
was pure by TLC. NMR (D6-DMSO) 89.84 (s, 1H), 9.81 (s, 1H), 8.98 (t, j=5.6Hz, 
1H), 8.02 (t, j=5.0Hz, 1H), 7.98 (t, j=5.1Hz, 1H), 7.62 (d, j=8.1Hz, 1H), 7.59 (d, 
j=8.1Hz, 1H), 7.39 (m, 5H), 7.16 (s, 1H), 7.14 (s, 1H), 6.85 (s, 1H), 6.82 (s, 1H), 
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6.80 (m, 1H), 4.95 (s, 2H), 3.81 (s, 3H), 3.79 (s, 3H), 3.31 (s, 3H), 3.17 (m, 2H), 
3.13 (m, 2H), 2.94 (q,j=5.2Hz, 2H), 2.41 (s, 3H), 2.25 (m, 6H), 2.13 (bs, 2H), 1.71 
(p,j=6.8Hz, 2H), 1.61 (m, 2H), 1.52 (m, 2H), 1.36 (s, 9H). 
llb: To a solution of 150mg (167 J.Lmol) lla in 3ml dichloromethane was added 
2ml trifluoroacetic acid with vigorous stirring. The solution was stirred in the 
dark at room temperature for 10min followed by dilution with 15ml diethyl ether. 
The trifluoroacetate salt of the crude product was removed by filtration and chro-
matographed with 12% concentrated aqueous ammonium hydroxide in methanol 
affording 127mg (95%) llb as a light yellow solid which was pure by TLC. NMR 
(D6-DMSO) 69.87 (bs, 1H), 9.85 (s, 1H), 9.08 (bs, 2H), 8.50 (bs, 1H), 7.64 (d, 
j=7.8Hz, 1H), 7.58 (d, j=7.9Hz, 1H), 7.41 (m, 5H), 7.18 (s, 1H), 7.15 (s, 1H), 6.85 
(s, 1H), 6.80 (s, 1H), 4.95 (s, 3H), 3.80 (m, 6H), 3.18 (m, 2H), 3.12 (m, 2H), 2.41 
(s, 2H), 2.28 (m, 4H), 2.12 (s, 3H), 1.72 (p, j=7.3Hz, 2H), 1.61 (p, j=6.7Hz, 2H), 
1.53 (p, j=6.8Hz, 2H) . 
12a: A solution of 117mg (312J.Lmol, Seq) EDTA triethyl ester47 and 51mg 
(315J.Lmol) acydiimidazole in 0.5ml DMF was stirred for 2hr at room tempera-
ture. A solution of 50mg (62J.Lmol) llb in 2ml DMF was added and the resulting 
solution stirred overnight in the dark. DMF was removed under reduced pressure 
and the crude product triturated with diethyl ether (3x). Chromatography with 
1% concentrated aqueous ammonium hydroxide in methanol afforded 56mg (78%) 
12a as a yellow glass which was pure by TLC. NMR ( CDCl3) 89.34 (bs, 1H), 8.66 
(bs, 1H), 8.33 (m, 1H), 7.81 (bs, 1H), 7.71 (bs, lH), 7.36 (m, 5H), 7.28 (m, 2H), 
7.16 (s, 1H), 6.72 (s, 1H), 6.58 (s, 1H), 4.91 (s, 3H), 4.12 (m, 6H), 4.03 (bs, 2H), 
3.89 (s, 3H), 3.85 (s, 3H), 3.49 (s, 3H), 3.30 (m, 8H), 2.74 (m, 4H), 2.48 (m, 2H), 
2.39 (m, 8H), 2.31 (s, 3H), 2.19 (s, 2H), 1.89 (m, 2H), 1.71 (m, 4H), 1.24 (m, 9H), 
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12b: To a solution of 56mg ( 48t-tmol) 12a in 1ml methanol was added 0.435ml 
1N (9eq) lithium hydroxide and the resulting solution was stirred 4hrs at room 
temperature in the dark. The solvents were removed under reduced pressure and 
the crude product chromatographed with 2% concentrated aqueous ammonium 
hydroxide in methanol giving 35mg (67%) 12b as a yellow solid which was pure 
by TLC. NMR (10% trifiuoroacetic acidjD6-DMSO) 89.82 (s, 1H), 9.76 (s, 1H) , 
9.25 (bs, 1H), 8.94 (t,j=5 6. Hz, 1H), 8.43 (t,j=5 2. Hz, 1H), 8.12 (bs, 1H) , 7.93 
(t, j=5.6Hz, 1H), 7.57 (d, j=8.0Hz, 1H), 7.52 (d, j=7.8Hz, 1H), 7.35 (m, 5H), 7.10 
(s, 1H), 7.08 (s, 1H), 6.89 (s, 1H), 6.82 (s, 1H), 4.90 (s, 2H), 3.98 (s, 4H), 3.87 (s, 
2H), 3.83 (s, 4H), 3.75 (s, 6H), 3.10 (m, 12H), 2.71 (bs, 4H), 2.35 (s, 3H), 2.19 (m, 
2H), 1.79 (m, 4H), 1.66 (m, 2H), 
BENP: A solution of 35mg (33t-tmol) 12b, 10mg 5% palladium on carbon and 15t-tl 
triethylamine in 4ml methanol was hydrogenated under 1atm hydrogen in the dark 
for 3hrs. The solution was filtered through a 0.45t-tm cellulose acetate filter and 
the filter washed with 2ml methanol. To this solution was added 27mg (82t-tmol) 
potassium ferricyanide in 5ml 67mM phosphate buffer, pH 7.12. The solution 
was stirred two minutes in the dark during which time it turned deep red-orange 
characteristic of the phenoxazone moeity. After standing an additional 30min in 
the dark, the methanol was removed under reduced pressure and the remaining 
aqueous solution frozen and lyophilized. The crude product was dissolved in water 
and passed through a Chelex-100 (sodium form, Biorad) column, the eluent was 
frozen and lyphilized affording 22mg (71 %) BENP as a red-orange solid which 
was homogenous by TLC. UV /VIS (H20) 448nm (phenoxazone), 300nm (pyrroles), 
and 220nm; t 300jt448=2.65. NMR (10% trifiuoroacetic acid/D6-DMSO) 810.80 (t, 
j=2.0Hz, 1H), 9.94 (d, j=6.0Hz, 2H), 9.83 (d, j=6.0Hz, 2H), 9.35 (m, 4H), 8.98 (t, 
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j=4.7Hz, 1H), 8.50 (m, 2H), 8.19 (m, 2H), 8.09 (m, 1H), 7.92 (m, 1H), 7.66 (d, 
j=7.9Hz, 1H), 7.44 (d, j=7.7Hz, 1H) , 7.19 (s, 2H), 7.13 (s, 1H), 7.11 (s, lH), 6.96 
(s, 2H), 6.91 (s, 1H), 6.89 (s, 1H), 4.11 (s, 4H), 3.98 (s, 4H), 3.93 (s, 8H), 3.85 (m, 
12H), 3.39 (m, 4H), 3.25 (m, 16H), 3.17 (m, 8H), 3.05 (m, 4H), 2.79 (m, 6H), 2.30 
(m, 4H), 2.16 (s, 3H), 1.87 (m, 12H), 1.79 (m, 8H), 1.28 (s, 2H) . 
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CHAPTER III: 
Bleomycin-Distamycin Hybrid Affinity Cleaving Molecules 
As in the work described in Chapter II of this report, this chapter describes 
work aimed at the design, synthesis and characterization of hybrids of two naturally 
occurring sequence specific DNA binding compounds. In particular we will attempt 
to modify the A+T specificity of distamycin-like (DST) tripyrrolecarboxamides by 
incorporating the putative 5'-GC recognition domain of bleomycin (BLM). 
Bleomycin 
The bleomycins (figure 1) are a family of naturally occurring glycopeptide 
derived antibiotics that were first discovered in the 1960's by Umezawa and 
coworkers.1- 4 BLM has been used clinically against certain malignant lymphomas 
and squamous cell carcinomas4 where its therapeutic activity is believed to be re-
lated to its ability to bind to and degrade DNA.5 Numerous studies of BLM in-
duced DNA degradation have established that DNA strand scission requires molec-
ular oxygen and a metal ion, with Fe(II) (see figure lb) being the most active and 
most extensively studied. 6 - 10 
Chemical degradation studies,3 as well as total synthesis, 11•12 indicate that 
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Figure 1: (Top) The three domains of bleomycin A2. (Bottom) A proposed 
structure for the iron chelate of bleomycin.5 
moeities are believed to be required for cellular transport, 13 the pyrimidine, {3-
aminoalanine and /3-hydroxyimidazole for metal binding, and the bithiazole and 
terminal sulfonium domain for DNA recognition.14•15 
BLM preferentially cleaves the double stranded DNA sequence 5'-Pyr-G-C-
Pur at the cysteine residue16 by a specific oxidative degradation of the deoxyribose . 
Cleavage products are free nucleotide base and base propenal from the degraded 
nucleoside, and S' phosphate and 3' phosphoglycolate termini for the flanking DNA 
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sequences. 10•17•18 The observed products are consistent with a mechanism involving 
abstraction of the deoxyribose C4' hydrogen which is accessible via the DNA minor 
groove.5 Hydroxyl radical and/ or superoxide have been implicated as the hydrogen 
abstracting species.19- 21 However, the highly specific cleavage observed, i.e. only 
one deoxyribose per strand, indicates that the oxidant is not freely diffusable. 
The sequence specific DNA recognition domain of BLM has been identified 
as the bithiazole containing tripeptide-S (figure 1a). Synthetic BLM's which 
lack tripeptide-S are not competent at DNA cleavage. Furthermore, synthetic 
tripeptide-S efficiently inhibits DNA strand scission by wild type BLM, which 
indicates that the tripeptide-S is involved in DNA binding and not metal chela-
tion. The association constants for tripeptide-S and BLM in the absence of metal 
ions are essentially identical, 1.2x105M-1 and 1.4x105M-1, respectively.22•23 DNA 
binding of several tripeptide-S derivatives has been reported as shown in Table I. 
Though there is little doubt about the major role of the bithiazole contain-
ing tripeptide-S in DNA binding, the mode of binding is still controversial.5 The 
two major DNA binding models for tripeptide-S are intercalation and minor-groove 
binding. Evidence for intercalation of the bithiazole group includes a DNA unwind-
ing angle of 12° (versus 26° for ethidium)23 and an upfield shift in the 1H-NMR 
bithiazole resonances in the presences ofpoly(dAdT).22•25 However, the magnitude 
of both the unwinding angle and the 1H-NMR shifts are significantly smaller than 
those observed for compounds which have been unambigously assigned as interca-
lators, i.e. ethidium, implying that the bithiazole does not fully intercalate. The 
minor groove model for the bithiazole•DNA complex is based on the observation 
that the cleavage chemistry occurs in the minor groove and on the structural sim-
ilarities between the bithiazole and known minor groove binding molecules such 
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Table 1: DNA interactions of bithiazole derivatives. Entries marked with "-" are 
the most directly related to the Bleomycins. 
0 
A' N r -r~ !J NH-R" 
R' R" Ma reference 
-+ CH3CONHCH2CH2 ( CH2)ss+ ( CH3)z 5xlo-
3 b,c 
CH3CONHCH2CH2 (CH2)4N+H3 10-
4 - 5xlo-3 b 
C6Hs ( CH2)ss+ ( CH3)z 10-4 b 
4-thiazolyl ( CH2)ss+ ( CH3)z 10-4 b 
0 
( CH2)ss+ ( CH3)z -+ "·'t,~"' 
get c 
HO ~ CH:! 
-+ "ofi'f ~ ( CH2)ss+ ( CH3)z 3xlo-5 c : NH~ 
. 0 . 
H2N ;. CH:! HO ;. CH:! 
H H 
II NH(CH2)4NHC(NH2)f 2xlo-4 -+ c 
NH2(CH2)z NH(CH2)sNH(CH2)4NH2 6xlo-6 c 
a. Concentration for 50% inhibition of Fe•BLM-mediated DNA cleavage. 
b. From Oberley and Beuther.21 
c. From Mayer and Que.24 
as netropsin and Hoechst 3325826 (shown in figure 2). Furthermore, phleomycin, 
which contains a reduced, and hence nonplanar, bithiazole ring, also binds and 
cleaves DNA with specificity similar to BLM.27 DNA cleavage with phleomycin 
argues against a classical intercalation event. 
There is also evidence that BLM may have more than one DNA binding 
mode. 1H-NMR studies of tripeptide-825 and DNA-induced fl.uoresence quenching 







Figure 2: Comparison of the structures of netropsin, Hoechst 33258 and the 
DNA binding bithiazole portion of BLM. Arrows indicate potential hydrogen bond 
donors and acceptors. Note the common cresent shape of the three molecules with 
hydrogen bonding sites located on the concave side. 5 
mutually exclusive intercalation and minor groove binding modes for its bithiazole 
domain. Whether just one or both potential binding modes are the DNA cleaving 
modes is unclear. 
Bleomycin-Distamycin Hybrids, Design and Synthesis 
The conversion of the sequence specific DNA binding distamycin (DST) into 
a sequence specific DNA cleaving molecule by the incorporation of EDTA•Fe was 
described in the background section of Chapter II. We are concerned here with 
modifying the A+T specificity of the DST-like trypyrrolecarboxamides by in-
corporating the 5'-GC specific bithiazole domain of BLM. To this end I have 
prepared two hybrids of DST and BLM. The DST portions of the hybrids are 
tris-N-methylpyrrolecarboxamide units and the BLM portions are the bithiazole 
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Figure 3: Iron chelates of the bleomycin-distamycin hybrids EDbT and 
biDE and the bithiazole binding probes BrbT and (bT)2succinate. 
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unit of the BLM tripeptide-S. Additionaly, I have incoporated the metal chelator 
EDTA to facilitate identification of DNA binding sites. In the first hybrid, EDTA-
distamycin-bithiazole (EDbT, see figure 3), the bithiazole is coupled through its 
carboxy terminus directly to the amino terminus of the tripyrrolecarboxamide do-
main. The resulting EDbT is similar to a pyrrolecarboxamide homolog in which 
the cresent shape and extended 7f system are retained. The tripyrrolecarboxam-
ide replaces the carboxy-terminal positive charge of BLM. In the second hybrid, 
bithiazole-distamycin- EDTA (bTDE), the amino terminus of the bithiazole is 
coupled to the carboxy terminus of the tripyrrolecarboxamide domain. The result-
ing bTDE has a two carbon linker between the two domains which interupts the 
extended 7f system and provides some independence in the positioning of the two 
domains. In bTDE, the carboxy terminus positive charge of BLM is retained. 
Both EDbT and bTDE were designed to bind to DNA sequences of the form 
5'-(A•T)sGC and 5'-GC(A•T)5 . 
In addition to the two hybrid molecules, I have also prepared two bithiazole 
based molecules to try to gain insight into the mode of the BLM interaction 
with DNA. Previous work by Schultz and Dervan29 has shown that an EDTA•Fe 
equipped bithiazole does not sequence-specificaly cleave DNA. Their results, how-
ever, do not rule out the possibility that the bithiazole unit is sequence specific . It 
may be that the specificity of the bithiazole is for a mono- or dinucleotide, i.e. G 
or GC and GT, and the EDTA•Fe cleavage over several base pairs has obscured 
the specific DNA binding. Furthermore, the EDTA•Fe moeity may be too large to 
be specifically delivered to the DNA binding site by the bithiazole. To circumvent 
these possible problems I have prepared a bromoacetyl equiped bithiazole similar to 
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the bromoacetyl-tripyrrolecarboxamide of Baker and Dervan.30 Bromoacetyl com-
pounds alkylate the N3 of adenines (minor groove) and the N7 of guanines (major 
groove), which labilizes the nucleoside and cause DNA strand scission when heated 
in basic solution. The bromoacetyl function replaces the metal chelating and sugar 
domains of BLM (BrbT, figure 3) . If the bithiazole unit is competent at sequence 
specific DNA binding, the bromoacetyl induced strand scission should provide in-
formation on both binding site location and groove identity. 
A fourth compound was also prepared to examine the possibility that a bithi-
azole dimer may be more specific, and have a higher binding affinity, than the 
monomer. To investigate this possibility, the amino terminus of two bithiazole 
units was dimerized with a succinic acid linker to form· (bThsuccinate. The 
dimer retained both carboxy-terminal positive charges of BLM. 
Synthesis of EDbT 
The synthetic route to EDbT is shown in Scheme 1. The bithiazole amino acid 
methyl ester was prepared in nine steps using the published procedures from the 
BLM total synthesis.31- 35 The preparation of the tripyrrolecarboxamide starting 
material 2 was described in Chapter II of this report. The bithiazole methyl 
ester was acetylated with acetic anhydride (Sa, 92%), followed by saponification 
to give the amino capped bithiazole acid 8b in 87% yield. The tBOC-linker-
nitropyrrole carboxarnide, 2, was hydrogenated to the aminopyrrole and coupled 
to N-hydroxybenzotriazole plus dicyclohexylcarbodiimide activated 8b to afford 
9a in 70% yield. The tBOC protecting group was removed (9b, 93%), and EDTA 
triethyl ester attached via N-hydroxybenzotriazole plus dicyclohexylcarbodiimide 
mediated coupling to afford the triethyl ester of EDbT (10, 67%). Saponification 
of 10 produced EDbT in 76% yield. 
Scheme 1: 
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Synthetic route to EDTA-distamycin-bithiazole, EDbT. 
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Synthesis of bTDE 
The synthetic route to bTDE is shown in Scheme 2. Heating the bithia-
zole methyl ester31- 33 with excess N,N-dimethylaminopropyldiamine produced the 
amino capped bithiazole 4 in 91% yield. N-hydroxybenzotriazole plus dicyclo-
hexylcarbodiimide mediated coupling of 4 with nitrotripyrrolecarboxamide acid 
1 afforded 5 in 61% yield. Catalytic hydrogenation of 5, followed by reaction 
with acydiimidazole activated EDTA triethyl ester 1-aminobutyric acid amide (6), 
produced the triethyl ester of bTDE (7) in 17% yield. Saponification of 7 gave 
bTDE in 80% yield. 
Synthesis of BrbT and (bThsuccinate 
The synthetic routes to BrbT and (bT)zsuccinate are shown in Scheme 3. 
The amino-capped bithiazole 4 was alkylated with bromacetyl bromide to afford 
BrbT•HBr in 70% yield. 
Two equivalences of amino-capped bithiazole 4 were coupled to N-hyd-
roxybenzotriazole plus dicyclohexylcarbodiimide activated succinic acid to afford 
(bThsuccinate in 48% yield. 
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Scheme 2: Synthetic route to bithiazole-distamycin-EDTA, bTDE. 
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Scheme 3: Synthetic route to bromoacetyl-bithiazole, BrbT, 
and the dimer (bT)zsuccinate. 
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DNA Cleavage with EDbT·Fe and bTDE·Fe 
The gel autoradiograms for EDbT•Fe and bTDE•Fe induced DNA cleavage 
on the 167 and 517 base pair fragments from pBR322 are shown in figures 4 and 
6 , respectively. For comparison EDTA-distamycin (ED) is included in both gels. 
Histograms for these cleavage reactions are shown in figures 5 and 7. 
It is clear from the histograms that both EDbT•Fe and bTDE•Fe bind to the 
same DNA sequences as ED•Fe. The only significant difference observed between 
the bithiazole containing compounds and ED is the apparent binding site size as 
defined by the cleavage patterns. ED•Fe binds to five base pair A + T sequences, 
whereas both EDbT and bTDE apparently bind to six base pair sequences. In-
spection of the binding site sequences does not appear to indicate altered specificity 
for the bithiazole containing compounds relative to ED. In particular there is no 
evidence for preferred binding at the type of DNA sequence for which the hybrid 
molecules were designed, i.e. 51-GC(A+T)5 or 5'-(A+T)sGC. Furthermore, both 
bTDE•Fe and EDbT•Fe appear somewhat less efficient at DNA cleavage than 
ED• Fe. 
The cause of the increased apparent binding site size is unclear. If the bithia-
zoles were not contributing to DNA binding, both EDbT and bTDE should have 
the same binding site size as ED. The observed increase in site size from 5 to 6 base 
pairs may reflect attempts by the hybrids to center themselves in A+ T tracks of 
DNA in order to avoid steric clashes with the guanine 2-amino group. If this is the 
case, the hybrids are behaving somewhat like a higher homolog of DST. However 
the decrease in cleavage efficiency indicates that no significant specific interactions 
between the bithiazole and DNA occur. 
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Figure 4: Autoradiogram of the DNA cleavage products on the 517bp fragment 
from pBR322. Reaction conditions were 18,000cpm 32P end-labelled DNA, lOOJ.LM 
bp calf thymus DNA, 40mM TRIS-acetate pH 7.9. The EDTA•Fe chelates were 
equilbrated with the DNA for 30 minutes at room temperature prior to the addition 
of DTT (5mM final concentration). EDTA•Fe cleavage reactions were run for one 
hour at room temperature. BrbT reactions were run for two hours at 45°C. All 
reactions were terminated by ethanol precipitation and analyzed on an 8%, 1:20 
crosslinked, 50% urea denaturing polyacrylamide wedge gel. The gel was 0.2mm 
thick at the top and 0.4mm thick at the bottom. Lanes 1-9 and 19-21 contain 
3' labelled and lanes 10-18 and 22-24 5' labelled restriction fragment. Lanes 1 and 
10 are DNA controls and 2 and 11 Maxam-Gilbert G reactions. The remaining 
lanes contain ED•Fe, EDbT•Fe, bTDE•Fe and BrbT as indicated on the gel. 
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Figure 6: Autoradiogram of the DNA cleavage products on the 167bp fragment 
from pBR322. Reaction conditions were 18,000cpm 32P end-labelled DNA, lOOJ.LM 
bp calf thymus DNA, 40mM TRIS-acetate pH 7.9. The EDTA•Fe chelates were 
equilbrated with the DNA for 30 minutes at room temperature prior to the addition 
of DTT (5mM final concentration). EDTA•Fe cleavage reactions were run for one 
hour at room temperature. All reactions were terminated by ethanol precipitation 
and analyzed on an 8%, 1:20 crosslinked, 50% urea denaturing polyacrylamide 
wedge gel. The gel was 0.2mm thick at the top and 0.4mm thick at the bot-
tom. Lanes 1-9 contain 3' labelled and lanes 10-18 51 labelled restriction fragment. 
Lanes 1 and 10 are DNA controls and 2 and 11 Maxam-Gilbert G reactions. The 
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DNA Cleavage with BrbT 
The ability of BrbT to cleave DNA via specific alkylation of adenines and 
guanines was investigated by incubation of BrbT with 32P end-labelled DNA. 
It was found that reaction in sodium cacodylate or phosphate buffer, followed 
by heating in 10% aqueous piperidine, caused DNA cleavage at all guanine and 
some adenine residues. Additionaly, reaction in TRIS buffer at 45°C gave the 
same DNA cleavage pattern without the piperidine work-up. BrbT mediated 
DNA cleavage and cleavage histograms are shown in figures 4 and 5, respectively. 
BrbT gives strong cleavage at all G 's and weakly cleaves a subset of the A's. If 
it is assumed that BrbT alkylates (cleaves) G's in the major groove and A's m 
the minor groove, as does dimethyl sulfate, then the observed cleavage pattern 
indicates that the bithiazole is not preferentially bound to either groove of the 
DNA. Cleavage at all G's could result from either specific, and equivalent, binding 
to, and alkylation of, all G's, or, alternatively, non-specific binding and alkylation 
of only G's. On the other hand, cleavage at only certain A's indicates specific 
binding of BrbT which results in enhanced cleavage of A's in/near the binding 
site. Inspection of the histogram in figure 5 allows several conclusions about the 
recognition sequence. First, A's in tracks of three or more A's, i.e. 5'-AAA or 
5'-AAAA, are not cleaved, and double A's are only sometimes cleaved. Analysis of 
the flanking sequences around both the cleaved and uncleaved adenines indicates 
that cleavage most often occurs at 51-pyrimidine-adenine sequences. 
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DNA binding by (bT)zsuccinate 
The sequence specific DNA binding of (bT)zsuccinate was investigated by 
both MPE•Fe and Dnase I footprinting on the 167 and 517 base pair fragments 
from pBR322. (bT)zsuccinate at 25, 50 and lOOJ.LM (100J.LM bp DNA) gave no 
discernable footprints with either reagent. 
Discussion 
The DNA cleavage with BrbT indicates that though the bithiazole does ap-
pear to have some sequence specific DNA recognition ability, it is not very great . 
Furthermore, the absence of significant differences in sequence specificity for the 
hybrid molecules relative to ED, as well as the lack of detectable binding by the 
bithiazole dimer, both strongly suggest that the bithiazole is not a DNA minor 
groove binding function in the same sense as is tripyrrolecarboxamide. 
Conclusion 
Hybrids of the DNA binding domains of Bleomycin and distamycin have been 
described. The sequence specific DNA binding abilities of these hybrids have been 
investigated by affinity cleaving methods which indicate that either the bithiazole 
group of bleomycin does not bind in the minor groove of DNA, or, alternatively, its 
binding mode is not compatible, and substantially weaker, than the tripyrrolecar-
boxamide of distamycin. The DNA binding ability of bithiazole itself was examined 
by including a bromoacetyl function which causes DNA strand scission via specific 
alkylation of adenine and guanine residues. The DNA cleaving ability of the bro-
moacetyl bithiazole indicates that the bithiazole has only modest preference for 
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5'-pyrymidine-adenine sequences in the minor groove and readily alkylates all gua-
nines, presumably from the major groove. A bithiazole dimer was also investigated 
by footprinting methods, but no specific DNA binding was observed. 
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Experimental 
See Chapter II for general procedures, the synthesis of nitrotripyrrolecarboxam-
ide 1 and 7 , as well as the procedures used for the preparation of 32P end-labelled 
DNA restriction fragments. 
4: A solution of 140mg (0.52mmol) 331 - 35 in 5ml (~50mmol, 100eq) N,N-
dimethyldipropylamine was heated at 80°C for 15hrs, followed by removal of excess 
amine under reduced pressure. Chromatography with 5% concentrated aqueous 
ammonium hydroxide in methanol afforded 160mg (91 %) 4 as a colorless liquid. 
TLC (4% NH40H/ MeOH) Rr=0.27. 
1H-NMR (CDC13) 8 8.29 (t, j=6Hz, 1H), 8.11 
(s, 1H), 7.85 (s, 1H) , 3.53 (q, j = 6Hz, 2H), 3.43 (s, 2H), 3.18 (s, 2H), 2.70 (bs, 2H), 
2.43 (t, j=7Hz, 2H), 2.27 (s, 6H), 1.80 (p, j=7Hz, 2H) . 
5: A solution of 100mg (295J.Lmol) 4, 134mg (325J.Lmol, 1.1eq) 1 , 99mg (650J.Lmol, 
2.2eq) N-hydroxybenzotriazole monohydrate and 67mg (325J.Lmol, 1.1eq) dicyclo-
hexylcarbodiimide in 3ml DMF was stirred overnight under a dry atmosphere. The 
DMF was removed under reduced pressure and the crude product triturated with 
diethyl ether (3x) . Chromatography with 1:1 methanol-dichloromethane afforded 
134mg (61%) 5 as a yellow solid. TLC (4% NH40H/ dichloromethane) Rr=0.17. 
1H-NMR (D6-DMSO) 8 10.29 (s, 1H), 9.97 (s, 1H), 8.65 (t, j=6Hz, 1H), 8.24 (m, 
2H), 8.19 (d,j=2Hz, 1H), 8.15 (d,j=2Hz, 1H) , 7.60 (d,j=2Hz, 1H), 7.28 (d,j=2Hz, 
1H), 7.22 (d, j=2Hz, 1H) , 7.04 (s, 1H), 6.89 (d, j=2Hz, 1H), 3.97 (s, 3H), 3.86 (s, 
3H), 3.80 (s, 3H), 3.59 (q, j=6Hz, 2H), 3.32 (m, 4H), 2.28 (t, j=7Hz, 2H), 2.16 (s, 
6H), 1.67 (p, j=7Hz, 2H). 
EDTA triethyl ester 1-aminobutyric acid amide, 6: To a solution of 
5g (13mmol) EDTA triethyl ester36 and 1.52g (13mmol) N-hydroxysuccinimide 
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in 100ml dioxane was added, with stirring, 2.7g (13mmol) dicyclohexycarbodi-
imide in 20ml dioxane. The solution was stirred for 12 hours at room temper-
ature, filtered and the filtrate concentrated. The filtrate was then dissolved in 
lOOml dimethoxyethane and added with stirring to a solution of 2g (20mmol) 
1-aminobutyric acid and 1.68g (20mmol) sodium bicarbonate in 100ml water. 
After stirring 12 hours, the solution was concentrated under vacuum and chro-
matographed with 10% methanol in dichloromethane to give 4g (65%) 6 as a 
yellow glass. 1H-NMR (D6- DMSO) o 8.00 (t, j=5Hz, 1H), 4.08 (m, 6H), 3.53 (s, 
4H), 3.45 (s, 2H), 3.19 (s, 2H) , 3.10 (m, 2H) , 2.70 (t, j=6Hz, 2H), 2.20 (t, j=6Hz, 
2H), 1.63 (m, 2H), 1.19 (t, j=7Hz, 9H) . 
bTDE triethyl ester, 1: A solution of 100mg (136,umol) 5 and 20mg 5% palla-
dium on carbon in 2ml DMF was hydrogenated under one atmosphere hydrogen 
overnight in the dark. The hydrogenation mixture was filtered through celite and 
the celite washed with 2ml DMF. To the resulting yellow solution was added 69mg 
(150,umol, 1.1eq) 6 and 31mg (190,umol, 1.4eq) acyldiimidazole. After stirring 15 
hours, the DMF was removed under reduced pressure and the crude product tritu-
rated with diethyl ether (3x). Chromatography with 0.75% concentrated aqueous 
ammonium hydroxide in methanol afforded 27mg (17%) 7 as a yellow solid. 1H-
NMR (D6-DMSO) o 9.91 (s, 1H), 9.90 (s, 1H), 9.81 (s, 1H), 8.64 (t, j=7Hz, lH), 
8.31 (s, 1H), 8.24 (s, 1H), 8.14 (s, 1H), 7.23 (d, 1H), 7.20 (d, 1H), 7.16 (d, j=2Hz, 
1H), 7.05 (d, j=2Hz, lH), 6.90 (d, j=2Hz, 1H) , 6.88 (d, j=2Hz, 1H), 4.10 (m, 6H), 
3.85 (s, 3H), 3.83 (s, 3H), 3.80 (s, 3H), 3.60 (m, 6H), 3.50 (m, 4H), 3.20 (m, 4H), 
2.75 (m, 4H), 2.30 (m, 6H), 2.22 (m, 4H), 1.70 (m, 6H), 1.20 (m, 9H). 
bTDE: To a suspension of 22mg (19,umol) 1 in 0.5ml ethanol plus 0.25ml water 
was added 0.25ml 1N lithium hyroxide. After stirring for four hours in the dark, 
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the solvents were removed under reduced pressure at room temperature. The crude 
product was redissolved in 2ml water, filtered , frozen and lyophilized. Chromatog-
raphy with 2% concentrated aqueous ammonium hydroxide in methanol afforded 
16mg (80%) bTDE as a yellow solid. UV / VIS (H20) 212nm, 245nm, 298nm, 
(€= 46,000M-1). 1H- NMR (1:10 trifluroacetic acid- D6-DMSO) 8 9.94 (s, lH), 
9.93 (s, lH), 9.86 (s , 1H) , 9.36 (bs, 2H) , 8.66 (t, j=6Hz, lH), 8.49 (t, j = 6Hz, lH) , 
8.30 (s , 1H), 8 .28 (bs, 1H), 8.16 (s, lH) , 7.24 (d, j = 2Hz, lH), 7.21 (d, j = 2Hz, lH) , 
7.19 (d, j=2Hz, 1H) , 7.10 (d, j = 2Hz , 1H), 6.96 (d, j=2Hz, 1H), 6.91 (d, j=2Hz, 
1H) , 4 .12 (s , 2H) , 3.99 (bs, 4H), 3.90 (s, 3H), 3.86 (s, 3H), 3.83 (s, 3H), 3.63 (bs, 
4H) , 3.40 (m, 4H), 3.30 (m, 2H) , 3.20 (m, 2H), 3.16 (m, 2H), 3.00 (m, 2H), 2.82 
(m, SH), 2.32 (t, j=7Hz, 2H) , 1.96 (p, j = 7Hz, 2H) , 1.79 (p, j = 7Hz, 2H), 
Sa: To a solution of 80mg (300J.Lmol) 3 and 200J.Ll (1.4mmol) triethylamine in 2ml 
DMF was added 72J.Ll (760J,Lmol, 2.6eq) acetic anhydride. After stirring for 14 hours 
at room temperature, the DMF was removed under vacuum at room temperature. 
Chromatography with 8% methanol in dichloromethane afforded 85mg (92%) Sa 
as a white solid. 
Sb: To a solution of 81mg (270J.Lmol) Sa in 2ml 50% aqueous ethanol was added 
100mg (2.5mmol) sodium hydroxide. The resulting solution was refluxed 2.5 hours, 
followed by removal of the ethanol under reduced pressure. The resulting solution 
was acidified with 1N HCl and the water removed under vacuum. The crude 
product was dissolved in 15ml hot ethanol, cooled to room temperature and N aCl 
removed by filtration. Concentration of the supernatants afforded 67mg (87%) 8b. 
9a: A solution of 174mg (270J.Lmol) 2 and 25mg 5% palladium on carbon in Sml 
DMF was hydrogenated under one atmosphere hydrogen for 15 hours in the dark. 
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The catalyst was removed by filtration through celite and to the reulting solu-
tion was added 67mg (230J.Lmol) 8b, 76mg (500J.Lmol) N-hydrozybenzotriazole and 
56mg (271J.Lmol) dicyclohexylcarbodiimide. After stirring 14 hours in the dark, the 
DMF was removed under vacuum at room temperature and the crude product trit-
urated with diethyl ether (3x). Chromatography with 0.5% concentrated aqueous 
ammonium hydroxide in methanol afforded 140mg (70%) 9a as a yellow solid. 
9b: To a solution of 120mg (135J.Lmol) 9a in 3ml dichloromethane was added 2ml 
trifluoroacetic acid. After stirring 10 minutes, the solvents were removed under 
reduced pressure. Chromatography with 12% concentrated aqueous ammomum 
hydroxide in methanol afforded 99mg (93%) 9b as a yellow solid. 
EDbT triethyl ester, 10: A solution of 90mg (114J.Lmol) 9b, 47mg (125J.Lmol) 
EDTA triethyl ester36, 38mg (250J.Lmol) N-hydroxybenzotriazole and 26mg (125-
J.Lmol) dicyclohexylcarbodiimide in 5ml DMF was stirred 14 hours in the dark. 
Dicyclohexylurea was removed by filtration and the DMF under reduced pressure. 
The crude product was triturated with diethyl ether (3x), followed by chromatog-
raphy with 1% concentrated aqueous ammonium hydroxide in methanol to give 
89mg (67%) 10 as a yellow solid. 
EDbT: To a solution of 60mg (52J.Lmol) 10 in 1ml ethanol was added 1ml of 0.5N 
lithium hydroxide. After stirring for four hours at room temperature, the solvents 
were removed under reduced pressure. Chromatography with 2% concentrated 
aqueous ammonium hydroxide in methanol afforded 42mg (76%) EDbT as a yellow 
solid. The 500MHz 1H-NMR was consistent with the assigned structure. UV / VIS 
(H20) 220nm, 248nm (€=34,000M-
1), 304nm (€=45,000M-1). 
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BrbT: To a solution of 53mg (160J.Lmol) 4 in 10ml dichloromethane was added 15J.Ll 
(1.05eq) bromoacetyl bromide. After stirring at room temperature for 30 minutes, 
the solvents were removed under reduced pressure at room temperature. The crude 
product was chromatographed with 2% aqueous ammonium hydroxide in methanol. 
The combined fractions ( 40ml) were concentrated to 10ml and hydrogen bromide 
was bubbled through the solution, followed by final drying under reduced pressure 
to afford 62mg (70%) BrbT as a white solid. 1H-NMR (D6-DMSO) 8 8.91 (bs, 
1H) , 8.68 (bs, 1H), 8.31 (s, 1H), 8.18 (s, 1H), 5.76 (s, 2H), 4.12 (m, 2H), 3.54 (m, 
2H), 3.32 (d, j=7Hz, 6H), 3.19 (m, 4H), 2.02 (m, 2H). 
(bThsuccinate: To a cold (0°C) solution of 50mg (147J.Lmol) 4, 47mg {310J.Lmol) 
N-hydroxybenzotriazole and 8.1mg (70J.Lmol) succinic acid in Sml DMF was added 
31mg (150J.Lmol) dicyclohexylcarbodiimide. After stirring 14 hours at room tem-
perature, the DMF was removed under reduced pressure and the crude product 
triturated with diethyl ether {3x). Chromatography with 4% concentrated aqueous 
ammonium hydroxide in methanol gave 25mg ( 48%) (bThsuccinate as a white 
solid. The 400MHz 1H-NMR was consistent with the assigned structure. UV / VIS 
(H20) 285nm ( t=28,000M-1), 215nm. 
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CHAPTER IV: 
Studies In Metalloporphyrin Mediated Affinity Cleaving 
The general strategy of covalently linking a DNA-binding small molecule to a 
function capable of cleaving duplex DNA, i.e. "affinity cleaving," has been exploited 
by several groups including our own. Affinity cleaving reagents can be separated 
into two general classes; sequence specific and non-sequence specific. One of several 
examples of a non-sequence specific affinity cleaving molecule is methidiumpropyl-
EDTA-Fe(II), MPE•Fe.1•2 MPE•Fe consists of the DNA binding moiety meth-
idium3-6 covalently linked to an EDTA•Fe chelate known to cause DNA strand 
scission in the presence of a reducing agent and molecular oxygen.1•2 
There are also examples of sequence specific affinity cleaving molecules. This 
class of compounds is perhaps best exemplified by DE•Fe{II), which consists of 
the sequence specific minor groove binding N-methylpyrrole tripeptide covalently 
linked to EDTA•Fe(II) .7 The DNA binding portions of both MPE and DE are 
modeled after compounds known to have high affinity for double stranded DNA. 
MPE is derived from ethidium bromide and ED from distamycin A, a naturally 
occurring antibiotic. 
The mode of action of a different type of cleaving moiety, metalloporphyrins, 
has not been reported in detail. Several porphyrin containing affinity cleaving 
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molecules have appeared in the literature, but, to date, none have been sequence 
specific. We have undertaken the design, synthesis and characterization of a se-
quence specific affinity cleaving compound which contains a metalloporphyrin as 
the reactive moiety; porphyrin-distamycin- Fe(II), (PD•Fe(II)) . Before examining 
PD• Fe we shall first look at some of the oxidative chemistry of metalloporphrins 
in general, as well as their interactions with double stranded DNA. 
Metalloporphyrins as Oxidation Catalysts 
Oxidation reactions catalyzed by metalloporphrins have received considerable 
attention of late as potentially useful organic oxidation systems, and as models for 
the catalytic cycle of the mono-oxygenase cytochrome P-450. B-l2 Reactions studied 
have included unactivated C-H to C-OH and C-X and epoxidation of olefins. 
From a conceptual viewpoint, the oxidation reactions can be divided into two 
limiting classes: the generation of a diffusable reactive species and the genera-
t ion of a bound metal-oxygen species. In the first class, the oxidation products 
are consistent with hydroxy radical attack (and selectivity) , and are independent 
of the method of generation. Fenton type reactions10 are in this class, includ-
ing EDTA•Fe(II), tetraphenylporphinato-Fe(II) or P-450 with hydroperoxides or 
peracids.13 
Fe(II) + H 2o2 --+ Fe(III) + HO- + HO• 
HO• + substrate --+ products 
The second class of reactions is one in which the method of generation of 
the active species is reflected in the product(s). If the active oxidizing species 
is a metallo-oxygen compound, the observed products should be sensitive to the 
environment, i.e. the metal chelator, of the active species . 
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metal(ligands) + oxygen source -+ active metal-oxo species 
active metal-oxo species + substrate -+ metal(ligands) + products 
A number of metalloporphrins have been studied which appear to belong to the 
second class of reactions. Studies have been carried out on the effect of different 
metals (Fe, Mn, Cr etc.) 8•9 and oxygen sources (iodosobenzene9 and p-cyano-N,N-
dimethy laniline-N -oxide 6) on epoxidation. 
Metalloporphrin Mediated DNA Cleavage 
It has been proposed that hemin (ferriprotoporphyrin IX chloride) is im-
portant in gene expression in vivo, where it is possible that some of its effects 
are due to nicking of the DNA.14 It has also been observed that hemin, in the 
presence of a reducing agent and molecular oxygen, cleaves supercoiled plasmid 
DNA in vitro.14 Various synthetic porphyrins, such as iron(III)-meso-tetra(N-
methylpyridyl)porphines, are believed to interact with duplex DNA in several ways: 
1. Intercalate into G•C regions.15 
2 . Outside bind in A•T regions. 15 
3 . Cause strand scission in the presence of dithiothrietol and oxygen. 16•17 
Several affinity cleaving molecules which use an iron porphrin to generate DNA 
strand scission have been studied. Covalent attachment of an iron porphrin and 
a DNA intercalator produces a family of compounds which, in the presence of 2-
mercaptoethanol or sodium bisulfite and oxygen, cleave plasmid DNA 17•18 (Table 
I) . To date, the sequence specificity (if any) and cleavage products have not been re-
ported for these compounds. It seems reasonable however, to expect that sequence 
specificity is small, and since the cofactors are similar ( 0 2+ reducing agent) , the 
products should be similar to those produced by MPE•Fe. 
I 
Ia; X2 (CH2h 
lb; X· (CH2h 
lc; X= (CH2)4 
ld; X • (CH2hNH(CH2h 












HN~ NH(C~)3NH(C~)4NH(CH2hNy R 
0 0 
Table 1: Cleavage of Closed Circular DNA by Iron Porphyrin Derivatives. 
Small Cone. DNA % 
Molecule (J.LM) (J.LM bp) Cleavage 
Iaa 50 ? 67 
Ib 50 ? 67 
Ic 50 ? 69 
Id 50 ? 70 
Ie 25 ? 88 
IIab 10 100 39 
100 100 45 
lib 50 100 76 
100 100 76 
IIIb 100 100 52c 
PM2-CCC-DNA, pH 7.1, 20mM 2-mercaptoethanol, 37°C, 20min. 18 a. 
b. PM2-CCC-DNA, pH 7.8, 4mM Na2 S2 0 4 , 50mM 
NaCl, 20°C, 1hr.17 
c. Total recovery of DNA was low, reason unknown. 
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Porphyrin-Distamycin: PD 
Since metalloporphrins are capable of generating strand sc1ss1on m duplex 
DNA, we set out to design, synthesize and characterize a sequence specific affin-
ity cleaving molecule with a metalloporphyrin as the reactive moiety. Sequence 
specific delivery of the metalloporphyrin should allow us to differentiate between 
a diffusable reactive species, such as hydroxy radical, and a metal-oxo mediated 
reaction where the binding site is better defined. 
We choose a strategy similar to that used for ED; sequence specific mmor 
groove binding by a moiety related to the natural product distamycin A, covalently 
linked to a function capable of causing strand scission of double stranded DNA. 
Porphyrin-distamycin, PD, uses mesoporphyrin IX as the iron chelator, which is 
linked through one of its own side chains to a short tether. This, in turn, is linked 
to the carboxy terminus of an N-methylpyrrole tripeptide, which is known to have 
a high affinity for A+T regions of duplex DNA (see chapter II for a more detailed 
description) . 
Synthesis 
The synthesis of PD is given in Scheme I. Mesoporphyrin IX was choosen for 
two reasons; its high stability in solution (protoporphyrin IX, the natural prod-
uct, is notoriously light sensitve) and ease of preparation from readily available 
hemin chloride. Catalytic hydrogenation of hemin chloride reduces the vinyl side 
chains and removes the iron, giving mesoporphyrin IX diacid.19,2° Catalytic hy-
drogenation of 1 (see chapter II), followed by reaction with acetyl chloride gave 
2 in 86% yield. Saponification of 2 (3, 85%), followed by diimidazole mediated 
coupling with N,N-diaminopropyl-N-methyl amine, afforded 4 in 31% yield. The 
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M =Fe or Mn 
porphyrin diacid was activated with diimidazole, coupled with 4 and worked up 
in methanol, giving the porphrin free base PD (34%). Iron and manganese were 
inserted by reaction with the appropriate metal (II) chloride in refl.uxing DMF. 21 
Results 
The cleavage of duplex DNA by PD•Fe was determined by monitoring the 
conversion of supercoiled (form I) pBR322 plasmid DNA 22 to open circular (II) 
and linear forms (III)23 by non-denaturing 1% agrose gel electrophoresis followed 
by ethidium bromide staining. The introduction of one single strand break converts 
form I to II. The generation of a second single strand break within -16 base pairs 
of an existing break converts II to III.24 The results for PD•Fe and diacid•Fe are 
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t double strand cleavage 
I II III 
Table II: Cleavage of pBR322 plasmid DNA.a 
Cone % formb % DNA 
Reagent J.tM I II III recov.c 
none 97 3 0 100 
PD•Fe 100 0 0 0 0 
PD•Fe 80 46 54 0 5 
PD•Fe 40 59 41 0 60 
PD•Fe 20 90 10 0 100 
PD•Fe 1 98 2 0 100 
DIACID•Fed 100 3 92 4 100 
DIACID•Fed 10 40 60 0 100 
ED• Fee 1 26 76 1 100 
ED• Fee 0 .1 74 26 0 100 
a. Form I pBR322, reagent, buffer (40mM TRIS, SmM NaOAc, pH 7.9) and DTT (1mM) were 
allowed to react at 25°C for 2h in the dark. 
b. Corrected for the decreased stainability of form I. 
c. Total recovery of DNA as determined by densitometry; I+ II + III, ±10%. 
d. Agrees well with Mueller et at.14 
e. From Taylor et at? 
The data in Table II clearly shows that PD•Fe does not cause DNA strand 
scission at levels comparable to ED•Fe(II). At 1J.tM ED•Fe appears to be at least 40 
times more efficient than PD•Fe. PD•Fe is not even as efficient as the diacid•Fe. 14 
The last column in Table II lists the approximate total recovery of DNA calcu-
lated by summing the form I, II and III bands and comparing to the DNA standard 
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lanes. PD•Fe at concentrations greater than about 40J.LM gives very low total re-
covery of DNA. The missing DNA is not even apparent as a smear the length of 
the gel, which implies that the low recovery is not due to gross over-digestion of 
the DNA (giving a population of linear DNA's of various lengths). At high PD•Fe 
concentrations, a band was frequently observed at the beginning of the gel, i.e. did 
not migrate at all, which suggests that the low recovery may be due to PD•Fe 
induced precipitation of the DNA. Low recovery of DNA in this type of assay has 
also been reported for a hemin-bis-intercalator (compound Ill in Table I). 
In an attempt to increase the efficiency of PD•Fe cleavage, different reducing 
agents and oxygen sources were tested as cofactors under the same reaction condi-
tions. Sodium borohydride, thioethanol and sodium ascorbate (at 1mM), in place 
of DTT as the reducing agent, all gave similar or worse results. Different oxygen 
sources (iodosobenzene, m-chloroperbenzoic acid and peracetic acid at 1mM) also 
did not improve PD• Fe cleavage. 
To determine whether PD•Fe was exhibiting any sequence specificity, even 
at its low effi.cency, strand cleavage was examined on 3'- and 5'-32P labelled 516 
base pair restriction fragments from pBR322.7 The 516 fragment is known to have 
at least four strong DE•Fe cleavage sites. With 20J.LM PD•Fe at standard as-
say conditions (100J.LM base pair, 2mR/ hr•lane.), no DNA cleavage was detected. 
At higher activity levels (4mR/hr•lane) and long autoradiogram exposures (three 
times normal), faint but even cutting was observed, and was indistinguishable from 
the background obtained without PD•Fe. It appears then, that PD•Fe does not 
sequence specifically cleave, and therefore bind, duplex DNA. 
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Discussion 
Since PD•Fe is not an affinity cleaving molecule, the obvious question is why. 
Iron porphyrins do cause DNA cleavage (Table I), and covalent attachment of 
a DNA cleaving function to distamycin gives an efficient sequence specific DNA 
cleaving molecule, i.e. ED. PD•Fe is not only not sequence specific, it is also 
less efficient at causing strand scission than diacid•Fe. It appears that the 1ron 
porphyrin is interfering with the binding of the pyrrole tripeptide and the pyrrole 
tripeptide is interfering with the iron porphyrin's ability to cleave DNA. 
The exact nature of the interactions which prevent PD•Fe from behaving as 
expected are unknown. One possible cause of low cleavage/binding affinity is ag-
gregation of PD due to hydrophobic effects and/ or J.L-oxo dimer formation. 25•26 
Supporting evidence for aggregation effects is found in the low solubility of PD• Fe 
in the aqueous reaction mixture (saturated solution of PD<0.5m.M) . ED•Fe is at 
least an order of magnitude more soluble than PD• Fe. An alternative cause of the 
low binding affinity is the stearic bulk of the porphyrin ring system, which may 
prevent the tripyrrole from binding in the minor groove of DNA. A third possible 
cause of low cleavage efficiency is intramolecular chelation of the iron-porphyrin by 
the tripyrrole unit . Intramolecular chelation could block both proper DNA binding 
by the tripyrrole and inhibit the redox chemistry of the metalloporphyrin. 
The difference in cleavage efficiency of two molecules with the same DNA bind-
ing unit, methidium, but different cleaving functions (EDTA•Fe versus TPP•Fe) , 
is of interest (Figure 1). It appears that the EDTA version is effective at reagent 
concentrations that are two to three orders of magnitude lower than for the por-
phyrin version. This particular porphyrin even has the advantage of the spermine 
0 0 
NH ~0 
\ o (N\/'r=o 




[MPE•Fe(II)] = 10-7M 
[DNA] = 10-5Mbp 
Form II= 91% 




HN~ NH(CH2)3NH(CH2)4 NH(CH2hNy R 
0 0 
[lib] = 10-4M 
[DNA] = 10-4Mbp 
Form II = 76% 
(20°C, lh, 4mM Na2S204) 
Figure 1: Comparson of the efficiences of two Fe-chelate equiped ethidium based 
DNA cleaving molecules. 
linker whose positive charges (the two amines at pH 7.8) should increase the overall 
binding affinity electrostatically. If the same pattern is followed in DE and PD, 
and since DE cuts efficiently at 10-6M, PD concentrations of about 10-4M should 
be needed. Unfortunately, 10-4M PD is too high a concentration for meaningful 
analysis (Table II), since it is apparently near the solubility limit and the reagent 
to base pair ratio is excessively high (10 PD•Fe:bp) . 
Conclusion 
The design, synthesis and DNA binding/cleaving ability of PD•Fe was de-
scribed. PD• Fe consists of iron-mesoporphyrin IX coupled to the sequence specific 
DNA binding N-methylpyrrole tripeptide. PD•Fe was found to be very inefficient 
at cleaving duplex DNA and to exhibit no detectable sequence specificity. 
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Experimental 
See the experimental sections for Chapter I, II and III for general comments. 
N-methyl-4-[N-methyl-4-(N-methyl-4-(acetamide)pyrrole-2-carboxam-
ide)-pyrrole-2-carboxamide]-pyrrole-2-carboxylic acid methyl ester, 2: 
A solution of 8.0g (19mmol) nitro ester 1 (Chapter II) and 1g palladium on char-
coal in 100ml DMF was hydrogenated under 1atm hydrogen for 15 hours. The 
catalyst was removed by filtration through celite and a solution of 9.4g (93mmol) 
triethylamine and 4.4g (56mmol) acetyl chloride in 10ml DMF was added. The 
solution was stirred over night. The reaction mixture was concentrated under 
reduced pressure to 50ml and diluted with 100ml cold water. The product was 
removed by filtration, washed with water, cold methanol and ether followed by 
vacuum drying. Recrystalization from 2:3 methanol/water gave 7.0g (86%) 2 as a 
yellow solid: NMR (D6-DMSO) S 9.1 (s, 2H), 9.80 (s, 1H), 7.45 (d, 1H, j=2Hz), 
7.21 (d, 1H,j=2Hz), 7.13 (d, 1H,j=2Hz), 7.05 (d, 1H,j=2Hz), 6.90 (d, 1H,j=2Hz), 
6.84 (d, 1H, j=2Hz), 3.88 (s, 9H), 3.74 (s, 3H), 1.97 (s, 3H). 
N-Methyl-4-[N-methyl-4-(N-methyl-4-(acetamide)-pyrrole-2-carboxam-
ide)-pyrrole-2-carboxamide]-pyrrole -2-carboxylic acid, 3: A solution of 
2.6g (5.9mmol) 2 and 2.5g (64mmol) sodium hydroxide in 1:1 ethanol/water was 
refluxed for two hours. The ethanol was removed on a rotovap and the aqueous 
solution slowly acidified with 6N hydrochloric acid. The product was removed by 
filtration, washed with 0.1N hydrochloric acid and cold methanol, and dried un-
der vacuum giving 2.1g (86%) 3: NMR (D6-DMSO) S 9.90 (s, 2H), 9.82 (s, 1H), 
7.40 (d, 1H, j=1.5Hz), 7.21 (d, 1H, j=l.5Hz), 7.14 (d, 1H, j=l.5Hz), 7.05 (d, 1H, 
j=l.5Hz), 6.83 (d, 2H, j=1, 5Hz), 3.82 (s, 9H), 1.93 (s, 3H). 
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P3-linker, 4: A solution of 2.5g (15mmol) carbonyl diimidazole in 10ml DMF 
was added to 3.3g (7.8mmol) 3 in 60ml DMF. After stirring for five hours, llg 
(78mmol) N, N-di(3-amino-propyl)-N-methyl amine were added and stirring con-
tinued overnight. DMF was removed under reduced pressure and the product 
triturated three times with ether. Chromatography with 10% concentrated aque-
ous ammonia in methanol gave 1.4g (31 %) 4 as a bright yellow solid: NMR (D6-
DMSO) 8 9.88 (s, 1H), 9.86 (s, 1H), 9 .78 (s, 1H) , 8.02 (t, 1H, j=5Hz), 7.25 (s , 1H), 
7.19 (s, 1H), 7.15 (s, 1H), 7.05 (s, 1H), 6.88 (s, 1H), 6.84 (s, 1H), 3.86 (s, 3H), 3.84 
(s, 3H), 3.80 (s, 3H), 3.20 (m, 2H), 3.08 (broad singlet, 2H), 2.68 (m, 6H), 2.15 
(s, 3H), 1.96 (s, 3H), 1.62 (p, 2H, j=8Hz), 2.50 (p, 2H, j=8Hz); UV / VIS (H20) 
302nm (€=32,000), 233nm (€=27,000). 
PD: In 4ml DMF was placed 100mg (0:16mmol) mesoporphyrin IX dihydro-
chloride19•20 and 80mg (0.52mmol) acydiimidazole. After stirring for five hours, a 
solution of 86mg (0.16mmol) 4 in 1ml DMF was added and the solution stirred 
overnight. Another 30mg (0.16mmol) acydiimidazole were added, the solution 
stirred two hours, and 4ml methanol added. After stirring overnight, the solvents 
were removed under reduced pressure at 35°C and the product was triturated 
three times with ether. Chromatography with 3% concentrated aqueous ammonia 
in methanol afforded 60mg (34%) PD as a purple solid: NMR (D6-DMSO) 8 10.27 
(s, 1H), 10.14 (s, 1H), 9.91 (s, 1H), 9.88 (s, 1H) , 9.83 (s, 1H), 7.98 (broad singlet, 
1H), 7.88 (broad singlet, 1H), 7.26 (s, 1H), 7.18 (s, lH), 7.15 (s, 1H), 7.08 (s, 1H), 
6.89 (s, 1H), 6.80 (s, 1H), 4.35 (broad singlet, 4H), 4.08 (broad singlet, 4H), 3.80 (s, 
9H), 3.73 (s, 3H), 3.62 (s, 6H), 3.59 (s, 6H), 3.11 (broad singlet, 4H), 3.02 (broad 
singlet, 6H), 2.03 (s, 3H), 1.84 (s, 3H), 1.80 (broad singlet, 6H), 1.68 (m, 2H), 1.33 
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(broad singlet, 2H), 1.24 (broad singlet, 2H), -4.04 (s, 2H); UV / VIS (methanol) 
615, 565, 530, 496, 390, 305, 235, 210nm. 
Metal Insertion: Iron and manganese were inserted by adding 1.1 equivalence 
of the appropriate metal (II) chloride to a refiuxing solution of the porphyrin in 
DMF.21 The solution was heated until a small aliquot was no longer bright red 
under long wavelength UV on a TLC plate. The DMF was removed under reduced 
pressure and the product triturated three times with ether. Metal insertion was 
confirmed by changes in the adsorption spectra characteristic of iron (III) and 
manganese (III) mesoporphyrins. 27 •28 
-220-
References and Notes 
1. Hertzberg, R. P., Dervan, P. B., J. Am. Chem. Soc., 104, 313 (1982) . 
2. Hertzberg, R. P., Dervan, P. B., Biochemistry, 23, 3934 (1984). 
3. Bresloff, J. L., Crothers, D. M., J. Mol. Bioi., 95, 103 (1975). 
4 . Bauer, W., Vinograd, J., J. Mol. Bioi., 33, 141 (1968). 
5. LePecq, J. B., Paoletti, C., J. Mol. Bioi., 27, 87 (1967). 
6. Waring, M. J. in "The Molecular Basis of Antibiotic Action" Wiley: New 
York, 1981, p. 274-306. 
7 . Taylor, J. S., Schultz, P. G., Dervan, P. B., Tetrahedron, 40, 457 (1984). 
8. Groves, J. T., Haushalter, R. C., Nakamura, M., Nemo, T. E., Evans, B. J., J. 
Am. Chem. Soc., 103, 2884 (1981). 
9 . Groves, J. T., Nemo, T. E., J. Am. Chem. Soc., 105, 5786 (1983). 
10. Tabushi, I., Yazaki, A., J. Am. Chem. Soc., 103, 7371 (1981). 
11. Nee, M. W., Bruice, T. C., J. Am. Chem. Soc., 104, 6123 (1982). 
12. Chank, C. K., Kuo, M. S., J. Am. Chem. Soc., 101, 3413 (1979) . 
13. Walling, C., Accts. Chem. Res. , 8, 125 (1975). 
14. Mueller, G. C., Aft, R. L., J. Biological Chem., 19, 12069 (1983). 
15. Pasternak, R. F., Gibbs, E. J., Villafranca, R. J., Biochemistry, 22, 2406 
(1983). 
16. Byrnes, R. W ., Fiel, E . J . in "Conversation in Biomolecular Stereodynamics 
III, Collected Abstracts", State University of New York, New York, 1983, p. 
126. 
17. Hashimoto, Y ., Lee, C. -S., Shudo, K., Okamato, T., Tetrahedron Lett., 24, 
1523 (1983). 
18. Lown, J. W., Joshua, A. V ., J. Chem. Soc., Chem. Commun., 1298 (1982). 
19. Corwin, A. H., Erdman, J. G., J. Am. Chem. Soc., 68, 2473 (1946). 
20. Caughey, T. et al., J. Org. Chem., 31, 2631 (1966). 
-221-
21. Adler, A. D., Longo, F. R., Kamps, F., Kim, J., J. Inorg. Nucl. Chern., 32, 
2443 (1970). 
22. The entire sequence of pBR322 has been determined: Sutcliffe, J. G. Cold 
Spring Harbor Symposium Quant. Biol., (1982). However an error has been 
found in the original sequence: Peden, K. W. C., Gene, 22 , 277, (1983). 
23. Johnson, P . J., Grossman, L. 1., Biochemistry, 16, 4217 (1977). 
24. Friefelder, D., Biopolymers, 1, 681 (1969). 
25. Fleischer, E. B., Srivastava, T . S., J. Am. Chern. Soc., 91, 2403 (1969). 
26. Cohen, I. A., J . Am. Chern. Soc., 91, 1980 (1969). 
27. Collman, J. P ., Gagne, R. R., Reed, C. A., Halbert, T . R ., Lang, G., Robin-
son, W. T ., J . Am. Chern. Soc., 97, 1427 (1975) . 
28. "The Porphyrins" vol. I and II, Dolphin, D., Ed., Academic Press, New York, 
1978. 
